New dioxa and oxaza-tricyclononanes and study of their biological activity by Vidal Pascual, María
NEW DIOXA AND OXAZA-TRICYCLONONANES  
AND STUDY OF  
THEIR BIOLOGICAL ACTIVITY 
 
 
 
 
 
 
 
 
Vom Fachbereich Chemie 
der Universität Hannover 
 
 
zur Erlangung des Grades 
 
 
 
 
Doktor der Naturwissenschaften 
–– Dr. rer. nat. –– 
 
 
 
genehmigte Dissertation 
 
 
 
 
von 
 
 
María Vidal Pascual M.Sc. 
geboren am 30.09.1967  
in Madrid / Spain 
 
2003 
  
Hiermit versichere ich and Eides Statt, die vorliegende Dissertation selbständing 
durchgeführt und keine unerlaubte Hilfe in Anspruch genommen zu haben. Die aus 
fremden Quellen übernommenen Gedanken sind als solche kenntlich gemacht. 
 
Hannover, im Juni 2003 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Referent:       Prof. H. M. R. Hoffmann, PhD, DSc 
Korreferent:  Prof. Dr. H. Meyer 
Tag der Prüfung: 31.07.2003 
 
 
 
KURZFASSUNG 
María Vidal Pascual 
 
New Dioxa and Oxaza-tricyclononanes and Study of their Biological Activity 
Mehrere Naturstoffe, die einen Oxetanring in ihrer Struktur besitzen, zeigen 
interessante pharmakologische Eigenschaften. In dieser Doktorarbeit wurden eine Reihe 
neuer oxygenierter 2,7-Dioxatricyclo[4.2.1.0]nonan ausgehend von funktionalisiertem 8-
Oxabicyclo[3.2.1]oct-6-en-3-on synthetisiert. 
Als Vorläufersubstanzen für die Dioxatricyclen dienten tricyclische Epoxyalkohole 
mit verschiedenen Etherfunktionalitäten (Methyl, Ethyl und Propyl) an der C3-Position. 
Hierbei erwies sich der Methylether als beste Schutzgruppe zur Herstellung des 
dioxatricyclischen Systems. Dieser Dioxatricyclus kann zur Herstellung pharmakologisch 
aktiver C-Glycoside und Glycosidmimetica benutzt werden. 
Die PCC-Oxidation der Hydroxygruppe der tricyclischen Struktur 4a-Methoxy-
2,7-dioxatricyclo[4.2.1.03,8]nonan-6-on generiert das tricyclische Lacton 9a-Methoxy-
2,4,7-trioxa-tricyclo[4.2.2.03,8]decan-5-on über eine Art Baeyer-Villiger-Oxidation. 
Die [4+3] Cycloaddition zwischen dem chiralen Silyloxyallylkationen und Furan 
bildet eine Schlüsselreaktion zur Herstellung des enantiomerenreinen, oxygenierten 2,7-
Dioxatricyclo[4.2.1.03,8]nonan. 
Eine elektrophile Substitution konkurrierte sehr stark mit der [4+3] 
Cycloadditionsreaktion zwischen N-Alkylpyrrolen und Silyloxyallylkationen und führte 
ausschließlich zu der Formierung sogennanter Klasse C Produkte (Hoffmann-
Terminologie). 
Tropan-Alkaloide bilden eine Naturstoffklasse mit wertvollen pharmakologischen 
Eigenschaften sowie verblüffender phytochemischer Diversität. Mehrere Derivate des 
Tropan-Alkaloids Scopolin wurden in der folgenden Doktorarbeit synthetisiert. Eine 
reduktive Aminierung von 8-Oxabicyclo[3.2.1]oct-6-en-3-on gefolgt von einer N-BOC-
Schützung generierte verschiedene 2-Oxa-6-azatricyclo[3.3.1.03,7]nonanscopolinderivate.  
Eines dieser hergestellten Scopolinderivate zeigte Cytotoxizität (< 0.5 mg/mL) gegenüber 
Tumorzelllinien (Zell-Linien: HM02, Hep G2 und MCE 7). 
 
Schlagworte:  
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ABSTRACT 
María Vidal Pascual 
 
New Dioxa and Oxaza-tricyclononanes and Study of their Biological Activity 
Several natural products containing an oxetane ring in their structure show 
important pharmacological properties. In the present thesis, a series of new oxygenated 
2,7-dioxatricyclo[4.2.1.03,8]nonanes are synthesized starting from functionalized 8-
oxabicyclo[3.2.1]oct-6-en-3-one. 
The precursors of the dioxatricyclic structures are tricyclic epoxy alcohols with 
different ether functions (methyl, ethyl, and propyl) located at the C3-position. The methyl 
ether as protecting group is the best choice to prepare the dioxatricyclic system. The 
generated dioxatricycles can be employed to develop pharmacologically active C-
glycoside and glycoside mimetics.  
The PCC oxidation of the free alcohol function in the tricycle 4a-Methoxy-2,7-
dioxatricyclo[4.2.1.03,8]nonane-6-one generates the tricyclic lactone 9a-Methoxy-2,4,7-
trioxa-tricyclo[4.2.2.03,8]decane-5-one which is similar to that of a Baeyer-Villiger 
oxidation product. 
The [4+3] cycloaddition between chiral silyloxyallyl cation and furan is the key 
reaction to provide enantiopure oxygenated 2,7-dioxatricyclo[4.2.1.03,8]nonanes. 
In the [4+3] cycloaddition between N-alkylpyrroles and silyloxyallyl cations 
electrophilic substitution competed strongly with cycloaddition reaction leading to the 
exclusive formation of substitution products of Class C process, using the terminology by 
Hoffmann. 
Tropane alkaloids are a group with valuable pharmacological characteristics and 
perplexing phytochemical diversity. In the present doctoral thesis, several derivatives of 
the tropane alkaloid Scopoline are synthesized. 
A reductive amination of 8-oxabicyclo[3.2.1]oct-6-en-3-one followed by N-BOC 
protection generates Scopoline derivatives, 2-oxa-6-azatricyclo[3.3.1.03,7]nonanes. One of 
the synthesized Scopoline derivative shows cytotoxicity (< 0.5 µg/mL) towards tumor cells 
(cell- lines: HM02, Hep G2 and MCE 7). 
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BF3·OEt2 Boron Trifluoride Etherate  m multiplet / medium intensity 
Bn Benzyl group  M Molarity 
BnBr Benzyl bromide  Me Methyl group 
BOC tert-butoxycarbonyl  min minute 
br broad signal   mL mililiter 
BuLi Butyllithium  m.p. melting point 
ButMgCl tert-butylmagnesiumchloride  MS Mass Spectroscopy 
Calcd. Calculated  MTBE tert-butylmethyl ether 
CH Cyclohexane  NMO N-Methylmorpholine N-oxide 
CH-COSY Carbon-Hydrogen Correlation 
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 NMR Nuclear Magnetic Resonance 
(COCl)2 Oxalyl Chloride  NOE  Nuclear Overhauser 
Enhancement 
m-CPBA m-Chloroperoxybenzoic acid  NaBH(OAc)3 Sodium  
triacetoxyborohydride 
d Doublet  NaBH3CN Sodium cyanoborohydride 
DCM Dichloromethane  o, p ortho- and para-position  in 
phenyl group 
DIBAH Diisobutylaluminium hydride  PCC Pyridinium Chlorochromate 
DMAP 4-Dimethylaminopyridine  Ph Phenyl group 
DMF N,N-Dimethylformamide  PivCl Pivaloyl chloride 
DMSO Dimethyl Sulfoxide  PrBr Propyl bromide 
EA Ethyl acetate  PrMgCl Propylmagnesiumchloride 
EtBr Ethylbromide  rt room temperature 
Et3N Triethylamine  s strong intesity / singlet 
e.e. Enantioselectivity  TBDS tert-butyldimethylsilyl 
eq equatorial / equivalent  TES Triethylsilane 
Et2O Diethyl ether  THF Tetrahydrofuran 
h Hour  TLC Thin Lied Chromatography 
HR-MS High resolution mass 
spectroscopy 
 TMS Trimethylsilane 
IR Infrared spectroscopy  TMSOTf Trimethylsilyl 
Trifluoromethanesulfonate 
KOBut Potassium tert-butoxide  TPAP tetra-n-propylammonium  
perruthenate 
LDA Lithium Diisopropylamine  TsCl Tosyl chloride 
M meta-position in phenyl group   w weak intesity 
PRELIMINARY REMARKS 
 
 
The stereochemical notation at the figures and scheme follows the convention given by 
Maehr.1 Enantiopure substances are drawn using solid and broken wedge to represent its 
absolute configuration. The relative configuration of racemic substances is drawn 
employing bold and broken lines.  
 
(+)-122 rac-108
O
O
HO
OMe
O
O
HO
OMe
 
 
 
The nomenclature for the dioxatricycle rac-108 and for the oxazatricycle rac-141 is 
according to the IUPAC system.2 The atom numbering follows generally the IUPAC rules. 
For reasons of clarity, the numbering of the atomic positions in the tricyclic systems was 
changed to follow the numeration of the bicycle rac-94. 
 
 
1
33
22
2
11
3
4 4
4
5 5 5
6 6 67 7 7
rac-108 rac-94 rac-141
8-Oxabicyclo[3.2.1]
octane
2,7-Dioxatricyclo
[4.2.1.03,8]nonane
2-Oxa-6-azatricyclo
[3.3.1.03,7]nonane
O
O
HO
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O
O
OBn
N
OBn
O
HO
BOC
 
 
 
 
 
                                                 
1  Maehr, H. J. Chem. Ed. 1985, 26, 114. 
2  a) Bowers, K. G.; Mann, J.;  Walsh, E. B.; Howarth, O. W. J. Chem. Soc. Perkin. Trans 1  1987, 1657; b) 
Khuoung-Huu, F. C. R. Hebd. Seances Acad. Sci. Ser. C., Fr, 1975, 275, 499. 
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1. INTRODUCTION 
 
Most of the natural products with important pharmacological activity are isolated from the 
nature only in small quantities. The search for new synthetic compounds with a 
pharmacological activity similar to these natural products has been the objective of the 
modern synthetic organic chemistry in the last years. Under the medical point of view 
these substances showing potential anti-cancerous properties have special importance in 
terms of cytotoxic and cytostatic activity. In fact, the search for microtubules stabilizing 
agents is a major activity for pharmaceutical companies and scientist. 
 
1.1 Structure and properties of natural products containing an oxetane ring  
 
The oxetane ring is present in several natural products which show important 
pharmacological properties. General interest in naturally occurring oxetanes continues to 
be high because of their variable activity with a wide spectrum of indications.3 The 
structures and properties of some important biologically active compounds are described in 
this chapter into three different groups.   
 
Dictyoxetane 1 has been isolated from the algae Dictyota dichotoma4 and is structurally 
related to the class of dolabellanes which shown a variety of pharmacological properties. 
Oxetanocin A 2 is anti HIV active and has an antiviral effect.5 The oxatricyclic norbornane 
3 is a potent herbicide and plant growth regulator.6 Taxol 4 was isolated as the first high 
potent anti-cancerous agent extracted from the bark of the Pacific yew (Taxus brevifolia 
Nutt). Thromboxane A2 5 is a powerful vasoconstrictor and a promoter of blood platelet 
aggregation7 (Figure 1). 
                                                 
3  a) Shimada, N.; Hasegawa, S.; Harada, T.; Tomisawa, T.; Fujii, A.; Takita, T. J. Antibiot . 1986, 39, 1623; 
b) Hoshino, H.; Shimizu, N.; Shimada, N.; Takita, T.; Takeuchi, T. J. Antibiot. 1987, 40, 1077; c) Reinecke, 
J.; Hoffmann, H. M. R. Chem. Eur. J. 1995, 1, 368; d) Wittenberg, J.; Beil, W; Hoffmann, H. M. R. Tet. Lett. 
1998, 39, 8259-8262; e) Proemmel, S.; Hoffmann, H. M. R. Tetrahedron 2002, 58, 6199-6206. 
4  a) Pullaiah, K. C.; Suprapaneni, R. K.; Rao, C. B.; Albizati, K. F.; Faulkner, D. J.; Cunheng, H.; Clardy, J. 
J. Org. Chem. 1985, 50, 3666; b) Pullaiah, K. C.; Suprapaneni, R. K.; Rao, C. B.; Albizati, K. F.; Faulkner, 
D. J.; Cunheng, H.; Clardy, J. J. Org. Chem. 1986, 51, 2736. 
5  syntheis of L-oxetanocin: Gumina, G.; Chu, C. C. Org. Lett. 2002, 4, 1147. 
6  Soloway, S. B.; Vogel, P.; Le Drian, C. H. A.; Powell, J. E. U.S. Patent 916 334, 1986; Eur. Pat. Appl. 
87201907.87201900, 1987. 
7  a) New synthetic routes of Prostaglandins and Thromboxanes, Roberts, S. M. Scheinmann, F., Eds.; 
Academic: New York, 1982; b) total synthesis of  TXA2: Bhawat, S. S.; Hamann, P. R.; Still, W. C. J. Am. 
Chem. Soc. 1985, 107,6372; c) Corey, E. J. Angew. Chem. Int. Ed. Engl. 1991, 30, 455. 
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Figure 1: Pharmacologically active natural products containing an oxetane ring in their 
structure 
 
There are some natural compounds with a four-ring ß- lactone present in their structure: 
Ebelactone 6 is an enzyme-inhibitor, lipstatine 7 and panclicine 8 are inhibitors of the 
pancreas- lipase, obafluorine 9 is an antibiotic and papulinone 10 which shows a phytotoxic 
effect (Figure 2).  
 
O
O
COOCH3
HO
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O
O
(CH2)7
C7H15
O
O NH
CHO
8 Panclicine
O
O
H
N
NO2
OOH
HO
9 Obafluorine
O
O
C6H13
O
NH CHO
H11C5 
7 Lipstatine
O
O
R
H
CH3 CH3
O
CH3
OH
CH3
6 Ebelactone  
Figure 2: Pharmacologically active natural products with ß- lactone structure containing an 
oxetane ring 
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The antibiotic oxetin8 11 (Figure 3) is a naturally occurring ß-amino acid containing an 
oxetane ring. In order to study the potential of oxetane amino acids as a new family of 
foldamers, an efficient route to suitable oxetane scaffolds is reported by Barker9 using an 
oxetane ring. 
O
COOHH2N
11 Oxetin  
 
Figure 3: The naturally occurring ß-amino acid antibiotic oxetin 
 
1.2 Alkaloids  
 
Studies on alkaloids and their biosynthesis were originally initiated because of their 
pharmacological characteristics and perplexing phytochemical diversity. 
The term Alkaloid is designed to the members of a class of natural products of a basic 
nature, and it is derived from the name “vegetable alkali” first applied to these substances. 
In a broad sense, alkaloids are nitrogenous bases, which occur naturally in plants. 
Alkaloids usually show specific pharmacological activity on the animal organism. 
Alkaloids are very interesting compounds for the organic chemists in terms of the complex 
structural and synthetic puzzles that they pose. 
There is not any structural classification of alkaloids but an attempt has been made to 
arrange them in different groups on the basis of their basic ring system: Pyrrolidine group, 
Pyridine group, Isoquinoline group, Morphine group, Quinoline group, Indole group, 
Erythrina alkaloids and Colchicine 13. 
Recently, has been demonstrated that the [4+3] cycloaddition reaction of an oxyallyl cation 
to a suitable functionalized furan, followed by a double elimination of the resulting 
oxabridge, provides ready access to the tropoisoquinoline alkaloids, imerubine, 
grandirubine and isoimerubrine, as well as colchicine.10 Some of these alkaloids showed 
cytotoxic properties and colchicine 13 is well-known because its antimiotic properties 
(Figure 4). 
 
                                                 
8  a) Kawahata, Y.; Takatsuto, S.; Ikekawa, N.; Murata, M.; Omura, S. Chem. Pharm. Bull. 1986, 34, 3102-
3110; b) Schröder, J.; Bach, T. Liebigs Ann./Recl. 1997, 11, 2265-2267. 
9  Barker, S. F.; Angus, D.; Taillefumier, C.; Probert, M.; Watkin, D. J.; Watterson, M. P.; Claridge, T. D. 
W.; Hungerford, N. L.; Fleet, G. W. J. Tet. Letters 2001, 42, 4247-4250. 
10  Lee, J. C.; Cha, J. K. J. Am. Chem. Soc. 2001, 123, 3243-3246. 
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Figure 4: Tropoisoquinoline alkaloids with: a) cytotoxic effect; b) antimiotic properties 
 
 
The realization that alkaloidal sugar mimics might have enormous therapeutic potential in 
many diseases such as viral infection, cancer and diabetes has led to increasing interest and 
demand for these compounds. Most of these effects can be shown to result from the direct 
or indirect inhibition of glycosidases. Naturally occurring sugar mimics with a nitrogen in 
the ring are classified into five structural classes: polyhydroxylated piperidines, 
pyrrolidines, indolizidines, pyrrolizidines and nortropanes. An entirely new class has now 
been added to this group with the discovery of the calystegines. 
 
1.2.1 Tropane Alkaloids 
 
Tropane alkaloids are a well-established group with valuable pharmacological properties 
which have been frequently and comprehensively review. 11 Scopolamine and related 
alkaloids occur in the plant family Solanaceae (Physalis alkekengi) and bear a methyl 
substituent on the nitrogen atom. In contrast, nortropane alkaloids have rarely been isolated 
although they occasionally occur as minor constituents in plants containing tropane 
alkaloids. The genera Datura, Atropa, Hyoscyamus, Scopolia and Duboisia of the 
Solanaceae are especially rich sources of hyoscyamine and/or scopolamine. Calystegines 
have now been found in all of these genera, and Atropa belladonna contained higher 
amounts of calystegines A3, B1 and B2 in the aerial parts than in the roots12 (Figure 5). 
 
                                                 
11  a) Lounasmaa, M. In The Alkaloids: Chemistry and Pharmacology; Brossi, A., Ed., Academic Press: New 
York, 1988; Vol. 33, pp. 1-81; b) Lounasmaa, M.; Tamminen, T. In The Alkaloids: Chemistry and 
Pharmacology; Cordell, G. A., Ed., Academic Press: New York, 1993; Vol. 44, pp. 1-115. 
12  Dräger, B. Phytochem. Anal. 1995, 6, 31. 
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Figure 5: Calystegines contained in Atropa belladonna 
 
Most of the medicinally important tropane alkaloids are obtained from plants. However, 
tremendous efforts have been made to develop economically feasible methods to produce 
hyoscyamine, scopolamine, anisodamine and isodine.13 The important major aromatic 
tropanes, hyoscyamine 17 (named also atropine) and hyoscine 18 (also scopolamine)14 act 
as acetylcholine antagonist15 and have stimulated considerable interest in determining their 
biosynthetic pathways.16 Hyoscyamine 17 is the most common tropane alkaloid and was 
first isolated from henbane by Geiger17 in 1883, and it was subsequently isolated from 
Datura species. Scopolamine 18 presents an analgesic action and showed similarly 
properties as atropine 17 which is a muscle relaxant of high potency and it is used in the 
medicine as sedative  against the travel sickness, as respiratory stimulant and as strong 
anesthesia. Scopoline 19 is isolated from Datura species and from Scopolia tanguticus and 
it is possible to obtain from the hydrolysis of the scopolamine 18. A pharmacological 
effect can not be assigned to the scopoline 19 since it always occurs in the nature in 
connection with the scopolamine 18 or their derivates (Figure 6). 
 
 
 
 
                                                 
13  Review of the biosynthesis of tropane alkaloids published by: Lounasmaa, M.; Tamminen, T. In The 
Alkaloids: Chemistry and Pharmacology ; Cordell, G. A., Academic Press: New York 1993; Vol. 44, p. 1. 
14  a) Fodor, G. Nature 1952, 170, 218; b) Fodor, G.; Kovacs, O. J. Org. Chem. 1953, 2341. 
15  Evans, W. C. In Trease and Evans´ Pharmacognosy 13th edn., Ed.,  Baillière Tindall, London 1989, p. 
832. 
16  a) Leete, E. Planta Med. 1990 , 56, 339; b) Leete, E. Planta Med. 1979, 36, 97. 
17 Geiger, L. Liebigs Ann. Chem. 1833, 7, 269. 
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Figure 6: Structures of the Scopoline 19 and Tropane 20 and the major aromatic tropane 
alkaloids Scopolamine 18 and Atropine 17 
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2. REVIEW OF THE PAST RESULTS 
 
2.1 Dioxatricyclononanes  
 
For the synthesis of the 6,8-dimethyl-2,7-dioxatricyclo[4.2.1.03,8]nonane system 21 (Figure 
7), three different strategies have been published in the last ten years. The first publication 
appeared in 1995 by J. Reinecke and H. M. R. Hoffmann. 35 In 1996 Heathcock et al.36 
presented a second strategy and two years later, J. Wittenberg and H. M. R. Hoffmann 
published an improved synthesis of dioxatricyclic systems some of which showed 
cytostatic and cytotoxic activity toward HMO2 and HEP G2 cells (see chapter 2.1.5).37 In 
2002, S. Proemmel and H. M. R. Hoffmann published several new dioxatricyclic structures 
which showed cytostatic activity towards tumor cells HEP G7 and MCF7 (see chapter 
2.1.5).38 
O
O
21
O
O
 
  
Figure 7: Structure of 6,8-dimethyl-2,7-dioxatricyclo[4.2.1.03,8]nonane 
 
2.1.1 [4+3] Cycloaddition reactions 
 
The [4C(4p) + 3C(2p)] cycloaddition reaction of oxyallyl cations to furans is a general and 
efficient method to synthesize seven-membered carbocycles.39 
Figure 8 shows a general view of the generation of a-alkoxylated oxabicyclo[3.2.1] 
ketones. Starting from 1,1-dimethoxyaceton 22 and under standard acetylation conditions 
is synthesized the corresponding ketone and by addition of a catalytic amount of a Lewis 
acid an allyl cation is obtained which with the 4p-partner (e. g. furan) attempt the bicyclic 
                                                 
35  a) Reinecke, J. Doctoral thesis, University of Hannover 1994; b) Reinecke, J.; Hoffmann, H. M. R. Chem. 
Eur. J. 1995, 1, 368. 
36  Marshall, K. A.; Mapp, A. K.; Heathcock, C.H. J. Org. Chem. 1996, 61, 9135. 
37  Wittenberg, J.; Beil, W.; Hoffmann, H. M. R. Tet. Lett. 1998, 39, 8259-8262. 
38  Proemmel, S.; Wartchow, R.; Hoffmann, H. M. R. Tetrahedron  2002 , 58, 6199-6206. 
39  For [4 + 3] Cycloaddition, see: a) Hoffmann, H. M. R. Angew. Chem. 1973, 85, 877; b) Noyori, R.; 
Hayakawa, Y. Org. React. 1983, 29, 163; c) Hoffmann, H. M .R. Angew. Chem. 1984, 96, 29; d) Mann, J. 
Tetrahedron 1986, 42, 4611; e) Hosomi, A.; Tominga, Y. Comprehensive Organic Synthesis Vol. 5 , Trost, B. 
M.; Fleming, I.; Eds., Pergamon: Oxford 1991, 593; f) Lautens, M. Top. Curr. Chem. Metz, P.; Ed., Springer: 
Berlin 1997, 190, 1; g) Rigby, J. H.; Pigge, F. C. Org. React. 1997, 51, 351. 
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adduct. To obtain the oxabicyclic system two types of coupling are possible through both 
faces of the oxyallyl cation and the in case of non chiral furans the resulting cycloadducts 
are enantiomers.  
OSiR`3
OR
OR
O
O
O
OR
OR
O
OMe
OMe
O
OR
O
O
OR RO
SiR 3`
OSiR`3
OR
Re
Si
Base, R`3SiCl
ROH, PTSA,
heptan, reflux,
Dean-Stark 
separator
Lewis acid
rac
22
O O
 
 
Figure 8: Synthetic route to oxabicycles by [4+3] cycloaddition   
 
Some examples of different [4+3] cycloadditions were reported previously40 by using furan 
as 1,3-diene partner with various oxyallyl cations (Figure 9). 
OOSiMe3 O
O
23
MeO OMe
O
O
+
OMe
OMe
rac-24 rac-25
DCM, TMSOTf
a)
OOSiEt3
26
O +
(+)-27A (+)-27B
DCM, TMSOTf
b) Ph
OMe
O
O
O
O
O
Ph
O
Ph
-90°C
-95°C
R
R
R
R
S
 
Figure 9: Some examples of [4+3] cycloaddition by: a) A. M. Misske; b) C. B. W. Stark 
2.1.2 J. Reinecke strategy 
                                                 
40  See: a) Pierau, S. Doctoral  thesis, University of Hannover 1997; b) Gaertzen, O. Doctoral  thesis, 
University of Hannover 1999; c) Misske, A. M. Doctoral  thesis, University of Hannover 1999; d) Stark, C. 
B. W. Doctoral  thesis, University of Hannover 2000. 
2. REVIEW OF THE PAST RESULTS                                                                                                     - 9 -                                                                    
To obtain the desired oxatricyclic system 21, the oxabicycle[3.2.1]ketone meso-28 was 
employed as starting material. This type of bicycle structure has a special importance in the 
synthesis of natural products as a precursor of subunits of biologically active natural 
compounds.41 
Bicyclic system meso-28 was synthesized by a [4+3] cycloaddition between 2,5-
dimethylfuran and an oxyallyl cation  which was prepared by reducing the polyhaloketone 
29 with Zn and B(OEt)3 (Figure 10). 
 
O
Br
Br
O
O
29
Br
Br
meso-28
1) 2,5-dimethylfuran, THF,
B(OEt)3, Zn, rt
2) Zn/Cu, NH4Cl, 0°C-rt
O
O
 
 
Figure 10: Synthesis of the bicycle system meso-28 by J. Reinecke 
 
The bicycle ketone meso-28 was transformed into the mesylate ketone 30 in four steps and 
further treatment with DBU in acetonitrile yielded the  unsaturated ketone 31 which was 
separated from its diastereomer 32 by column chromatography. The bicycle structure 34 
was obtained after six steps and afterwards it was employed as precursor to generate the 
tricycle system 21 by an anionic intramolecular cyclization (Figure 11).  
 
                                                 
41  a) Montaña, A. M.; García, F.; Grima, P. M. Tet. Lett. 1999, 40, 1375-1378; b) Montaña, A. M.; García, 
F.; Grima, P. M. Tet. Lett. 1999, 55, 5483-5504; c) Rama Rao, A.V.; Yadav, J.S.; Vidyasagar, V. Chem. 
Comm. 1985, 55-56. 
2. REVIEW OF THE PAST RESULTS                                                                                                     - 10 -                                                                    
+
4 steps DBU, acetonitrile,reflux, 79%
8  :  1
meso-28
3 steps
3 stepsTBAF, THF,
4Å sieves
reflux, 39%
30 31 32
21 3334
O
O
O
O
O
O
OMs
O
O
O
O
O
OTES
OTs
O
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Figure 11: Synthesis of dioxatricycle 21 by an anionic intramolecular cyclization by  
J. Reinecke  
 
Dioxatricycles 36 and 37 were prepared from the epoxy alcohol 35 by a non-selective 
intramolecular epoxy opening with BF3.OEt2. On the other hand, the treatment of 35 under 
basic conditions yielded selectively the dioxatricycle 36 (Figure 12). 
 
+
KOH, DMSO/H2O
BF3.OEt2
DCM, rt
36
35
37
36
rt, 80%
2  :  1
O
O
OH
O
OH
O
O
OH
O
OH
O
O
 
 
Figure 12: Synthesis of dioxatricycles 36 and 37 by intramolecular epoxy opening, by 
 J. Reinecke  
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2.1.3 Heathcock et al. strategy 
 
In this second strategy the bicycle ketone 38 was employed as starting material to obtain 
the desired dioxatricycles system 21 and 42. The bicycle structure 38 was prepared in three 
steps from the 5-methylfurfural 39. After further eight steps, the hydroxyl bicycle 40 was 
obtained and utilized as precursor for the cyclization to obtain the tricycle structure 21. 
Moreover, another precursor 41 was synthesized from bicycle 38 to obtain the highly 
functionalized dioxatricyclic structure 42. Both dioxatricyclic systems 21 and 42 were 
obtained using the same reaction conditions. The precursors 40 and 41 were treated with 
NaH in THF in reflux (Figure 13). 
 
8 steps
8 steps
2138 40
NaH, THF,
reflux
41 42
NaH, THF,
reflux
88%
3 stepsO
O
39
O
O
O
O
NC
MeO Bu
MeO
O
OMs
MeO Bu
MeO OH
O
O
O
HO
MsO
 
 
Figure 13: Synthesis of dioxatricycle core 21 and 42 by Heathcock et al. 
 
2.1.4 The improved strategy of J. Wittenberg 
 
Starting from 1,1-bisbenzyloxy propanone 43 four biologically active Dictyoxetane 
structures were synthesized in only eight steps. The a-keto acetal 43 was converted into 
silyl enol ether 44 and reacted by a [4+3] cycloaddition with 2,5-dimethylfuran. 42 A 
diastereoselective reduction of rac-45 generated selectively the endo-alcohol 46, which 
was utilized as precursor for the four dioxatricyclic systems. Deoxygenation of bicycle 46 
followed by epoxidation and debenzylation provided the hydroxy oxetane 49.  
                                                 
42 a) Reinecke, J.; Hoffmann, H. M. R. Chem. Eur. J . 1995, 1, 368; b) Stark, C. B. W.; Eggert, U.; Hoffmann, 
H. M. R. Angew, Chem. 1998, 110, 1137; Angew. Chem. Int. Ed. 1998, 37, 1266. 
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Alternatively, the hydroxy group of 38 was methylated and afterwards the oxabicyclic 
system was epoxidized and deprotected of the benzyl group to provide the epoxy alcohol 
50 as the precursor for the other three oxetane systems (Figure 14). The synthesized 
dictyoxetane structures 49, 51, 52 and 53 showed cytotoxic and cytostatic activity (see 
chapter 2.1.6). 
 
DIBAH,THF,
-78°C, 94%
rac-45
46
2,5-dimethylfuran
TMSOTf, DCM,
-78°C
53% over 2 stepsOBn
OBn
OTMS
44
OBn
OBn
O
43
LDA, TMSCl,
THF, -78°C - rt
a) NaH, CS2, MeI,
THF, 0°C - rt, 77%
b) Bu3SnH, AIBN,
toluene, 95°C, 92%
47
a) m-CPBA, DCM, 
 0°C - rt, 85%
b) H2, Pd/C, 
MeOH, 85%
48
BF3.OEt2, DCM,
0°C, 72%
49
51
DMSO, (COCl)2, DCM,
Et3N, -78°C - rt, 78%
52
allylmagnesium
bromide, Et2O,
53
-30° to -10°C, 70%
a) NaH, MeI,THF,
0°C - rt, 100%
b) m-CPBA, DCM, 
 0°C - rt, 97%
c) H2, Pd/C, MeOH, 
AcOH, 80%
50
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O
OH
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O
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Figure 14: Synthesis strategy employed by J. Wittenberg to obtain the dioxatricyclic 
skeleton 
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2.1.5 New dioxatricyclic systems by S. Proemmel  
 
Starting from functionalized 8-oxabicyclo[3.2.1]oct-6-en-3-one rac-45 series of tricyclic 
oxetanes were prepared in short synthetic order following the strategy of J. Wittenberg. 
Ketone rac-45 was reduced and the resulting hydroxy group was protected with benzoyl 
and pivaloyl groups. Oxidation of the double bond and debenzylation at C2-position 
generated a bicyclic epoxy alcohol structure. The four-membered ring was synthesized by 
intramolecular epoxy opening carried out with equimolar BF3.OEt2. After cyclization the 
ester was cleaved reductively to diol 56 which was oxidized to the diketone 57. The 
oxidation of the hydroxy ester 55b generated the keto ester 58 which was further reduced 
to the alcohol 59 (Figure 15).   
 
rac-45
DMSO, (COCl)2, DCM,
Et3N, -78°C - rt, 50%
56
a) DIBAH,THF,
-78°C, 98%
b) ROCl, Py, DMAP,
THF, 0°C - rt , 98%
c) m-CPBA, DCM, 
 0°C - rt, 71%
d) H2, Pd/C, EtOAc,
AcOH, 2-3 d, 90%
54a R = But
54b R = Ph
BF3.OEt2, DCM,
0°C, 69%
55a R = But
55b R = Ph
57
DIBAH,THF,
-78°C, Na, 
K-tartatre
98%
DMSO, (COCl)2, 
DCM, Et3N,
 -78°C - rt, 77%
58
NaBH3CN, MeOH,
rt, 1 d, 50%
59
O
O
OBn
O
OH
O
O
O
HO
O
O
O
O
O
O
O
OPiv
O
O
HO
OPiv
OH
O
O
HO
O
O
RO
O
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Figure 15: Route employed by S. Proemmel to generate oxatricycles and dioxatricycles  
 
 
Wittig-olefination of the keto ester 58 gave olefins 60a and 60b. Further derivations of the 
olefin 60a conduced to the protected keto alcohol 61. Afterwards, silyl protected keto 
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alcohol 62 was converted into alkynyl substituted alcohol 63. Structure 64 was generated 
by a nitrile oxide cycloaddition43 using as dipolarophile the exocyclic olefin double bond 
contained in tricyclic silylether 61 (Figure 16).  
 
58
Ph3P=CHR, DCM,
rt, 1 d, 74%
60a R = H
60b R = CO2Me
61
b) TBSCl, DCM, 
Imidazole, rt, 98%
Br2C=N-OH, 
DBU, acetonitrile, 
0°C - rt,  20%
64
a) O3, DCM,
5 min, -78°C
b) Ph3P, 1 h, 
81%
6263
Phenylacetylene, 
ButMgCl, THF,
 -20°C - rt, 81%
a) DIBAH,THF, 
-78°C, 77%O
O
O
OPiv
O
O
OPiv
R
O
O
OTBS
O
O
O
OTBS
O
O
OTBS
HO
Ph
O
O
OTBS
O
N
Br  
 
Figure 16: Derivations of some dioxatricycles synthesized by S. Proemmel 
 
After the evaluation of biological activities of several tricyclic systems, only the 
dioxatricyclic ester rac-60b showed weak cytostatic activity, but no cytotoxic activity 
towards tumor cells (see chapter 2.1.6).  
Aminated oxetanes were generated by reductive amination44 of oxabicyclic ketone rac-45 
and posterior protection of the amino function aminated bicyclic olefin 65. Epoxidation 
and debenzylation at the C2-position provided a proper precursor for the synthesis of 
desired tricyc le 66 (Figure 17). 
 
                                                 
43  a) De Amici, M.; De Micheli, C.; Misani, V. Tetrahedron 1990, 46, 1975; b) Halling, K.; Thomsen, I.; 
Torssell, K. B. G.; Lach, D. L. Liebigs Ann. Chem. 1989, 985; c) De Amici, M.; De Micheli, C.; Spezia, S. J. 
Org. Chem. 1989, 54, 2646. 
44  a) Lane, C. F.; Synthesis 1975, 135; b) Borch, R. F.; Berstein, M. D.; Durst; H. D. J. Am. Chem. Soc. 1971, 
93, 2897; c) Mori, K.; Sugai, T.; Maeda, Y.; Okazaki, T.; Naito, H. Tetrahedron, 1985, 41, 5307; d) Abdel-
Magid, A. F.; Carson, K. G.; Harris, B. D.; Maryanoff, C. A.; Shah, R. D. J. Org. Chem. 1996, 61, 3849. 
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Figure 17: Aminated oxetane synthesized by S. Proemmel 
 
Analogue oxatricycles containing an acetate ester at the C3-position were obtained 
employing a similar route as in previous synthesis (Figure 18). 
 
 
rac-45
+
3  :  2
67 68
+
69 70
3 steps
5 stepsO
O
OBn
O
O
O
TBSO
O
OAc
O
HO
O
OAc
O
OH
O
O
O
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Figure 18: Oxatricyclic systems with acetate ester at the C3-position (S. Proemmel) 
 
Several tricyclic structures were evaluated in terms of biological activity. Substances 66 
and 67 did not show any cytostatic or cytotoxic activity up to concentrations of 50 µMol.  
 
2.1.6 In-vitro test for the characterization of dioxatricyclic structures  
 
Some of the dioxatricycles synthesized by J. Wittenberg and S. Proemmel showed 
biological activity (cytotoxic and cytostatic) towards tumor cells (Figure 19).  
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Figure 19: Biological active oxatricycles synthesized by J. Wittenberg and S. Proemmel 
 
The four substrates 49-53 show cytostatic activity, in the range of 5-fluorouracil, a well 
known antimetabolite, capable of entering the synthesis and function of nucleic acids, 
similar to AZT, an anti-AIDS drug. Substance rac-60b showed cytostatic but no cytotoxic 
activity towards tumor cells (cell lines: HEP G7 and MCF7). The results of the 
investigation are summarized in the Table 1. 
 
Table 1. Antitumor activity (µmol/l) measured toward HMO2, HEP G2 and MCF7 cells 
Substance Carcinoma type GI50a TGIb LC50c 
HMO2 4.0 50 >100 49 
HEP G2 0.1 30 >50 
HMO2 3.0 57 >100 51 
HEP G2 <0.1 45 >50 
HMO2 <1.0 72 >100 52 
HEP G2 <0.1 35 >50 
HMO2 <1.0 54 >100 53 
HEP G2 <0.1 30 >50 
HMO2 >50 >50 >50 
HEP G2 13 >50 >50 
rac-60b 
MCF7 10 >50 >50 
HMO2 1.2 35 >50 5-fluorouracil 
HEP G2 0.15 50 >50 
HMO2 0.1 2.5 40 cis-platinum 
HEP G2 0.5 30 >50 
a Drug concentration causing 50% growth inhibition. b Drug concentration causing 100% growth inhibition. 
c Drug concentration causing 50% reduction of the cells present at time point zero, i. e at 24 h. 
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Due to these results, the synthesis of new dioxatricyclic derivatives with an increased 
cytostatic and/or cytotoxic effect was an interesting goal of the present work. 
 
2.2 Oxazatricyclononane structures 
 
Recently, a short synthetic route to generate structures similar to the system 1,3-dimethyl-
2-oxa-6-azatricyclo[3.3.1.03,7]nonane 71 with the same skeleton as the Scopolamine 18 
was introduced by S. Proemmel45 (Figure 20).  
 
71
N
R
O
N
O
R
 
 
Figure 20: Structure of 1,3-dimethyl-2-oxa-6-azatricyclo[3.3.1.03,7]nonane 
 
Starting from functionalized 8-oxabicyc lo[3.2.1]oct-6-en-3-one rac-45 two new 
oxazatricyclic systems were prepared following similar strategy as in previously described 
routes. The amino bicyclic olefin 72 was generated by reductive amination of ketone rac-
45. Oxidation of the double bond and debenzylation at C2-position generated a bicyclic 
epoxy alcohol structure 73. An intramolecular cyclization using a Grignard agent provided 
the tricyclic noradamantanes 74 and 75 (Figure 21). 
 
                                                 
45  Proemmel, S. Doctoral thesis, University of Hannover 2001. 
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Figure 21: Oxazatricycles synthesized by S. Proemmel 
 
Structures 74 and 75 were separated by column chromatography. Further derivations of the 
main product 74 gave biologically active oxazatricycle 77 (Figure 22). 
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Figure 22: Derived oxazatricyclic systems synthesized by S. Proemmel 
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2.2.1 in-vitro Test for the characterization of oxazatricyclic structure  
 
Scopolamine derivates 74 and 77 were evaluated in terms of biological activity. Tricyclic 
system 74 does not show any cytostatic or cytotoxic effect up to concentrations of 10 
µMol. Oxazatricyclic compound 77 present a cytostatic effect tumor cells (cell lines: HEP 
G2, HMO2 and MCF7) (Figure 23). The results of the investigation are summarized in the 
Table 2. 
 
77
N
BOC
HO
H
N
O
O
N
H
O
OBn
 
 
Figure 23: Oxazatricycle with cytostatic effect towards tumor cells (S. Proemmel) 
 
 
Table 2. Antitumor activity (µg/mL) measured toward HMO2, HEP G2 and MCF7 cells 
Oxazatricyclic Carcinoma type GI50a  TGIb  LC50c  
HMO2 18 >50 >50 
HEP G2 18 >50 >50 
77 
MCF7 18 >50 >50 
a Drug concentration causing 50% growth inhibition. b Drug concentration causing 100% growth inhibition. 
c Drug concentration causing 50% reduction of the cells present at time point zero, i. e at 24 h. 
 
The Scopolin derivate 77 showed cytotoxic activity in the three cell lines. Due to this result 
the synthesis of new Scopolamine derivates with an enhanced cytostatic and/or cytotoxic 
activity was an important aim for the present work. 
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2.3 Azabicyclic structures  
 
For the synthesis of the system 8-azabicyclo[3.2.1]octane 78, a [4+3] cycloaddition 
between substituted pyrroles and an oxyallyl cation was employed in 1993 by C. 
Dannenberg. 46 Cycloadduct 78 had obvious structural similarities to the tropane alkaloids 
as Tropane 20, Cocaine 79 and Tropinone 80 (Figure 24). 
 
N
Tropane20 Tropinone80
N
O
78
N
O
Cocaine79
N
OBz
COOMe
 
 
 
Figure 24: Azabicycle 78, synthesized by C. Dannenberg, similar to the structures of 
Tropane 20, Cocaine 79 and Tropinone 80 
 
 
 
2.3.1 Synthesized substituted pyrrole by C. Dannenberg 
 
The first step to get the cycloadduct 78 was to protect the amino group of the pyrrole 81. 
Several protecting groups were employed: different ester groups, arylsulfonyl and alkyl 
silyl groups (Figure 25). 
                                                 
46  Dannenberg, C. Doctoral  thesis, University of Hannover 1993. 
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Figure 25: Some examples of synthesized substituted pyrroles by C. Dannenberg 
 
To obtain the substituted pyrrole 83-85 different a-bromo acetic acid alkyl ester were used 
to react with the potassium salt 82 and a catalytic amount of 18-crown-6. To form the 
potassium salt 82 in quantitative yield, bases like KH or KOBut are efficient reagents. The 
TMS-protected pyrrole 86 was synthesized following the method of Fessenden47 with 
acceptable yield. Compound 87 was generated using tosyl chloride in dichloromethane 
employing the method proposed by Illi.48  
 
2.3.2 [4+3] Cycloaddition of substituted pyrrole by C. Dannenberg 
 
Several [4+3] cycloadditions were carried out with substituted pyrroles toward the 
synthesis of similar structures to Tropane 20 and Tropinone 80 (Figure 26).  
 
N
R = Me    83
N
O
+
88
tBu    85
Br Br
O CO2R
NaI, Cu
CO2R
Et     84
MeCN
R = Me    89   49%
tBu    91   47%
Et     90   70%
 
 
 
Figure 26: Examples of [4+3] cycloadditions by using NaI/Cu method by C. Dannenberg 
                                                 
47  Fessenden, R.; Crowe, D. F. J. Org. Chem. 1960, 25, 598. 
48  Illi, V. O. Synthesis 1979, 136 
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These cycloaddition reactions were carried out using the NaI/Cu method developed by 
Hoffmann and Mann. 49 In this reaction, the oxyallyl cation reaction partner was generated 
from the dibromo ketone 88 in the presence of NaI and Copper by a consecutive 
nucleophilic substitution SN2 reaction to the diiodo ketone 92.  Reducing the ketone 92 the  
enolate 93 was obtained which through a SN1 reaction lost an iodide anion (Figure 27).  
 
Br Br
O
NaI
-NaBr
I I
O
2 Cu, NaI
-2 CuI
I
O-Na+
O-Na+
+
O-Na+
+
O-Na+I-
+
88 92 93
 
 
Figure 27: Generation of the oxyallyl cation employed in the NaI/Cu method 
 
To obtain a cycloadduct with a similar skeleton such as the tropane alkaloids several [4+3] 
cycloadditions with substituted pyrroles and different oxyallyl cations as reaction partner 
were carried out and reported. Various methods were developed to obtain an adequate 
oxyallyl cation. For example, Mann50 elaborated a method to generate the oxyallyl cation 
using Et2Zn and Noyori51 employed an iron reagent with N-Methyloxycarbonylpyrrole to 
generate the corresponding cycloadduct.  
One of the objectives in the present work is the synthesis of azabicycles by a [4+3] 
cycloaddition between substituted pyrroles and silyl oxyallyl cations instead of the oxyallyl 
cation generated in the NaI/Cu method. 
 
 
 
                                                 
49  a) Hoffmann H. M. R., Fierz, G.; Chidgey, R. Angew. Chem. 1974, 86, 444; b) Mann, J; Cowling, A. P. J. 
Chem. Soc. Perkin Trans. I 1978, 1564. 
50  Mann, J; de Almeida Barbosa, L. C. J. Chem. Soc. Perkin Trans. I 1992, 787. 
51  Noyori, R.; Hayakawa, Y.; Baba, Y.; Makino, S. J. Am. Chem. Soc. 1978, 100, 1786. 
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3. CONCEPTUAL FORMULATION 
 
 
The main aim of this project was to synthesize new oxatricyclic and oxazatricyclic 
structures to evaluate their biological activities following one of the investigation lines in 
our research group. In previous published works of the group of Prof. H. M. R. Hoffmann 
some synthesized dioxatricyclic compounds showed cytotoxic and cytostatic effects in 
human carcinoma. 
Following this objective new tricyclic structures were prepared introducing several ether 
and amino functions at the C3-position in the functionalized 8-oxabicyclo[3.2.1]oct-6-en-
3-one structure.  
A second objective of this work was to synthesize new bicyclic molecules with tropane 
skeleton using the [4+3] cycloaddition methodology developed in our group.  
As a third objective was projected to synthesize a bicyclic system containing an alkynyl 
chain side at the C1-position. 
Finally, several X-ray structures were analyzed to determinate the absolute configuration 
of the stereocenters contained in the different molecules. 
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4. RESULTS AND DISCUSSION 
 
4.1 Synthesis of Oxatricyclic substances 
 
Cycloaddition in its many manifestations represents one of the most powerful methods in 
organic chemistry to obtain cyclic structures. A [4+3] cycloaddition reaction between a 
1,3-diene and an allyl, or more frequently an oxyallyl cation, offers rapid access to 
functionalized seven-membered carbocyclic rings with many of the attendant advantages 
of other cycloaddition processes. Starting from functionalized 8-oxabicyclo[3.2.1]oct-6-en-
3-one rac-45 and rac-94, a series of dioxatricyclic structures were synthesized to evaluate 
their biological activity. Several dioxatricyclic structures obtained in previous works 
presented cytostatic activities (see chapter 2.1.6).  
 
O
OBn
O
R
R
R = H       rac-94
R = Me    rac-45
O RR
O
OBn
 
 
Figure 28: Starting oxabicycles for oxetane series 
 
4.1.1 [4 + 3] Cycloaddition reaction using silyl enol ethers 
 
The [4+3] cycloaddition reaction of oxyallyl cations to furans is a general and efficient 
method to synthesize functionalized 8-oxabicyclo[3.2.1]oct-6-en-3-one like the bicyclic 
systems  rac-45 and rac-94.  
In the present work, two different methods to obtain the silyl enol ether were used, kinetic 
method and thermodynamic method. In the kinetic method LDA in THF at -78°C is used 
to obtain silyl enol ethers and the thermodynamic method was carried out by using 
triethylamine in DMF at 75°C. 
Silyl enol ethers 44 and 95 were prepared from 43 by the two methods, kinetic method 
(named in this work method 1) and thermodynamic method (named method 2). Method 1 
is recommended for relatively small scale reactions, (up to 30 mmol of dibenzyl acetal 43), 
while method 2 is employed for large scale reactions (up to 130 mmol of dibenzyl acetal 
43). 
4. RESULTS AND DISCUSSION                                                                                                             - 25 -                                                                                          
Due to its acid sensitivity, [1-(benzyloxy-methoxy-methyl)-vinyloxy]-trimethyl-silane 44 
cannot easily be purified by column chromatography, unlike the TES-enol-ether. Using 
Et3SiCl as precursor to obtain the silyl enol ether, only Method 1 gave a good yield, Table 
3. 
 
Table 3 
O
OBn
OBn
OSiR3
OBn
OBnMethod 1
Method 2
43 R = Me    44
R = Et      95  
Entry  Method Conditions Yield [%] 
1 1 LDA, TMSCl, THF, -78°C no isolated 
2 1 LDA, TESCl, Et3N, THF, -78°C 82 
3 2 TMSCl, DMF, Et3N, 75°C, 16 h no isolated 
4 2 TESCl, DMF, Et3N, 75°C, 16 h no reaction 
Method 1: kinetic method; Method 2: thermodynamic method 
 
To get the desired cycloadducts silyl enol ether 44, synthesized by using method 1 and 
method 2, was reacted with furan and 2,5-dimethylfuran as 1,3-diene partners. The best 
yield (over two steps) was obtained with the substituted furan, Table 4. 
 
Table 4 
OOSiMe3
OBn
OBn
O
OBn
O
RR R
R
44
O
OBn
OBn
43
method 1 or    
method 2
R = H       rac-94
R = Me    rac-45
O RR
O
OBn
 
Entry  Silyl enol 
ether 44 
1,3-diene Conditions Yield [%] 
(over 2 steps) 
1 by method 1 Furan TMSOTf cat., DCM, -78°C 41 
2 by method 2 Furan TMSOTf cat., DCM, -78°C 61 
3 by method 1 2,5-Dimethylfuran TMSOTf cat., DCM, -78°C 53 
4 by method 2 2,5-Dimethylfuran TMSOTf cat., DCM, -78°C 67 
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4.1.2  Synthesis of Dioxatricyclic oxetanes as rigid C-Glycosides 
 
According to the results from the dioxatricycle a-methoxy-substituted at C3-position and 
its higher biological activity (see chapter 2.1.6), it was decided to continue synthesizing 
new dioxatricyclic derivatives to seek out their biological activities. The introduction of 
different ether functionalities to the oxabicycles rac-45 and rac-94 was the first kind of 
derivations investigated in the present work. Alkyl ethers are stable to a wide range of 
aqueous acidic and basic conditions, and are not readily attacked by most metal hydride 
reducing agents or mild oxidizing agents like Swern, PCC, etc. Methyl, ethyl, propyl and 
benzyl ether were utilized to observe possible variations in the biological activity for the 
corresponding oxetane structures (Figure 29).  
The dioxatricyclic systems were also synthesized by using a similar strategy from J. 
Wittenberg where an epoxy alcohol was employed as precursor in an intramolecular epoxy 
opening (see chapter 4.1.6). 
R = H    rac-94
R = Me  rac-45 R1= Me, Et, Pr, Bn
R = H, Me
R = H    96
R = Me  46
R1= Me, Et, Pr, Bn
R = H, Me
R1= Me, Et, Pr
R = H, Me
R1= Me, Et, Pr
R = H, Me
DIBAH, THF, 
-78°C - rt MeI 
EtBr, KI
PrBr, KI
m-CPBA, DCM,
0°C - rt
H2, Pd(C), AcOH, 
MeOH,
2 - 3 d, rt
KOBut, THF, 
1 d, rt,
NaH, THF,
0°C - rt, 3 h
BnBr, 70°C, 
16 h
O RR
O
OBn
O RR
OH
OBn
O RR
OR1
OBn
O RR
OH
O
O RR
O
HO
OR1 OR1
O RR
OBn
O
OR1
 
Figure 29: Route to oxetanes with an alkyl ether function at the C3-position 
 
4. RESULTS AND DISCUSSION                                                                                                             - 27 -                                                                                          
4.1.2.1 Bicyclic skeleton with alkyl ether in the C3-position 
 
The oxabicycles rac-45 and rac-94 obtained were treated with a DIBAH solution in THF 
at -78°C to reduce the corresponding ketone function and to generate the alcohols 96 and 
46. 
The introduction of a methoxy group at the C3-carbon atom in alcohols 96 and 46 gave 
excellent product yields obtained by following the Williamson69 ether synthesis method 
(Table 5, entries 1-2). In the case of other ether functions a catalytic amount of KI was 
needed to obtain the desired bicyclic ether. Alkyl bromide gave better results than alkyl 
chloride, due to the better leaving-group qualities of bromine.  
In accordance with the on growing sterical demands from methyl to propyl ether groups 
the yields in ether formation are decreasing. Interestingly, in comparison to the 
unsubstituted furan system the yields for the 2,5-dimethylfuran adducts are remarkably 
higher. This may be due to the stabilizing effects of the methyl groups at C1- and C5-
position for the whole molecule. These observations are summarized in Table 5.  
 
Table 5 
R1= Me, Et, Pr
R = H, Me
R = H    96
R = Me  46
O RR
OH
OBn
O RR
OR1
OBn
 
Entry R R1 Conditions Yield [%] 
1 Me Me NaH, MeI, THF, 0°C – rt, 3h 98 
2 H Me NaH, MeI, THF, 0°C – rt, 3h 86 
3 Me Et NaH, EtBr, KI, THF, 0°C – rt, 3h 83 
4 H Et NaH, EtBr, KI, THF, 0°C – rt, 3h 60 
5 Me Pr NaH, PrBr, KI, THF, 0°C – rt, 3h 60 
6 H Pr NaH, PrBr, KI, THF, 0°C – rt, 3h 54 
7 H Pr NaH, PrCl, KI, THF, 0°C – rt, 3h 20 
8 Me Pr NaH, PrI, THF, 0°C – rt, 3h no reaction 
9 H Pr NaH, PrI, THF, 0°C – rt, 3h no reaction 
 
                                                 
69  W. Williamson Justus Liebigs Ann. Chem. 1851, 77, 37-49. 
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4.1.2.2 Bicyclic skeleton with benzyl ether at the C3-position 
 
Due to the stability of the bicyclic skeleton with benzyl ether at C3-position, was decided 
to synthesize such oxabicyclic compounds to observe possible variations in biological 
activity on corresponding oxetane structures. The Williamson ether synthesis is employed 
as the most common method for preparing benzyl ethers. As in the case of alkyl ethers (see 
Table 5, entries 3-7), a catalytic amount of KI (TBAI could be also used) was added to 
accelerate the alkylation because iodide displaces bromide or chloride to give benzyl 
iodide in situ which is a much better alkylating agent.70 The iodide ion is then regenerated 
during the alkylation with benzyl iodide. Under these conditions also tertiary alcohols can 
be benzylated.71 
Several different conditions to generate in good yield the desired bicyclic structures 177 
and 178 were used, Table 6. 
 
Table 6 
R = H     96
R = Me   46
R = H     178  
R = Me   177
O RR
OH
OBn
O RR
OBn
OBn
 
Entry R Conditions Yield [%] 
1 Me NaH, BnCl, KI, THF, RT, 1 h 26 
2 Me NaH, BnBr, KI, THF, RT, 1 h 51 
3 Me NaH, BnBr, THF, 70°C , 16 h  89 
4 H NaH, BnBr, THF, 70°C , 16 h 80 
 
Above results showed higher yields for higher temperature and longer reaction time (the 
reaction time could be reduced, possibly, with the addition of a catalytic amount of KI). 
The same reaction was carried out  at room temperature using KI and as previously 
mentioned (see Table 5, entries 6 and 7) the maximum yield was obtained by employing 
BnBr as alkyl halogenated agent. In comparison to the unsubstituted furan system the yield 
for the 2,5-dimethyl oxabicyclic structure 177 was better. This may be due to the 
stabilizing effects of the methyl groups at C1- and C5-position on the whole molecule. 
                                                 
70  Willson, T. M.; Kocienski, P.; Jarowicki, K.; Isaac, K.; Hitchcock, P. M.; Faller, A.; Campbell, S. F. 
Tetrahedron 1990, 46, 1767. 
71  a) Nicolau, K. C.; Liu, J. J.; Wwang, C.-K.; Dai, W.-M.; Guy, R. K. J. Chem. Soc., Chem. Commun. 1992, 
1118; b) Evans, D. A.; Bender, S. L.; Morris, J. J. Am. Chem. Soc. 1998, 110, 2506. 
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4.1.2.3 Cleavage of benzyl ether group 
 
After the protection of the free alcohol function the double bond of the corresponding 
oxabicyclic structures was oxidized using m-CPBA in DCM at 0°C. Resulting epoxy 
bicyclic structures were afterwards, debenzylated at the C2-position. 
Numerous methods were available for benzyl ether removal.72 At elevated temperature, 
and in the presence of Lewis acids, benzyl ethers may cleave with metal hydrides by 
removing a benzylic proton from benzyl ether. In the presence of multiple functionalities 
several problems can occur, slow debenzylation rate, acyl group migration and reagent 
incompatibility. Takeda developed a different cleavage way by using anhydrous ferric 
chloride, which was highly efficient for the removal of benzyl and phenylbenzyl ethers at 
room temperature.73 With this method, methyl ether, benzoate and acetate groups were not 
affected by the removal conditions.  
Catalytic hydrogenolysis offers the mildest reaction conditions for the deprotection of 
benzyl ethers. The catalyst of choice was Pd(C) 10%. In this method, a solution of benzyl 
ether in ethanol was treated with Pd(C) in the presence of AcOH for 3 days. This method 
was used for deprotecting water-soluble alcohols and the yields were usually high in most 
bicyclic systems with alkyl ether function at the C3-position, Table 7. 
 
Table 7 
H2, Pd/C (10%),
R1OH, AcOH, rt
R1 = Me      163
        Et       164
        Pr       173
R1 = Me      174
        Et       175
        Pr       176
R = Me
R = H
R1 = Me      50
        Et       101
        Pr       102
R1 = Me      105
        Et       106
        Pr       107
O RR
OH
O
OR1
O RR
OBn
O
OR1
 
                                                 
72  a) Fuji, K.; Kawataba, T.; Fujita, E. Chem Pharm. Bull. 1980, 28, 3662; b) Kon, K; Ito, K.; Isoe S. Tet. 
Lett. 1984, 3739. 
73  Park, M. H.; Takeda, R.; Nakanishi, K. Tet. Lett. 1987, 28, 3823-3824. 
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Entry R R1 R2 Yield [%] 
1 H Me Me 52 
2 H Et Et 50 
3 H Pr Et 47 
4 Me Me Me 81 
5 Me Et Et 64 
6 Me Pr Et 54 
  
Obtained epoxy alcohols by entries 1 and 2 showed low yields, most probably due to their 
polarity and consequently the ir hydrophilic character which is unfavorable during aqueous 
work-up.  
In the case of structures 97 and 98, with benzyl groups in the C2 and C3-positions, the 
selective reduction of benzyl group at the C2-position was not obtained. The same 
conditions (Pd/C in MeOH in the presence of acetic acid for 3 days) were used for the 
selective reduction of one benzyl group. Several 1D and 2D-NMR measurements indicated 
that the cleavage was performed only to one benzyl group but most likely, to give a 
mixture of compounds with similar polarity and for this reason difficult to separate by 
column chromatography (Figure 30). 
H2, Pd/C(10%), EtOH
AcOH, RT, 3d
R = H    98
R = Me  97
+O RR
OH
O
OBn
O RR
OBn
O
OH
O RR
OBn
O
OBn
 
Figure 30: Unselective cleavage of benzyl ether group at the C2-position 
 
4.1.2.4 Formation of new tricyclic oxetane structures with an ether function in the C3-
position 
 
The cyclization towards the oxetane ring using BF3·OEt2 was presented recently by J. 
Wittenberg (see chapter 2). In that case of epoxy alcohol 50 the BF3·OEt2-mediated 
cyclizations caused cleavage of the methyl ether to the  endo-alcohol,  which  entered   into  
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facile 5-exo-tet cyclizations leading to a second tetrahydrofuran unit (two structural 
isomers, 100a and 100b) (Figure 31). However, base treatment, using KOBut in THF, 
afforded the desired tricyclic skeleton in good yield. 
+
50
BF3.OEt2, DCM, 0°C
100b100a99
O
OH
O
OMe
O
OH
O
OH
O
OH
O
OH
O
OH
O
HO
 
Figure 31: Cleavage of methyl ether by using BF3·OEt2 
 
Because of these results, the synthesis to the oxetane ring was carried out using an 
intramolecular epoxy opening by base treatment by using KOBut in THF at room 
temperature for 24 h, employing corresponding epoxy alcohol; yields are summarized in 
the Table 8. 
Table 8  
KOBut, THF
R1 = Me      50
        Et       101
        Pr       102
R1 = Me      105
        Et       106
        Pr       107
R1 = Me      51
        Et       103
        Pr       104
R1 = Me      108
        Et       109
        Pr       110
R = Me
R = H
rt, 1d
O RR
OH
O
OR1
O RR
O
HO
OR1
 
Entry R R1 Yield [%] 
1 H Me 62 
2 H Et 52 
3 H Pr 49 
4 Me Me 83 
5 Me Et 58 
6 Me Pr 56 
 
4. RESULTS AND DISCUSSION                                                                                                             - 32 -                                                                                          
The epoxy ring opening reaction afforded better yields for those epoxy alcohol which had 
smaller ether group at the C3-position. Comparing bicyclic epoxy alcohol skeletons (R = 
H, Me) we observed that the more substituted structure was easier opened. The reason is 
because the higher thermodynamic stability of the second type of structure. Crystal 
structure of compounds 108 and 109 confirmed the spectroscopic results (Figure 32). 
  
 
Figure 32: Crystal structure of oxetanes 108 and 109 
 
The transformation of the epoxy alcohol to the corresponding oxatricyclic structure must 
proceed via prior conformational change of the six membered oxacyclic ring into a minor 
boat, which brings the hydroxyl group close enough to the epoxy ring system for a stereo-
electronically controlled formation of the new oxetane C-O bond (Figure 33). 
K+
R1= Me, Et, Pr
R = H, Me
KOBut
O R
R
O
OR1
OH
O R
R
O
OR1
HO
O R
R
HO
OR1
O
O RR
OH
O
OR1
O RR
O
HO
OR1
O RR
O-
O
OR1
 
Figure 33: Mechanism for intramolecular cyclization to oxetane using KOBut 
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The epoxy alcohol mixture obtained in chapter 4.1.2.3 (see Figure 30) was treated with 
KOBut to afford the corresponding oxetane structures by intramolecular epoxy opening 
(Figure 34). The resulting mixture could not be separated by column chromatography. A 
posterior oxidation of oxetane tricyclic compounds was carried out with the idea to find a 
polarity difference to reach a column chromatography separation but again this method 
was not useful. 
R = H    
R = Me
+
+ +
KOBut, THF
rt, 24 h
O RR
OBn
O
OH
O RR
OH
O
OBn
RR
O
OBn
O RR
O
OBn
O
OH
O RR
O
HO
OBn
HO  
Figure 34: Resulting mixture of dioxatricycles by intramolecular epoxy opening  
 
4.1.3 Synthesis of new tricyclic oxetanes 
 
The free alcohol function in the oxetane 51 structure was oxidized using the Swern 
oxidation74 method to generate corresponding ketone 52. Afterwards a Wittig reaction75  
using the ylid76 111 did not give the desired tricyclic product (Figure 35). 
51 52
(COCl)2, DMSO,Et3N,      
DCM, -78°C - rt
77%
Ph3P=CHCH2OH
THF, -78°C - rt, 1d
111
112
O
O
O
OMe
O
O
HO
OMe
O
O
OMe
OH
 
 
Figure 35: Swern oxidation to oxetane 52 and attempted Wittig reaction 
                                                 
74  Shishido, K.; Takahashi, K.; Fukumoto, K. J. Org. Chem. 1987, 52, 5704. 
75  Wittig, G.; Geissler, G. Justus Liebigs Am. Chem. 1953, 580, 44-57. 
76  provided by S. Malik, see: a) Malik, S. Doctoral thesis, University of Hannover 2002; b) see also: 
Johnson, A. W. Ylid Chemistry, Academic Press, New York, 1979. 
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Although the tricyclic system 112 was not generated, Hands77 reported that the structure 
113 can reacted as a phosphonium ylid with aldehydes and ketones to give ?,d-unsaturated 
alcohols (Figure 36). 
Ph3P CH(CH2)2OH
+ - Ph
O
170°C
Ph (CH2)2OH
+
Ph
(CH2)2OH
44% 56%113  
 
Figure 36: Wittig olefination with the ylid 113 by Hands 
 
The same Swern oxidation procedure in the case of tricyclic 109 afforded ketone 114 with 
an acceptable yield (Figure 37). 
(COCl)2, DMSO,Et 3N,        
DCM, -78°C - rt
109 114
60 %
O
O
HO
OEt
O
O
O
OEt
 
 
Figure 37: Swern oxidation to tricyclic ketone 114  
 
As an alternative oxidative agent PCC was employed despite the above result. The tricyclic 
alcohol 108 was oxidized to the lactone 115 by PCC oxidation. 78 This oxidation was 
carried out using Pyridinium Chlorochromate in DCM at room temperature. The resulting 
unexpected lactone product 115 could be isolated in small yield (Figure 38).  
108 115
PCC, NaOAc, DCM               
rt, 16 h
12 %
O
O
HO
OMe
O
O
O
OMe
O
 
Figure 38: Oxatricyclic lactone by PCC oxidation from oxetane 115 
                                                 
77  Hands, A. R.; Mercer, A. J. H. J. Chem. Soc. (C) 1968, 2448-2452. 
78  Kassou, M.; Castillón, S.  J. Org. Chen. 1997, 62, 3696-3701. 
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The product obtained was similar to that of a Baeyer-Villiger oxidation79 where a cyclic 
ketone is transformed into a lactone by peracid. Overoxidations reactions by using PCC are 
rare, but acids can be directly prepared from aldehydes with stoichiometric sodium cyanide 
and PCC in THF.80 Pyridinium chlorochromate shows a slightly acidic character and in 
presence of compounds bearing acid-sensitive groups, the reaction can be buffered with 
powdered sodium acetate. Lactone 115 was obtained from alcohol 108 the most probable 
reason was an overoxidation effect of PCC generating at first ketone 116 which was 
oxidized immediately to lactone (Figure 39). 
108 115116
O
O
HO
OMe
O
O
O
OMe
O
O
O
O
OMe
 
 
Figure 39: Reaction steps of the PCC oxidation to lactone 115 
 
Lactone 115 represents a new interesting oxetane tricycle structure, which can be 
employed as precursor to further synthesis of new dioxatricyclic structures and as a source 
of biological activities and in total synthesis of natural products. The crystal structure of 
compound 115 confirmed the spectroscopic results (Figure 40). 
 
 
Figure 40: Crystal structure of lactone 115 
                                                 
79  a) Baeyer, A.; Villiger, V. Ber. Dtsch. Chem. Ges. 1899, 32, 3625-3633; b) Baeyer, A.; Villiger, V. Ber. 
Dtsch. Chem. Ges . 1900, 33, 858-864; c) Renz, M.; Meunier, B. Eur. J. Org. Chem. 1999, 737-750. 
80  Reddy, P. S.; Yadagiri, P.; Lumin, S.; Shin, D.-S.; Falck, J. R. Synthetic Comm. 1988, 18, 545. 
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4.1.4 Synthesis of enantiomerically pure oxatricyclic structures 
 
The racemic dioxatricyclic structure synthesized by J. Wittenberg a-methoxy-substituted at 
the C3-position showed anti-tumor activity (see chapter 2.1.6). Because of this interesting 
result an enantiomerically pure oxetane was synthesized to observe its biological activity.  
Diastereoselective generation of an a-alkoxy-substituted 8-oxabicyclico[3.2.1]ketone was 
accomplished by an asymmetric [4+3] cycloaddition81 at low temperature. In previous 
works a method for the asymmetrical [4+3] cycloaddition was developed by using a chiral 
oxy allyl cation in which a mixture of bicyclic diastereomers (7:1) was obtained (see 
chapter 2). The diastereoselective [4+3] cycloaddition between furan and oxy allyl cation 
(R)-117, optimized by C. B. W. Stark, generated diastereomers (2R)-27A and (4S)-27B 
which were separated by column chromatography. The 1-phenylethoxy group at carbon C2 
of the cycloadduct adopted the equatorial position exclusively82 (Figure 41). 
(2R)-27A
OSiEt3
OMe
O Ph(R) O
DCM, TMSOTf,
-95°C, 5 min
(R)-117
O
O
O
Ph
(R) +
O
O
O
Ph
(S)
(4S)-27B
74% 7 : 1
(99% de)
(R) (R)
 
Figure 41: Asymmetric [4+3] cycloaddition to oxabicyclic (+)-(2R)-27A 
 
After the derivation of the alcohol function at the C3-position to obtain the methoxy ether 
further derivations were carried out following the strategy previously mentioned. The 
bicyclic83 (+)-27A was reduced selectively by using DIBAH into the a-alcohol (+)-118 
which was protected with a methyl ether group affording methoxy bicyclic (+)-119. 
Alkene methyl ether was treated with a peracid, m-CPBA, to obtain the epoxy (+)-120 and 
the epoxy alcohol (+)-121 was generated by debenzylation. Base treatment with KOBut  
made possible an intramolecular epoxy opening to the desired oxetane structure (+)-122 in  
 
                                                 
81  a) Stark, C. B. W.; Eggert, U.; Hoffmann, H. M. R. Angew. Chem. 1998, 110, 1337; b) Pierau, S.; 
Hoffmann, H. M. R. Synlett 1999 , 213; c) Stark, C. B. W.; Pierau, S.; Wartchow, R.; Hoffmann, H. M. R. 
Chem. Eur. J. 2000, 6, 684; d) Beck, H.; Stark, C. B. W.; Hoffmann, H. M. R. Org. Lett. 2000, 2, 883. 
82  Pierau, S.; Hoffmann, H. M. R. Synlett 1999 , 213. 
83  provided by M. Schumann, unpublished work. 
4. RESULTS AND DISCUSSION                                                                                                             - 37 -                                                                                          
acceptable yield. The following Figure 42 illustrates the reaction sequence to synthesize 
the enantiomerically pure oxetane. 
(+)-27A (+)-118
93%
DIBAH, THF 
-78°C, 16 h
(+)-119
82%
NaH, MeI, THF
0°C - rt, 16 h
(+)-120
m-CPBA, DCM
0°C - rt
(+)-121
Pd/C, H2, AcOH
MeOH, rt
41%
KOBut, THF
      rt
53%
(+)-122
86%
O
O
O (R) Ph
O
OH
O (R) Ph
O
OMe
O (R) Ph
O
O
O
HO
OMe
O
OMe
O (R) Ph
O
OMe
OH
O
 
 
Figure 42: Strategy employed to synthesize enantiomer oxetane (+)-122 
 
4.1.5 Synthesis of new dioxatricyclic structures 
 
Epoxy alcohol 50 was oxidized to ketone 123 by per-ruthenate oxidation84 in acceptable 
yield. The same structure was obtained in previous work85 by Swern oxidation86 (Figure 
43). 
50 123
a)
b)
O
OH
O
OMe
O
O
O
OMe
 
 
Figure 43: Oxidations of epoxy alcohol 50, a) Per-ruthenate oxidation: TPAP, NMO, 
DCM, RT, 50%; b) Swern oxidation, (COCl)2, DMSO, Et3N, DCM, -78°C-rt, 70% 
                                                 
84  a) Griffith, W. P.; Ley, S. V. Aldrichimica Acta 1990, 23,13; b) Griffith, W. P.; Ley, S. V.; Whitcombe, G. 
P.; White, A. D. J. Chem. Soc. , Chem. Comm . 1987,1625. 
85  See chapter 2 by: Proemmel, S. Doctoral thesis, University of Hannover 2001 
86  Shishido, K.; Takahashi, K.; Fukumoto, K. J. Org. Chem. 1987, 52, 5704. 
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Ketone 123 was exposed to ylid 111 under Wittig conditions but the desired product was 
not obtained (Figure 44) although similar Ylids were employed in several Wittig reactions 
(see chapter 4.1.3).  
  
123 124
     
-78°C - rt, 1d
Ph3P=CHCH2OH+
111
THF
O
O
O
OMe
O
O
OMe
OH
 
 
Figure 44: Attempted Wittig olefination of the epoxy ketone 123 
 
In structure 124 a protection of the free alcohol function would be possible followed by the 
selective deprotection of the methoxy function to an alcohol. A subsequent intramolecular 
epoxy opening would generate a new dioxatricycle, which is highly functionalized and 
would offer several sites for further derivations (Figure 45). 
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Figure 45: A route to obtain new dioxatricyclic structures  
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4.2 Studies to synthesize tropane alkaloids via [4+3] cycloaddition by using oxyallyl 
cations  
 
The [4+3] cycloaddition of pyrrole and their derivatives should offer a favorable synthetic 
pathway to building blocks, which in further synthetic steps could be transformed to the 
tropane alkaloids Tropine 125, Tropinone 80 and Scopolamine 18, are compounds of 
pharmacological and toxicological interest (Figure 46).  
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Figure 46: Structure of some tropane alkaloids 
 
The cycloaddition reaction was executed between an oxyallyl cation and several 
substituted pyrrole structures. The desired bicyclic compound 126 should present a 
skeleton similar to the highly biological active Scopolamine 18, Tropine 125 and 
Tropinone 80 alkaloids (Figure 47). 
 
N
O
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Figure 47: Structure of the desired cycloadduct 126 similar to tropane skeleton 
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4.2.1 Protecting groups for the pyrrole 
  
It was necessary to protect the amino group at the pyrrole whose nucleophilicity and 
basicity could present a problem by the use of oxyallyl cations in the [4+3] cycloaddition 
to generate the corresponding cycloadduct. 
Several protecting groups such as BOC, Ts, Piv and Ms were employed to protect the 
amino group in the pyrrole structure. N-acyl protecting groups (e. g. tert-butoxycarnonyl, 
Boc) are easy to introduce and offer a wide range of deprotection conditions. Arylsulfonyl 
groups (e. g. p-toluenesulfonyl, Ts) are effective protecting groups for secondary amines. 
Pivaloyl group (Piv), is a typical hydroxyl protecting group but was also employed to 
protect the amino group of pyrrole structures and the corresponding products were 
generated with acceptable yields, Table 9. 
 
Table 9  
 
 
Entry R R1 Conditions Yield [%] 
1 H BOC (BOC)2O, THF, Et3N, DMAP, rt, 16 h 78 
2 H Piv PivCl, THF, Et3N, DMAP, 0°C - rt, 20 h 70 
3 H Ts TsCl, THF, Et3N, DMAP, 0°C - rt, 16 h n. r. 
4 H Ts TsCl, KOBut, DMF, 0°C - rt, 16 h 81 
5 H Ms MsCl, THF, Et3N, DMAP, 0°C - rt, 24 h 42 
6 Me BOC (BOC)2O, THF, Et3N, DMAP, rt, 16 h 82 
 
The results above showed that the p-toluenesulfonyl group was the most appropriate 
protecting group in case of pyrrole. The tert-butoxycarbonyl group was also adequate for 
pyrrole and 2,5-dimethylpyrrole being obtained acceptable yields. 
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4.2.2 [4+3] Cycloaddition between substituted pyrrole and oxy allyl cation 
 
The protected pyrrole was used afterwards in the [4+3] cycloaddition under the reaction 
conditions used for furan and 2,5-dimethylfuran as (4p)-component.  
In the present work was it interesting to try the [4+3] cycloaddition reaction employing 
silyl enol ether 44 as oxyallyl cation which had given excellent results in the same 
cycloaddition reactions with furan and 2,5-dimethylfuran. Several cycloaddition conditions 
with silyl enol ether 44 were tried to obtain the desired bicyclic structure, Table 10. 
 
Table 10 
N
OSiMe 3
OBn
OBn
R1 = BOC
TMSOTf, DCM, -78°C
R1
N
O
OBn
R1
+
44
RR
R
R
R = H
R = Me
Piv
R1 = BOC
163
128
127
N
O
OBn
R1
 
Entry R R1 Temperature t 
1 H Piv -78°C  10 min 
2 H Piv -78°C 7 min 
3 H BOC 0°C - rt 3 h 
4 H BOC -30°C 3 h 
5 H BOC -40°C 1.5 h 
6 H BOC -90°C 1 h 
7 H BOC -90°C 2 h 
8 H BOC -78°C 2 h 
9 H BOC -90°C 2 h 
10 Me BOC 0°C - rt 3 h 
11 Me BOC -20°C - rt 3 h 
 
A short time reaction (entry 1) showed the existence of the desired cycloadduct. It was not 
possible to isolate the bicycle via aqueous work-up. 
Afterwards, it was tried to obtain the cycloaddition product by using a smaller protecting 
group like methyl. Further, another type of silyl enol ether was employed in the reaction to 
observe the  influence of  different  oxyallyl  cations. The  cycloaddition  reaction  between  
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N-methylpyrrole 129 and silyl enol ethers 44 and 13087 were also unsuccessful (Figure 48). 
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Figure 48: Failed [4+3] Cycloaddition between methylpyrrole and oxy allyl cations 44 and 
130 
To obtain the desired cycloaddition products six different substituted pyrrole structures 
were used, two different silyloxyallyl cation and a range of temperatures between -90° and 
0°C was employed. In all the cases, the same solvent and catalyst were employed.  In no 
case an appropriate way was found to generate the expected cycloadduct. These results 
suggest to the necessity to choose a different type of oxyallyl cations with a proper blend 
of electrophilicity and nucleophilicity. 
Using pyrrole as diene partner in the [4+3] cycloaddition, electrophilic substitution 
competed strongly with cycloaddition reaction which can be accomplished by using an 
oxyallyl moiety88 (Figure 49).  
N
O-M
R
N
O
R
+ +
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R
cycloaddition product
substitution product
O
R = H, Me, COMe, Ph
M = ZnBr, Fe(II), Na
 
 
Figure 49: Possible products by [4+3] cycloaddition with substituted pyrrole 
                                                 
87  provided by M. Schumann, unpublished work. 
88  Sarhan, Abd El-Wareth A. O. Curr. Org. Chem. 2001, 5, 827-844. 
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It is suggested that in this case, the formation of the seven-membered ring proceeds in 
distinct stages, i.e., the stepwise pull-push mechanism involving formation of the first 
sigma bond in an electrophilic step and a second sigma bond in a nucleophilic step,89 Class 
B process using the terminology of Hoffmann90 (Figure 50). 
 
Y Z Y
intermediate
1) 2)
Z Y
 
 
Figure 50: Class B, Stepwise bond-formation 
 
 
It is reported that the use of the more electrophilic oxyallyl cations in conjunction with N-
alkylpyrroles leads to the exclusive formation of substitution products.91 These are 
formally products of a Class C process, using the terminology by Hoffmann in which an 
electrophilic addition is followed by loss of a proton with overall electrophilic substitution 
(Figure 51). 
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Figure 51: Class C, Electrophilic addition followed by a) loss of a proton with overall 
electrophilic substitution or b) intermolecular or c) intramolecular-nucleophilic capture of 
the carbocation  
                                                 
89  Rawson, D. I.; Carpenter, B. K.; Hoffmann, H. M. R. J. Am. Chem. Soc. 1979, 101, 1786. 
90  a) Hoffmann, H. M. R.; Angew. Chem. Int. Ed. Engl. 1984, 23, 1-19; b) Hoffmann, H. M. R.; Angew. 
Chem. 1984, 96, 29-48. 
91  For cycloaddition with pyrrole see: a) Mann, J. Tetrahedron 1986 , 42, 4611-4659; b) Sarhan Abd El-
Wareth A. O. Current Org. Chem. 2011, 5, 827-844. 
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An example of the influence of cation electrophilicity on the course of this reaction can be 
seen with N-methylpyrrole serving as the diene partner (Figure 52) where only the less 
electrophilic 2p(3C) partner (from NaI/Cu) generates [4+3] cycloadducts. Even a slightly 
more electrophilic species (from Zn/Cu) gives rise to regioisomeric mixtures of 
electrophilic substitution (Class C) products, and the strongly electrophilic oxyallyliron 
species gives only Class C products. 
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Figure 52: Influence of cation electrophilicity in [4+3] cycloaddition 
 
 
Presumably, silyl enol ethers as oxyallyl cation precursors in cycloaddition reaction 
conditions with pyrroles generate only substitution products. 
 
4.3 Synthesis of new biologically active Scopoline derivates from 8-
oxabicyclo[3.2.1]oct-6-en-3-one 
 
A synthetic way to generate the scopoline skeleton started from the bicyclic rac-45 and 
rac-94 which in further synthetical steps could be transformed to the tropane alkaloids 
Scopoline 19 and Scopolamine 18, compounds of pharmacological and toxicological 
interest (Figure 53).  
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Figure 53: Structure of some tropane alkaloids 
 
The synthetic strategy started from oxabicyclic systems rac-45 and rac-94 and further 
derivations yielded epoxides 134 and 135 which through an epoxy opening generated the 
desired Scopoline skeletons (Figure 54). 
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Figure 54: Synthesis strategy to Scopoline analogues 
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4.3.1 Amine function at t he C3-Position in bicyclic skeleton 
 
The introduction of an amino group at the C3-position was realized by a reductive 
amination under different reaction conditions, the results are shown in Table 11. 
 
Table 11 
R = H     rac-94
R = Me   rac-45
R = H     136
R = Me   72
O RR
O
OBn
O RR
NH2
OBn
 
Entry R Conditions Yield [%] 
1 Me NH4OAc, NaBH3CN, MeOH, RT, 2-3 d 63 
2 H NH4OAc, NaBH3CN, MeOH, RT, 2-3 d 55 
3 Me NH4OAc, NaBH(OAc)3, MeOH, 7 d no reaction 
 
Reductive amination with sodium triacetoxyborohydride (entry 3) was not successful 
because of the side reaction of the ketone to the corresponding alcohol, although 
procedures using this mild and selective reagent have been developed for a wide variety of 
substrates.92 Limitations of the reaction include aromatic and unsaturated ketones and some 
sterically hindered ketones and amines. Amines 72 and 136 were generated using sodium 
cyanoborohydride in methanol, by the method introduced by Borch and coworkers.93 The 
electron-withdrawing cyano ligand of NaBH3CN decreases the hydridic reactivity 
compared to sodium borohydride and allows the selective reduction of carbon-nitrogen 
double bonds in the presence of aldehydes or ketones at slightly acidic pH in the range of 
5-7 and is typically performed in alcoholic solvents. 
 
 
 
 
                                                 
92  Abdel-Magid, A. F.; Carson, K. G.; Harris, B. D.; Maryanoff, C. A.; Shah, R. D. J. Org. Chem. 1996, 61, 
3849-3862. 
93  Borch, R. F.; Bernstein, M. D.; Durst, H. P. J. Am. Chem. Soc. 1971, 93, 2897. 
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4.3.2 Protection of the free amino function 
 
The amino function has nucleophilic and basic character which represents a problem in the 
synthesis of a diverse array of biological molecules such as amino acids and alkaloids. 
The tert-butoxycarbonyl group (Boc), is one of the most frequently used amino protecting 
groups in organic synthesis being inert towards catalytic hydrogenolysis and extremely 
resistant towards basic and nucleophilic reagents. For this reason, the tert-butoxycarbonyl 
group was used to protect the amino function in both oxabicyclic systems 137 and 138. 
The amino compound was dissolved in THF/Et3N mixture and treated with (BOC)2O in the 
presence of a catalytic amount of DMAP at 0°C (Figure 55). 
R = H     136
R = Me   72
R = H     137
R = Me   138
(BOC)2O, Et 3N,
DMAP, THF
0°C - rt, 16 h
O RR
NH
OBn
BOC
O RR
NH2
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Figure 55: Protection of free amino function at the bicyclic structure 72 and 136  
 
After this protection, the bicyclic compounds could be used in the next steps of the 
synthetic pathway to the desired tropane skeleton. 
 
4.3.3 Formation of a tricyclic structure analogue to Scopoline skeleton  
 
In a previous chapter (see chapter 4.1.2.4) the interest of an intramolecular epoxy opening 
as a route to an oxetane structure was outlined. In a similar way, we made use of this 
strategy to come to analogous tricyclic structures of Scopoline by intramolecular epoxy 
opening. 
The cyclization of ß-amino acids was first reported in 1975 by using a Grignard-mediated 
cyclization of an N-silylated aspartate diester.94 This method was used in the synthesis of 
Thienamycin, synthesized by Merck.95 In this synthetic method, the cyclization to the 
desired b-lactam 145 was carried out from N-trimethylsilyl-dibenzylaspartate 146 by using 
                                                 
94  Birkofer, L.; Schramm, J. Justus Liebigs Ann. Chem. 1975, 2195. 
95  Salzman, T. N.; Ratclife, R. W.; Christensen, B. G.; Bouffard, F. A.; J. Am. Chem. Soc. 1980, 102, 6161. 
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tert-butylmagnesium chloride through an intramolecular cyclization (Figure 56). 
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Figure 56: Intra-molecular lactonization using ButMgCl  
 
A possible mechanism was described by Testa96 who carried out a cyclization with a 
Grignard reagent as strong and electrophilic base in an amount of 2 mol per mol of the 
amino ester 147. The pathway for the synthesis of the amide firstly involves a substitution 
step followed by a cyclization to generate the corresponding intermediate which after 
substitution and cleavage yields the desired amide (Figure 57). 
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Figure 57: Mechanism suggested by Testa for the cyclization using Grignard reagent  
 
To afford the Tropane structure by intramolecular epoxy opening several Grignard 
compounds were used, Table 12.  
                                                 
96  Testa, E.; Fontanella, L.; Cristiani, G. F.; Fava, F. Liebigs Ann. Chem. 1958, 614, 158. 
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Table 12 
+
R = H     134
R = Me   135
R = H     141
R = Me   142
R = H     143
R = Me   144
main products secondary products
20  :  1
O RR
NH
OBn
BOC
O
RR
N
OBn
O
HO
BOC
RR
N
OBn
O
OH
BOC
 
Entry R Conditions Yield [%] 
1 Me ButMgCl, THF, 0°C - rt, 2 h 77 
2 Me PrMgCl, THF, 0°C - rt, 4 h 75 
3 Me PrMgCl, THF, 0°C - rt, 65 h 68 
5 H ButMgCl, THF, 0°C - rt, 2 h 60 
6 H PrMgCl, THF, 0°C - rt, 4 h 61 
 
Above results showed good yields when tert-butylmagnesium chloride or 
propylmagnesium chloride were used. The Grignard compounds were ideal reagents for 
the formation of the stable NH-BOC-protected tricycle. The generated Tropane skeletons  
were highly functionalized and offered well defined stereocenters and functionality for 
further derivations (Figure 58). 
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Figure 58: Synthesized tricyclic products by intramolecular epoxy opening with Grignard-
reagent 
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The intra-molecular cyclization of the epoxides 134 and 135 to the Scopolin derivates gave 
two different diastereomers 141-143 and 142-144 (see figure 58). It was unexpected that 
the main products were generated by the cyclization to the C7-position giving a free 
alcohol function at the C6-position. It is possible that due the free electron pairs of the 
oxygene atom from the benzyl group a stable five membered ring chelat complex is 
generated attempting a selective ring opening (Figure 59).  
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Figure 59: Chelat complexes formed at the epoxy opening toward the main products 141 
and 142 
 
In the oxazatricycle structures 141 and 142 the hydroxyl and the benzyl groups are in the 
equatorial position at the C2 and C6-carbon atom respectively, unlike in the secondary 
product 143 and 144 where the hydroxyl groups were in the equatorial position at C2 and 
the benzyl groups were in the axial position at the C4-carbon atom. The diastereomers 
represented are different in two of the six containing stereocenters. Both diastereomers 
were available for separation by column chromatography and the crystal structure of 
compound 142 confirmed the spectroscopic results (Figure 60). 
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Figure 60: Crystal structure of the main tricyclic alcohol 142 
 
4.3.4 Derivation at the Tropane skeleton  
 
The free alcohol function offers possibilities for further transformations of the tropane 
structures 141-144. Oxidation of the major alcohols 141 and 142 under Swern conditions 
generates two new compounds, which nearly have a similar skeleton as 77, synthesized by 
S. Proemmel (see chapter 2), and later investigated for its cytostatic activity.  
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Figure 61: Tropane derivate with cytostatic activity 
Due to its potential biological importance, ketones 148 and 149 were synthesized to gain 
further information about for SAR studies.  
Swern oxidation reaction was carried out under similar conditions as used previously 
(chapter 4.1.3). Oxidation of tricyclic compound 141 gave low yields due to its structural 
instability, but the oxidation of oxazatricyclic 142 gave excellent yields (Figure 62).  
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Figure 62: Swern oxidation of main alcohols 141 and 142 to obtain similar tropane 
skeleton 148 and 149 
 
The X-ray crystal structure of compound 148 confirmed the spectroscopic results (Figure 
63). 
  
 
Figure 63: Crystal structure of two conformations of the oxazatricyclic ketone 148 
 
Tricyclic ketone 148 was examined for its pharmacological activity and showed strong 
cytotoxic activity (see chapter 4.5). 
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4.4 Studies toward substituted furans for [4+3] cycloadditions  
 
Substituted furans are an attractive target for biological active bicyclic compounds and a 
[4+3] cycloaddition seems to offer a simple access to these highly functionalized 
oxabicyclic systems. 
 
4.4.1 Furan substituted with alkyne function at the C2-position 
 
The alkyne function offers possibilities for further derivations at the bicyclic ring that 
could lead, after ring opening, to different cycloheptanones, which are valuable in 
carbohydrate and natural product chemistry. 
A 2-alkynyl substituted furan system should lead after [4+3] cycloaddition with the silyl 
enol ether 44 to a bicyclic system with the desired alkynyl side chain (Figure 64). 
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Figure 64: Strategy to synthesize desired oxabicycle by [4 + 3] cycloaddition between 
silyl enol ether 44 and substituted furan 
 
A prior introduction of a benzyl group firstly leads to a much more stable furan system. 
After introducing the benzyl group at the C2-position iodine should be incorporated in the 
C5-position by deprotonation with n-BuLi and iodination with I2 in THF at -40°C (Figure 
65).97  
O O Bn
151150
i)n-BuLi, THF, rt, 4h
ii)BnBr, rt, 16h
67%
O Bn
152
In-BuLi, I2, THF, -40°C
 
 
Figure 65: Failed introduction of I2 atom in structure 151 
                                                 
97  Kauffmann, T.; Lexy, H. Chem. Ber.  1981, 114, 3667-3673. 
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The desired product was not obtained. Different spectroscopy measurements showed the 
existence of an I atom in the structure. Two different possibilities were considered for the 
position of this iodine atom: at the ortho-position of the phenyl ring or at the –CH2 group 
of the benzyl moiety (Figure 66). 
O Bn
151
O
n-BuLi, I2, 
THF, -40°C
I
O
I
 
 
Figure 66: Possible products of substitution reaction 
 
As next step a Sonogashira coupling98 was planned between heterocyclic halide 152 and 
acetylene in the presence of a catalytic amount of bis(triphenylphosphine)palladium 
dichloride and cuprous iodide in diethylamine under mild condition (Figure 67).  
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Figure 67: Failed Sonogashira coupling with substituted furan and symmetrically 
acetylene 
 
The desired substituted furan was not generated because the use of the symmetrically 
acetylene generate the diyne 154 which was not possible to isolate. Doye et al99 
synthesized alkyl(aryl)alkyne 157 via 2-iodofuran and 1-pentyne by Sonogashira coupling 
under the following conditions (Figure 68).   
 
                                                 
98  a) Sonogashira, K.; Tohda, Y.; Hagihara, N. Tet. Lett. 1975, 16, 4467-4470.; b) Sonogashira, K. in 
Comprehensive Organic Synthesis Vol. 3 , Trost, B. M.;  Fleming, I.; Eds., Pergamon: Oxford 1991, 521. 
99  Siebeneicher, H.; Doye, S. Eur. J. Org. Chem., 2002, 1213-1220. 
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Figure 68: Sonogashira coupling with substituted furan and asymmetrically acetylene by 
Doye 
 
The [4+3] cycloaddition between substituted furan100 157 and the silyl enol ether 44 did 
not yield the desired adduct 158 (Figure 69). It is possible that the existence of a terminal 
alkyne leads to a [2+3] cycloaddition reaction unlike the expected [4+3] cycloaddition.  
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Figure 69: Failed [4+3] Cycloaddition between substituted furan 157 and silyl enol ether 
44 
 
Another route to a substituted furan with an ethynyl rest at C2-position was attempted 
(Figure 70). Intermediate dibromo olefin function was generated from furfural 159 by a 
synthetic method from by Corey and Fuchs 101 in good yield. The dibromo olefin 160 was 
taken for the next reaction to get the terminal alkyne 161 following the reaction conditions 
used by Rossi102 who realized this transformation into the corresponding terminal alkyne 
according to the Corey-Fuchs method but using methyllithium instead of n-butyllithium in 
the reaction with the dibromo olefin 160 in tetrahydrofuran at -78°C for 1 h. Unfortunately, 
alkyne 161 was not obtained in adequate yield so, the corresponding [4+3] cycloaddition 
was not attempted.  
 
                                                 
100  provided by H. Siebeneicher 
101  Corey, E. J.; Fuchs, P. L. Tet. Lett. 1972, 36, 3769-3772. 
102  Carpita, A.; Rossi, R.; Veracini, C. A. Tetrahedron, 1985, 41, 1919-1929. 
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Figure 70: Failed substituted alkyne by Corey-Fuchs method 
 
Furfural was also treated with the anion of dimethyldiazomethylphosphonate103 162 from 
Bestmann104 to afford compound 161. In this method, the reaction can be performed by 
adding the phosphonate 162 to a solution of K2CO3 and the aldehyde in methanol at room 
temperature. This method avoids the use of strong bases, low temperature and inert gas 
techniques unlike previous methods.105 The desired product was not isolated (Figure 71).  
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Figure 71: Failed substituted furan with terminal alkyne using Bestmann method 
 
4.5 In-vitro-tests for the characterization of the cytostatic or cytotoxic effect of 
functionality in Dioxa and Oxaza-tricyclononane structures 
 
The most commonly employed in vitro system is a cell line from a human epidermoid 
carcinoma of the nasopharynx, named KB. The KB procedure is used routinely for 
evaluating extracts from natural products. When the antineoplastic agent has been isolated, 
it is evaluated further in the cell line and studies begin in different systems like colon, 
mammary, etc. Biosynthetic products selected for preclinical development must show a 
high level of activity in several of these representative experimental tumor systems. 
A cytostatic activity means a preventive action on grow and proliferation of tumor cells 
and a cytotoxic effect means an attack and destroying action in the tumor cells. 
In the context of the thesis some of the synthesized compounds were examined for their 
pharmacological activity. Dioxatricyclic C-glycosides 108 and its cyclization precursor, 
                                                 
103  provided by L. O. Haustedt, see: Haustedt, L. O. Doctoral thesis, University of Hannover, 2002. 
104  Müller, S; Liepold, B.; Roth, G. J.; Bestmann, H. J. Synlett 1996, 521-522. 
105  see: a) Köbrich, G.; Trapp, H.; Flory, K.; Drischel, W. Chem. Ber. 1966, 99, 689; b) Matsumoto, M.; 
Kuroda, K. Tet. Lett. 1980, 21, 4021; c) Corey, E. J.; Achiwa, K.; Katzenellenbogen, J. A. J. Am. Chem. Soc. 
1969, 91, 4318; d) Bestmann, H. J.; Rippel, H.; Dostalek, R. Tet. Lett. 1989, 30, 5261. 
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the epoxy alcohol 105; the Scopoline derivate 148 and its cyclization precursor 134 were 
tested (Figure 72).  The examination, in vitro, about cytostatic and cytotoxic effects of the 
4 substances was attempted on growing tumor cell of three different cell- lines: HMO2 
(Gastric carcinoma), HEP G2, (Hepatic carcinoma), MCF7 (Mamma carcinoma). Only the 
Scopoline derivate 148 show a significant biological activity. The exact results are 
presented and discussed in following chapter 4.5.1. 
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Figure 72: Structures tested for biological activity  
 
4.5.1 Results of the cytostatic and cytotoxic in vitro test  
 
A relative strong cytotoxic effect could be determined in the Scopolin derivative 148. The 
other tested compounds did not show any effect until concentration of 10 µg/ml at the three 
cell- lines HMO2, HEP G2, MCF7 previously mentioned. The results of the investigation106 
are summarized in the Table 13. 
 
 
 
 
 
 
 
 
 
                                                 
106  Characterization of the pharmacological effects was realized by: Prof. W. Beil, Institut für Allgemeine 
Pharmakologie, Medizinische Hochschule Hannover. 
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Table 13 
148
N
BOC
BnO
O
O
 
 Cell- line 
Carcinoma type GI50  TGI  LC50 
HMO2 (Gastric carcinoma) 0,17 0,26 0,42 
HEP G2 (Hepatic carcinoma) 0,16 0,25 1,80 
MCF7 (Mamma carcinoma) 0,42 0,38 4,40 
 
Above values of cell line show the cytostatic effect (GI50 and TGI) and the cytotoxic 
effect (LC50) by concentration level of tested compound (all specification in µg/mL): 
GI50 = Drug concentration causing 50% growth inhibition  
TGI = Drug concentration causing 100% growth inhibition 
LC50 = Drug concentration causing 50% reduction of the cells present at time zero, i.e at  
24 h 
Internal limiting values for the evalua tion of cytotoxic effect are related to standard 
cytostatic (5-fluorouracil and cis-platinum, see chapter 2.1.6) are shown in Table 14. 
Table 14 
Estimation of cytotoxic activity Cytostatic limits 
good GI50 < 1 mmol/L  +   TGI < 5 mmol/L 
satisfactory GI50 < 5 mmol/L  +   TGI < 10 mmol/L 
weak efficient GI50 < 10 mmol/L oder TGI < 50 mmol/L 
inefficient GI50 > 10 mmol/L 
 
The comparison of the values in both tables (Table 13 and Table 14) indicated that the 
measured GI50 values were in the interval of GI50 < 1 mmol/L as well, values of TGI were 
in the interval TGI < 1 mmol/L too. In conclusion, the estimation of the cytotoxic effect of 
the Scopolin derivate 148 was relative strong. 
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5. SUMMARY AND CONCLUSIONS 
 
A series of tricyclic structures containing different ether functions at the C3-position were 
prepared from 8-oxabicyclo[3.2.1]oct-6-en-3-one as starting material. Three differing alkyl 
groups, methoxy, ethoxy and propoxy were employed to protect the free alcohol function 
at the C3-atom position in the bicyclic structures rac-45 and rac-94 (see chapter 4.1.2.1). 
Further derivations at the dioxatricyclic structures synthesized afforded two new 
compounds, ketone 114 and lactone 115 (Figure 73).  
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Figure 73: View of substituted oxatricyclic structures with an ether function at the  
C3-position 
 
In previous works the oxetane system 51 was synthesized and it showed cytostatic and 
cytotoxic effects using a human gastric carcinoma and a human heptocellular cell line (see 
chapter 2). The biological activity of the tricyclic structure 108 was measured by in vitro 
test. No cytostatic or cytotoxic activity up to a concentration of 10 µg/mL was observed 
(see chapter 4.5). The difference of the biological activity in both substances related to 
their structure. Dioxatricyclic systems 51 and 108 have a similar but they contain a 
different ether function at the C3-atom position. Moreover oxetane 51 include two methyl 
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groups at C1 and C5. It is not clear which group causes the distinction in biological 
activity. For this reason, it would be of pharmacological interest to synthesize and test 
some derivatived oxetanes (Figure 74). 
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Figure 74: Oxatricycles structures as pharmacological targets 
 
Lactone 115 represents an unexpected overoxidation with PCC from tricyclic alcohol 108 
(see chapter 4.1.3). The biological activity of this lactone has, as yet, not been tested, but if 
in-vitro-test gives a positive result, similar lactones with different alkyl ether functions at 
the C3-position will be of interest. 
The diastereoselective asymmetrical [4+3] cycloaddition with chiral oxyallyl cations was 
employed for the synthesis of enantiomerically pure tricyclic oxetane (Figure 75). A short 
and efficient synthesis provides access to enantiopure dioxatricycle (+)-122 (see chapter 
4.1.4). 
2 steps 3 steps
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Figure 75: Synthesized enantiopure dioxatricycle (+)-122  
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The reductive amination of the bicyclic ketones rac-45 and rac-94 with NH4OAc in the 
presence of NaBH3CN is a good method for the introduction of a primary a-amino 
function at the C3-position. After protecting the amino group with the BOC group, the 
oxazatricyclo-nonanes 141 and 142 were obtained in acceptable yields. Ketones 148 and 
149 were generated from the corresponding alcohols (Figure 76). 
 
R = H    rac-X
R = Me  rac-37
2 steps
2 steps
2 steps
2 steps
N
BOC
BnO
OH
O
N
BOC
BnO
OH
O
N
BOC
BnO
O
O
1 step
1 step
N
BOC
BnO
O
O
87%
71%54%
33%
65%
56%
138 142
137 141 148
149
O RR
O
OBn
O
NH
OBn
BOC
O
NH
OBn
BOC
 
 
Figure 76: Oxatricycles substituted at the C3-position with an amine function 
 
Scopoline skeleton 148 showed cytotoxic activity at the human gastric, human hepatic and 
human mamma carcinoma cell lines (see chapter 4.5.1). In only 5 steps the cytotoxic 
oxazatricyclic 148 was synthesized with a yield of 13% over all. 
Ketone 149 and tricyclic alcohols 141 and 142 have not yet been tested. It is expected that 
they show biological activity similar to ketone 148. Besides, different derivatives of the 
mentioned tricyclic alcohols 141 and 142 would be of interest to evaluate possible 
cytotoxic or cytostatic activity. The Scopoline derivative 77 showed cytostatic activity (see 
chapter 2.2.1). For this reason, new oxazatricyclic-nonane structures derived from ketones 
148 and 149 require further study (Figure 77). 
5. SUMMARY AND CONCLUSIONS                                                                                                      - 62 -                                                                      
N
O
O
O
HO
N
H
O
N
H
O
O
77
N
O
O
O
RBnO
N
H
O
N
H
O
O
R
N
O
O
O
RBnO
R
O
R = H     148
      Me   149
R = H     171
      Me   172
2 steps
a)
b)
 
 
Figure 77: a) Scopoline derivative with cytostatic effect; b) Scopoline derivatives with 
potential biological activity 
 
A new synthetic strategy was employed to obtain structures with Tropane skeleton by 
[4+3] cycloaddition between pyrrole or substituted pyrrole and different oxyallyl cations 
(see chapter 4.2). In previous works, similar structures were prepared using other oxyallyl 
cations with acceptable yields (see chapter 2). Pyrrole 81 and 2,5-dimethylpyrrole 139 
were protected with several groups before attempting the mentioned cycloaddition (Figure 
78). 
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Figure 78: Substituted pyrrole and 2,5-dimethylpyrrole 
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After several attempts, no cycloadduct product was synthesized. Although no compound 
could be isolated, it was supposed that, in the [4+3] cycloaddition reaction between the 
pyrrole structure and the silyloxyallyl cation probably only substitution products were 
generated (chapter 4.2.2). 
 
With the aim of preparing bicyclic systems with an alkynyl side chain several reactions 
were carried out to obtain the substituted furans 152 and 161 (Figure 79). Unfortunately, 
the desired alkyne furans were not obtained and consequently [4+3] cycloadditions could 
not be carried out (chapter 4.4). 
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Figure 79: Synthesized substituted furans as precursors of the corresponding alkyne furans 
 
Some X-ray structures were obtained to determine the relative configuration of the 
stereocenters in different molecules (chapter 7): the bicyclic ketone rac-45 and rac-94,  the 
tricyclic structures with methyl and ethyl function at the C3-atom position 105, 108, 109, 
the bicyclic amino compound 134, the Scopoline derivative 142 and two conformational 
structures from tricyclic Scopoline derivative 148 (Figure 80). 
 
 
5. SUMMARY AND CONCLUSIONS                                                                                                      - 64 -                                                                      
N
BOC
BnO
OH
O
N
BOC
BnO
O
O
   rac-94  rac-45
   105 108 115 109
148   142
O
O
OBn
O
O
OBn
O
OH
O
OMe
O
O
HO
OMe
O
O
O
OMe
O
O
O
HO
OEt
O
NH
OBn
BOC
O
 
 
 
Figure 80: Structures corroborated by X-ray crystal diffraction analysis 
6.1 Analytical methods                                                                                                                                - 65 - 
6.1 Analytical Methods  
 
1H NMR spectra were measured using the instrument Bruker WP 200 (200.1 MHz), 400 
(400 MHz) and AVS 400 (400.1 MHz). All NMR- measurements were curried out at room 
temperature in 5 mm NMR tubes, and in deuterated solvents, CDCl3 or CD3OD. 
Tetramethylsilane (TMS, d = 0.00) was used as internal standard. The chemical shifts d are 
represented in (ppm) and the coupling constant over n bond (nJ) is represented in Hertz 
(Hz). The multiplicity of the peaks were abbreviated as s = singlet, d = doublet, t = triplet, 
q = quartet, m = multiplet, br = broad signal, dd = doublet of doublets, ddd = doublet of 
double doublets, dt = doublet of triplets, dq = doublet of quartets. 
13C-NMR-Spectra were measured under 1H broad-band decoupling using the instrument 
Bruker AVS 200 (50.3 MHz) and AVS 400 (100.6 MHz). CDCl3 was used as solvent and 
as internal standard. The multiplicities of the signals were determined with DEPT90 (pulse 
angle q = 900 gave a CH-subspectrum with positive signal amplitudes) and the DEPT135 
(pulse angle q = 1350 gave a CH/CH3-subspectrum with positive as well as the CH2-
subspectrum in negative signal amplitudes). 
H,H-COSY-, C,H-COSY, HBMC-, HMQC and NOE spectra was measured with the 
devices AVD-500, AM-400 and AVS 400 of the company Bruker in CDCl3 with 400 or 
500 MHz. 
Infrared spectra (IR) were obtained using a PERKIN-ELMER FT 1710 spectrometer. The 
following abbreviations were used to indicate the intensity of the absorption bands: s = 
strong, m = middle, w = weak. The characteristic IR absorptions are presented in cm-1. 
Mass spectra (EI MS) were carried out using a FINNIGAN AM 400 mass spectrometer 
(Ionization potential 70 ev). The characteristic EI MS peaks are given m/z (mass to charge 
ratio) and relative percentage intensity of base peak (100 %).  
HR-MS was carried out using a VG-Autospec spectrometer with the peak-matching 
method (PKF), and the NBA-Matrix was used. 
Melting points (m.p.) were measured by using a Büchi equipment according to Dr.Tottoli 
and are not corrected.  
Elementary analyses (EA) were executed for CHN with a Häraeus instrument.  
Thin layer chromatography (TLC) was carried out using aluminium TLC plates coated 
with the silica gel 60F254 from Merck. The detection of substance over the TLC was done 
with the help of the UV-lamp (? = 254 nm) and developed in Ce(IV) 
sulfate/Molybdatophosphoric acid-solvent. 
Column chromatography was carried out using silica gel 60 ?  (40-60 µm) and 60 ?  (20-
45 µm) from the J.T. Baker.  
Absolute solvents were prepared according to the well-known regulations 145 and stored 
over molecular sieves, CaH2 or under an argon atmosphere. THF was distilled over 
Na/benzophenone in an argon atmosphere. Ethanol and methanol were dried over calcium 
hydride. Dichloromethane was dried over calcium chloride. Pyridine was dried over KOH. 
Reactions were executed under nitrogen atmosphere.  
General Remark: The naming of the molecules is according to the IUPAC system. The 
atom numbering follows generally the IUPAC rules. For reasons of clarity in some cases 
the numbering of the atomic positions was changed, this is indicated in the respective 
scheme. 
                                                 
145  Perring, D.D.; Armarego, W.L.F.; Purification of Laboratory Chemicals, 3rd Ed., Pergamon Press Oxford, 
1998. 
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6.2 General Procedures (GP) 
 
GP1. General Procedure for the preparation of silyl enol ether from dibenzyl acetal 
(kinetic conditions) 
LDA solution was prepared adding diisopropylamine (1.4 eq) in a solution mixture of THF 
and nBuLi (1.6 M/hexane, 1.4 eq) at -78°C. The resulting mixture was stirred for a further 
15 min at room temperature. In another round-bottomed flask dibenzyl acetal (1.0 eq) and 
trialkylsilyl chloride (1.6 eq) were dissolved in THF and stirred at -78°C. To this mixture 
LDA and triethylamine (4.5 eq) was added. The resulting reaction mixture was stirred for 
one hour at -78°C then warm till room temperature. The reaction mixture was washed with 
distilled water. The  aqueous phase was then extracted twice with cyclohexane. The organic 
layer was dried over Na2SO4 and concentrated under vacuum. 
 
GP2. General Procedure for the preparation of silyl enol ether from dibenzyl acetal 
(thermodynamic conditions) 
Dibenzyl acetal (1.0 eq) was dissolved in dry DMF (3M). To this mixture was added 
trialkylsilyl chloride (2.3 eq) and heated at 75°C. Triethylamine (2.8 eq) was then added 
via perfusion (30 ml/h). The reaction mixture was refluxed for 16 h at 75°C, and then 
cooled till 0°C, washed with saturated solution of ammonium chloride and with distilled 
water. The aqueous phase was re-extracted with cyclohexane for two times. The organic 
phase dried over Na2SO4 and the solvent removed with a rotatory evaporator.  
 
GP3. General Procedure for the [4+3] Cycloaddition at low temperature  
Silyl enol ether (1.0 eq) was dissolved in dichloromethane at -78°C. Under nitrogen 
atmosphere furan (1.0 eq) was added to the reaction mixture. After 15 min TMSOTf (0.1 
eq) was added. The mixture was stirred for 30 min at –78°C and then poured into a 
separating funnel containing a saturated solution of sodium bicarbonate. The solution was 
shaken thoroughly, it is important, until reach at room temperature. The aqueous layer was 
extracted with dichloromethane for three times and the combined organic phase was dried 
over Na2SO4. After removal of the solvent the crude product was purified by column 
chromatography on silica gel. 
 
GP4. General Procedure for the diastereoselective DIBAH reduction of ketone  
Bicycled ketone (1.0 eq) was dissolved in THF at -78°C and then was added, slowly, a 
DIBAH solution (1.2 M/toluene, 2.2 eq).The solution was left at this temperature over 
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night and quenched at room temperature with 6N aqueous HCl. The aqueous phase was 
extracted four times with MTBE. The combined organic layers were dried over Na2SO4, 
filtered, concentrated under vacuum and purified by column chromatography on silica gel. 
 
GP5. General Procedure of epoxidation using m-CPBA 
Bicycled alkene (1.0 eq) was dissolved in DCM and cooled at 0°C, then m-CPBA (70 - 
75%, 2.0-2.4 eq) was added. The solution was stirred for 1.5 h at 0°C and then, the reaction 
mixture was washed for three times with a 5% Na2CO3 solution. The aqueous phase was 
extracted three times with DCM. The combined organic layers were dried over Na2SO4, 
filtered, concentrated under vacuum and purified by column chromatography on silica gel. 
 
GP6. General Procedure for debenzylation  
A catalytic amount of Pd/C (10%) was dissolved in alcohol. To this suspens ion was added 
a solution of benzyl ether (1.0 eq) in methanol and AcOH. The mixture was stirred at room 
temperature under hydrogen atmosphere for three days, and then was filtered through a 
short silica gel column (EtOH/MTBE 1:1), concentrated under vacuum and washed for 
three times with a 5% Na2CO3 solution. The aqueous phase was extracted several times 
with DCM. The combined organic layers were dried over Na2SO4, filtered, concentrated 
under vacuum and purified by column chromatography on silica gel to afford the alcohol. 
 
GP7. General Procedure for oxetane formation with base treatment  
Epoxy alcohol (1.0 eq) was dissolved in THF and to this solution was added tBuOK (1.2 – 
2.5 eq). The mixture was stirred for 1 day at room temperature, and then was washed with 
distilled water. The aqueous phase was extracted several times with DCM. The combined 
organic layers were dried over Na2SO4, filtered, concentrated under vacuum and purified 
by column chromatography on silica gel. 
 
GP8. Formation of keto oxetane through Swern oxidation 
Oxalyl chloride (4.0 eq) was dissolved in DCM. To this mixture was added, at -78°C, 
DMSO (4.2 eq) and tricyclic alcohol (1.0 eq) in DCM. The solution was stirred for 1h at -
78°C and then NEt3 (9.0 eq) was added. Stirring was continued for 1h at -78°C and 1.5 h 
more at room temperature. The solvent was removed; the residue dissolved in MTBE and 
treated with water. The aqueous layer was extracted several times with MTBE. The 
combined organic phase was dried over Na2SO4, evaporated under vacuum and purified by 
column chromatography on silica gel. 
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6.3 Attempts to chapter 4 
 
6.3.1 Attempts to chapter 4.1.1 
 
1,1-Bis-benzyloxy-propan-2-one 43 
 
O
OMe
OMe
O
OBn
OBn1
2
3
4322  
 
Pyruvic aldehyde dimethyl acetal 24.2 mL (200 mmol, 1.0 eq) was dissolved in 50 mL of 
cyclohexane. To this mixture were added benzyl alcohol 45.5 mL (440 mmol, 2.2 eq) and 
1.9 g  p-toluenesulfonic acid (1.9 g, 10 mmol, 0.05 eq). The resulting mixture was heated 
for 6 h at 100°C to reflux using a Dean–Stark separator for the removal of MeOH. Upon 
the completion of reaction after 5.0 h, 16 mL (400 mmol) of MeOH was obtained. The 
reaction mixture was cooled down to room temperature and washed with 25 mL of 
saturated potassium carbonate solution and 20 mL of dist. water. The aqueous layer was 
extracted twice with cyclohexane (50 mL each). The combined organic phase was dried 
over Na2SO4, evaporated and purified by column chromatography on silica gel (MTBE/CH 
1:10) solvent system to afforded a-Keto acetal 43. 
 
Yield: 44.5 g (164.8 mmol), yellowish oil, 82 % 
           C17H18O3 (270.32) 
1H-NMR (400MHz, CDCl3 + TMS) 
7.43-7.26 (m, 10 H, Ar-H), 4.74 (s, 1 H, H-1), 4.69 (dd, 2J = 12.0 Hz, 2H, -OCH2Ph), 4.58 
(dd, 2J = 12.0 Hz, 2H, -OCH2Ph), 2.56 (s, 3 H, H-3) 
13C-NMR (100 MHz, CDCl3 + TMS) 
203.87(C, C-2), 136.92 (C, Ar-C), 128.17 (CH, Ar-C), 128.04 (CH, Ar-C), 100.94 (CH, C-
1), 69.41 (2XCH2, -OCH2Ph), 25.11 (CH3, C-3) 
IR (neat): 3008 s, 2928 s, 1728 s, 1496 m, 1452 m, 1356 m, 1232 m, 1108 s, 1052 s, 1024 
s, 908 w, 828 w 
EI MS (RT): no M+, 228 (9.8), 227 (28.5, M+-CH3CO),182 (27.8), 181(43.4), 164 (13.6); 
135 (9.7); 108 (18.9); 93 (12.1); 92 (46.7); 91 (100) 
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[1-(benzyloxy-methoxy-methyl)-vinyloxy]-trimethyl-silane 44 
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OSiMe3
OBn
OBnMethod 1
Method 2
43 44  
 
Method 1: GP1; LDA solution was prepared with diisopropylamine (4.8 mL, 35 mmol, 
1.4 eq) in 34.8 mL of THF and nBuLi (1.6 M/hexane, 21.8 mL, 35 mmol, 1.4 eq). 
Dibenzyl acetal 43 (6.75 g, 25 mmol, 1.0 eq) and chlorotrimethylsilane (5.0 mL, 40 mmol, 
1.6 eq) were dissolved in 25 mL of THF. To this mixture the LDA solution and 
triethylamine (15.6 mL, 112.5 mmol, 4.5 eq) was added. After completion the reaction was 
washed with 20 mL distilled water. The obtained yellowish oil was used directly in the 
next steps.  
 
Method 2: GP2; Dibenzyl acetal 43 (27 g, 100 mmol, 1 eq) was dissolved in anhydrous 
DMF (36 mL, 3M solution) and then, chlorotrimethylsilane (28.8 mL, 230 mmol, 2.3 eq) 
was added. The reaction mixture was heated at 75°C. Triethylamine (38.9 mL, 280 mmol, 
2.8 eq) was added via perfusion (30 mL/h). When the reaction was completed, was washed 
with 24 mL saturated solution of ammonium chloride and 20 mL distilled water. The 
resulting brown viscous oil was used directly in the next step. 
 
[1-(benzyloxy-methoxy-methyl)-vinyloxy]-triethyl-silane 95 
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43 95  
 
Method 1: GP1; LDA solution was prepared with diisopropylamine (3.6 mL, 25.9 mmol, 
1.4 eq) in 26 mL of THF and n-BuLi (1.6M/hexane, 18 mL, 25.9  mmol, 1.4 eq). Dibenzyl 
acetal 35 (5 g, 18.5 mmol, 1.0 eq) and triethylsilane chloride (4.9 mL, 29.6 mmol, 1.6 eq) 
were dissolved in 26 mL of THF. To this mixture the LDA solution and triethylamine 
(15.6 mL, 112.5 mmol, 4.5 eq) was added. After completion the reaction was washed with 
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20 mL distilled water. The crude product was purified by column chromatography on silica 
gel (MTBE/CH 1:10) to afford compound 95.  
 
Yield:  5.84 g (15.2 mmol), 82 % 
 C23H32O3Si (384.58)  
1H-NMR (400MHz, CDCl3 + TMS) 
7.40-7.23 (m, 10 H, Ar-H), 4.94 (s, 1 H, H-1), 4.75 (br s, 1 H, H-3trans), 4.68 (d, 2J = 12.0 
Hz, 2H, -OCH2Ph), 4.60 (d, 2J = 12.0 Hz, 2H, -OCH2Ph), 4.43 (d, 2J= 1 Hz, 1H, H-3cis), 
1.00 (t, 3J= 8.0 Hz, 9H, -Si(CH2CH3)3), 0.74 (q, 3J= 8.0 Hz, 6H, -Si(CH2CH3)3) 
13C-NMR (100 MHz, CDCl3 + TMS) 
153.73 (C, C-2), 138.12 (C, Ar-C), 128.27 (CH, m-Ar-C), 127.76 (CH, o-Ar-C), 127.46 
(CH, p-Ar-C), 99.09 (CH2, C-3), 92.23 (CH, C-1), 67.89 (CH2, -OCH2Ph), 6.62 (CH3, -
Si(CH2CH3)3), 4.82 (CH2, -Si(CH2CH3)3) 
IR (neat): 2956 s, 2912 m, 2857 s, 1640 m, 1456 m, 1256 s, 1112 s, 1056 s, 1024 s,  
EI MS (RT): no M+; 279 (9.2), 249 (4.2), 248 (2.7), 193 (3.7), 187 (6.4), 181 (6.5), 159 
(14.3), 157 (12.7), 115 (16.7), 91 (100) 
 
 
2a-Benzyloxy-1,5-dimethyl-8-oxabicyclo[3.2.1]oct-6-en-3-one rac-45 
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GP3; Silyl enol ether 36 (32.0 g, 93.5 mmol, 1.0 eq) was dissolved in 98 mL of 
dichloromethane and to the mixture 2,5-dimethylfuran (10 mL, 93.5 mmol, 1.0 eq) was 
added. After 15 min TMSOTf (1.7 mL, 9.35 mmol, 0.1 eq) was added. When the reaction 
was completed was poured into a separating funnel containing 84 mL of a saturated 
solution of sodium bicarbonate. The crude product was purified by column 
chromatography on silica gel (MTBE/CH, 1:2) to afford cycloadduct rac-37 as light 
yellow oil which crystallizes into a white solid. 
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Yield: 1.48 g (5.73 mmol), white solid, 67% (after two steps) 
C16H18O3 (258.31) 
m.p.: 79-80°C 
1H-NMR (400 MHz, CDCl3 + TMS) 
7.41-7.29 (m, 5 H, o, m, p-Ar-H), 6.06 (d, 3J = 6.0 Hz, 1 H, H-7), 6.00 (d, 3J = 6.0 Hz, 1H, 
H-6), 5.03 (d, 2J = 12.0 Hz, 1 H, -OCH2Ph), 4.58 (d, 2J = 12.0 Hz, 1H, -OCH2Ph), 3.81 (s, 
1H, H-2), 2.63 (d, 2J = 15.0 Hz, 1 H, H-4ax), 2.44 (dd, 3J= 0.5 Hz,  2J= 15.0 Hz, 1 H, H-
4eq), 1.48 (s, 6 H, 2x -CH3) 
13C-NMR (100 MHz, CDCl3 + TMS) 
206.22 (C, C-3), 137.62 (C, Ar-C), 137.12 (CH, C-6), 134.79 (CH, C-7), 128.33-127.89 
(CH, o, m, p-Ar-C), 87.43 (CH, C-2), 86.74 (C, C-5), 84.79 (C, C-1), 74.35 (CH2, -
OCH2Ph), 51.71 (CH2, C-4), 23.05 (CH3), 20.50 (CH3) 
IR (neat): 3034 w, 2976 m, 2929 m, 2874 m, 1718 vs, 1498 w, 1454 m, 1401 m, 1378 m, 
1340 m, 1319 m, 1269 w, 1243 w, 1220 w, 1177 m, 1109 vs, 758 s, 705 s 
EI MS (RT): no M+: 167 (34, M+-Bn); 152 (30); 139 (14); 109 (19); 97 (20); 95 (15); 92 
(12); 91 (100) 
EA:  C = 74.26 %, Calcd. C = 74.39 % 
 H = 6.91 %, Calcd. H = 7.02 % 
X-rays :  Its X-rays crystal structure data can be seen in chapter 7, pp. 127 
 
2a-Benzyloxy-8-oxabicyclo[3.2.1]oct-6-en-3-one rac-94 
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GP3; Silyl enol ether 36 (32.0 g, 93.5 mmol, 1.0 eq) was dissolved in 98 mL of 
dichloromethane and to the mixture furan (6.8 mL, 93.5 mmol, 1.0 eq) was added. After 15 
min TMSOTf (1.7 mL, 9.35 mmol, 0.1 eq) was added. When the reaction was completed 
was poured into a separating funnel containing 84 mL of a saturated solution of sodium 
bicarbonate. The crude product was purified by column chromatography on silica gel 
(MTBE/CH 1:2) to afford cycloadduct rac-94 as light yellow oil which crystallizes into a 
light yellowish solid. 
6.3.1 Attempts to chapter 4.1.1                                                                                                                   - 72 -  
Yield: 13.98 g (60.79 mmol), light yellowish solid, 61% (after two steps) 
C14H14O3 (230.26) 
m.p.: 64-65°C 
1H-NMR (400 MHz, CDCl3 + TMS) 
7.39-7.30 (m, 5H, o, m, p-Ar-H), 6.33 (dd, 3J = 1.5 Hz, 2J = 6.2 Hz, 1H, H-7), 6.29 (dd, 3J 
= 1.5 Hz, 2J = 6.2 Hz, 1H, H-6), 4.99 (d, 2J = 12.0 Hz, 1 H, -OCH2Ph), 4.97 (dt, 3J = 1.2 
Hz,  2J = 4.9 Hz, 1H, H-5), 4.90 (dd, 2J = 5.0 Hz, 2J = 1.5 Hz, 1 H, H-1), 4.62 (d, 2J = 12.0 
Hz, 1 H, -OCH2Ph), 4.12 (d, 3J = 5.0 Hz, 1H, H-2), 2.74 (dd, 3J = 4.9 Hz, 2J =15.3 Hz, 1 H, 
H-4ax); 2.35 (d, 2J = 15.3 Hz, 1H, H-4eq) 
13C-NMR (100 MHz, CDCl3 + TMS) 
204.9 (C, C-3), 140.9 (C, Ar-C), 137.6 (CH, C-6), 134.6 (CH, C-7), 128.5- 126.9 (CH, o, 
m, p-Ar-C), 84.1 (CH, C-2), 79.8 (C, C-5), 78.3 (C, C-1), 73.5 (CH2, -OCH2Ph), 45.9 
(CH2, C-4) 
IR (neat): 3063 w, 2977 m, 2862 m, 1719 s, 1497 m, 1453 m, 1411 w, 1385 m, 1329 m, 
1149 s, 1117 s, 1017 s, 730 s, 697 s 
EI MS (RT): 230 (M+, 28), 139 (48, M+-Bn), 158 (51), 121 (31), 107 (28), 91 (100), 81 
(60), 69 (55) 
EA:  C = 72.89 %, Calcd. C = 73.03 % 
 H = 6.05 %, Calcd. H = 6.13 % 
X-rays :  Its X-rays crystal structure data can be seen in chapter 7, pp. 129 
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6.3.2 Attempts to chapter 4.1.2 – 4.1.3 
 
2a-Benzyloxy-1,5-dimethyl-8-oxabicyclo[3.2.1]oct-6-en-3a-ol 46 
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GP4; Bicycled ketone rac-45 (3.0 g, 11.8 mmol, 1.0 eq) was dissolved in 8.5 mL THF at -
78°C. A DIBAH solution (1.2 M/toluene, 21.6 mL, 25.9 mmol, 2.2 eq) was added, slowly. 
The crude product was purified by column chromatography on silica gel (MTBE/CH 1:1) 
to afford cycloadduct 46 as white solid. 
 
Yield: 2.9 g (11.1 mmol), white solid, 94 % 
            C16H20O3 (260.33) 
m.p.: 65-66°C 
1H-NMR (400MHz, CDCl3 + TMS): 
7.40-7.24 (m, 5H, Ar-H), 6.06 (d, 3J = 6.0 Hz, 1H, H-7), 6.00 (d, 3J = 6.0 Hz, 1H, H-6), 
4.68 (d, 2J = 12.0 Hz, 1H, -OCH2Ph), 4.49 (d, 2J = 12.0 Hz, 1H, -OCH2Ph), 4.20 (m, 1H, 
H-3), 3.45 (dt, 3J = 5.5 Hz, 1H, H-2), 2.58 (d, 3J = 3.5 Hz, 1H, -OH), 1.93-1.91 (m, 2H, H-
4), 1.39 (s, 3H, -CH3), 1.33 (s, 3H, -CH3) 
13C-NMR (100 MHz, CDCl3 + TMS) 
139.5 (CH, C-6), 134.7 (CH, C-7), 137.4 (C, ipso-Ar-C), 128.4-128.0 (CH, o,m,p-Ar-C), 
85.0 (C, C-1), 84.1 (C, C-5), 79.3 (CH, C-2), 71.8 (CH2, -OCH2Ph), 64.6 (CH, C-3), 39.9 
(CH2, C-4), 23.9 (CH3, -CH3), 21.2 (CH3, -CH3) 
IR (neat): 3532 m, 3073 w, 2983 m, 2916 m, 2850 m, 1454 w, 1389 m, 1354 w, 1186 m, 
1114 s, 1051 m 
EI MS (RT): 260 (2, M+), 203 (2), 169 (4, M+-Bn), 167 (6), 154 (26), 109 (93), 91 (100) 
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2a-Benzyloxy-3a-methoxy-1,5-dimethyl-8-oxabicyclo[3.2.1]oct-6-ene 165 
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NaH (60 % suspension in oil, 0.1 g, 2.2 mmol, 2.0 eq) was dissolved in 5 mL THF and 
stirred at 0°C. In another R.B. bicycled alcohol 46 (0.3 g, 1.1 mmol, 1.0 eq) was dissolved 
in 3 mL THF, this mixture was added to the NaH solution and stirred for 1 h more at the 
same temperature. Then, CH3I (0.1 mL, 1.9 mmol, 1.7 eq) was added at 0°C and the 
resulting solution was stirred for 2 h more at 0°C then warm till the room temperature. The 
reaction mixture was washed with 10 mL of saturated solution of sodium thiosulfate and 
with 30 mL of distilled water. The aqueous phase was then extracted four times with 
MTBE. The organic layer was dried over Na2SO4 and concentrated under vacuum. The 
crude product was purified by column chromatography on silica gel (MTBE/CH 1:1) to 
afford cycloadduct 165.   
 
Yield: 0.29 g (1.04 mmol), yellowish oil, 95 %  
C17H22O3 (274.16) 
1H-NMR (400 MHz, CDCl3 + TMS) 
7.38-7.26 (m, 5H, Ar-H), 6.07 (d, 3J = 5.8 Hz, 1H, H-7), 6.00 (d, 3J = 5.8 Hz, 1H, H-6), 
4.68 (d, 2J = 11.9 Hz, 1H, -OCH2Ph), 4.46 (d, 2J = 11.9 Hz, 1H, -OCH2Ph), 3.65 (dt, 3J = 
5.4 Hz, 3J = 1Hz, 1H, H-3), 3.47 (dd, 3J = 5.4 Hz, 1H, H-2), 3.33 (s, 3H, -OCH3), 1.93 (dd, 
2J = 14.5 Hz, 3J = 1.1 Hz, 1H, H-4ax), 1.78 (dd, 2J = 14.5 Hz, 3J = 5.2 Hz, 1H, H-4eq), 
1.39 (s, 3H, -CH3), 1.33 (s, 3H, -CH3) 
13C-NMR (100 MHz, CDCl3 + TMS) 
138.2 (C, ipso-Ar-C), 137.6 (CH, C-6), 135.2 (CH, C-7), 128.2 (CH, o-Ar-C), 128.0 (CH, 
m-Ar-C), 127.6 (CH, p-Ar-C), 85.5 (C, C-1), 83.8 (C, C-5), 79.8 (CH, C-2), 75.1 (CH2, -
OCH2Ph), 71.3 (CH, C-3), 57.8 (CH3, -OCH3), 36.5 (CH2, C-4), 24.0 (CH3, -CH3), 21.0 
(CH3, -CH3) 
IR (neat): 3030 w, 2928 m, 2869 m, 1453 m, 1373 w, 1351 m, 1240 m, 1167 m, 1086 s 
EI MS (RT): 275 (3, M+), 215 (2), 183 (4), 168 (11), 151 (6), 137 (32), 109 (76), 91 (100)  
HR MS: C17H22O3, Exact: 274.1575, Calcd.: 274.1569 
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6a-Benzyloxy-7a-methoxy-1,5-dimethyl-3,9-dioxa-tricyclo[3.3.1.02,4]nonane 163 
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GP5; Bicycled alkene 165 (1.5 g, 5.3 mmol, 1.0 eq) was dissolved in 10 mL DCM and 
cooled at 0°C. To this mixture m-CPBA (70-75%, 2.6 g, 10.6 mmol, 2.0 eq) dissolved in 5 
mL DCM was added and the resulting reaction mixture was stirred for 1.5 h at the same 
temperature. The crude product was purified by column chromatography on silica gel 
(MTBE/CH 1:1) to afford epoxy 163. 
 
Yield: 1.5 g (5.0 mmol), white solid, 94 %  
C17H22O4 (290.15) 
m.p.: 63-64°C 
1H-NMR (400 MHz, CDCl3 + TMS) 
7.36-7.26 (m, 5H, Ar-H), 4.68 (d, 2J = 11.9 Hz, 1H, -OCH2Ph), 4.49 (d, 2J = 11.9 Hz, 1H, -
OCH2Ph), 3.61 (d, 3J = 3.3 Hz, 1H, H-7), 3.58 (dt, 3J = 4.5 Hz, 3J = 1.7 Hz, 1H, H-3), 3.38 
(d, 3J = 4.6 Hz, 1H, H-2), 3.36 (s, 3H, -OCH3), 3.33 (d, 3J = 3.3 Hz, 1H, H-6), 3.38 (d, 3J = 
4.6 Hz, 1H, H-2), 2.01 (dd, 2J = 14.9 Hz, 3J = 1.6 Hz, 1H, H-4ax), 1.74 (dd, 2J = 14.9 Hz, 
3J = 4.4 Hz, 1H, H-4eq), 1.38 (s, 3H, -CH3), 1.29 (s, 3H, -CH3) 
13C-NMR (100 MHz, CDCl3 + TMS) 
137.8 (C, ipso-Ar-C), 128.3 (CH, o-Ar-C), 128.0 (CH, m-Ar-C), 127.8 (CH, p-Ar-C), 79.7 
(C, C-1), 79.4 (CH, C-2), 77.2 (C, C-5), 74.2 (CH, C-3), 71.4 (CH2, -OCH2Ph), 58.1 (CH, 
C-7), 57.8 (CH, C-6), 57.2 (CH3, -OCH3), 37.0 (CH2, C-4), 19.9 (CH3, -CH3), 17.3 (CH3, -
CH3) 
IR (neat):3031 w, 2937 m, 2886 m, 1452 m, 1368 w, 1224 w, 1120 m, 1092 s, 764 s, 699 s 
EI MS (RT): 290 (4, M+), 258 (19), 207 (10), 143 (76), 164 (13), 125 (20), 91 (100) 
HR MS: C17H22O4, Exact: 290.1520, Calcd.: 290.1518 
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7a-Methoxy-1,5-dimethyl-3,9-dioxatricyclo[3.3.1.02,4]nonane-6a-ol 50 
 
50163
1
2
3
76
4
O
OH
O
OMe
5
O
OBn
O
OMe
 
 
GP6; A catalytic amount of Pd/C (10%) was dissolved in 20 mL methanol. To this 
suspension a solution of benzyl ether (0.9 g, 3.1 mmol, 1.0 eq) in 40 mL methanol and 0.4 
mL AcOH was added. The crude product was purified by column chromatography on 
silica gel using MTBE as eluent to afford epoxy alcohol 50. 
 
Yield: 0.5 g (2.5 mmol), white solid, 81 %  
C10H16O4 (200. 10) 
m.p.: 119-120°C 
1H-NMR (400 MHz, CDCl3 + TMS) 
3.58 (dt, 3J = 4.0 Hz, 3J = 1.5 Hz, 1H, H-3), 3.53 (dd, 3J = 9.5 Hz, 3J = 5.0 Hz 1H, H-2), 
3.45 (d, 3J = 3.2 Hz, 1H, H-7), 3.40 (s, 3H, -OCH3), 3.28 (d, 3J = 3.2 Hz, 1H, H-6), 3.02 (d, 
3J = 9.5 Hz, 1H, -OH), 2.07 (dd, 2J = 15.0 Hz, 3J = 1.5 Hz, 1H, H-4ax), 1.82 (dd, 2J = 15.0 
Hz, 3J = 4.0 Hz, 1H, H-4eq), 1.41 (s, 3H, -CH3), 1.31 (s, 3H, -CH3) 
13C-NMR (100 MHz, CDCl3 + TMS) 
79.7 (C, C-1), 76.7 (C, C-5), 76.2 (CH, C-2), 72.0 (CH, C-3), 57.9 (CH, C-7), 57.6 (CH3, -
OCH3), 56.5 (CH, C-6), 36.0 (CH2, C-4), 19.9 (CH3, -CH3), 17.0 (CH3, -CH3) 
IR (neat): 3463 s, 2969 m, 2930 s, 1455 w, 1390 m, 1121 m, 1093 s, 1075 s, 878 m  
EI MS (RT): 200 (12, M+), 168 (28), 143 (85), 101 (48), 85 (34), 74 (100), 69 (28) 
HR MS: C10H16O4, Exact: 200.1042, Calcd.: 200.1049 
 
7a-Methoxy-1,5-dimethyl-3,9-dioxatricyclo[3.3.1.02,4]nonane-6-one 123 
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6.3.2 Attempts to chapter 4.1.2-4.1.3                                                                                                        - 77 -   
Epoxy alcohol 50 (0.23 g, 1.20 mmol, 1.0 eq) was dissolved in 5 mL THF and stirred at 
room temperature. To this mixture TPAP (0.008 g, 0.02 mmol, 0.02 eq) and NMO (0.21 g, 
1.80 mmol, 1.5 eq) were added and the solution was stirred for 8 h at room temperature. 
The resulting reaction mixture was concentrated under vacuum and the crude product was 
purified by column chromatography on silica gel using MTBE as eluent to afford 123. 
 
Yield: 0.12 g (0.60 mmol), white solid, 50 %  
C10H14O4 (198. 22) 
1H-NMR (400 MHz, CDCl3 + TMS) 
3.52 (dd, 3J = 8.5 Hz, 3J = 5.6 Hz, 1H, H-3), 3.50 (d, 3J = 3.2 Hz, 1H, H-7), 3.46 (d, 3J = 
3.2 Hz, 1H, H-6), 2.52 (dd, 2J = 13.9 Hz, 3J = 8.5 Hz, 1H, H-4ax), 1.90 (dd, 2J = 13.9 Hz, 
3J = 5.6 Hz, 1H, H-4eq), 3.38 (s, 3H, -OCH3), 1.50 (s, 3H, -CH3), 1.42 (s, 3H, -CH3) 
13C-NMR (100 MHz, CDCl3 + TMS) 
205.8 (CH, C-2), 84.0 (C, C-1), 78.0 (CH, C-3), 77.1 (C, C-5), 58.7 (CH3, -OCH3), 58.0 
(CH, C-7), 55.9 (CH, C-6), 38.9 (CH2, C-4), 20.8 (CH3, -CH3), 15.0 (CH3, -CH3) 
IR (neat): 2978 m, 2930 m, 2829 w, 1730 s, 1452 m, 1373 m, 1212 w, 1307 s, 1070 m, 
859 w 
EI MS (RT): 198 (14, M+), 170 (9), 141 (22), 127 (100), 112 (25), 109 (25), 98 (49), 85 
(38) 
 
 
4a-Methoxy-6,8-dimethyl-2,7-dioxatricyclo[4.2.1.03,8]nonane-9ß-ol 51 
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GP7; Epoxy alcohol 50 (0.2 g, 1.2 mmol, 1.0 eq) was dissolved in 12 mL THF and to this 
mixture a solution of KOBut (0.2 g, 1.4 mmol, 1.2 eq) in 11 mL THF was added. The 
crude product was purified by column chromatography on silica gel using MTBE as eluent 
to afford 51. 
 
Yield: 0.2 g (1.0 mmol), white solid, 83 %  
C10H16O4 (200. 10) 
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1H-NMR (400 MHz, CDCl3 + TMS) 
4.69 (d, 3J = 1.7 Hz, 1H, H-2), 4.56 (s, 1H, H-7), 3.91 (s1H, H-6), 3.48 (dt, 3J = 8.8 Hz, 3J 
= 1.9 Hz, 1H, H-3), 3.32 (s, 3H, -OCH3), 2.40 (br.s, 1H, -OH), 2.30 (dd, 2J = 13.4 Hz, 3J = 
8.0 Hz, 1H, H-4ax), 1.83 (dd, 2J = 13.4 Hz, 3J = 8.9 Hz, 1H, H-4eq), 1.60 (s, 3H, -CH3), 
1.44 (s, 3H, -CH3) 
13C-NMR (100 MHz, CDCl3 + TMS) 
94.1 (CH, C-2), 85.0 (CH, C-7), 83.5 (C, C-1), 81.1 (C, C-5), 80.5 (CH, C-6), 75.3 (CH, C-
3), 56.0 (CH3, -OCH3), 34.8 (CH2, C-4), 21.6 (CH3, -CH3), 19.1 (CH3, -CH3) 
IR (neat): 3420 s, 2933 m, 1446 m, 1390 w, 1374 m, 1096 s, 1066 m, 986 m, 914 w 
EI MS (RT): 200 (6, M+), 169 (17), 155 (15), 141 (85), 127 (41), 112 (100), 101 (87), 85 
(76), 71 (66) 
HR MS: C10H16O4, Exact: 200. 1046, Calcd.: 200. 1049 
 
 
4a-Methoxy-6,8-dimethyl-2,7-dioxatricyclo[4.2.1.03,8]nonane-9-one 52 
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GP8; Oxalyl chloride (0.3 mL, 3.6 mmol, 4.0 eq) was dissolved in 5 mL DCM. To this 
mixture was added, at -78°C, DMSO (0.3 mL, 3.8 mmol, 4.2 eq) and tricyclic alcohol (0.2 
g, 0.9 mmol, 1.0 eq) in 3 mL DCM. The solution was stirred for 1h at -78°C and then NEt3 
(1.1 mL, 8.1 mmol, 9.0 eq) was added. The crude product was purified by column 
chromatography on silica gel using MTBE as eluent to afford 52. 
 
Yield: 0.13 g (0.67 mmol), yellowish solid, 74 %  
C10H14O4 (198.09) 
1H-NMR (400 MHz, CDCl3 + TMS) 
5.12 (d, 3J = 1.8 Hz, 1H, H-2), 4.40 (s, 1H, H-7), 3.68 (dt, 3J =8.8 Hz, 3J =1.8 Hz, 1H, H-
3), 3.35 (s, 3H, -OCH3), 2.34 (dd, 2J = 14.0 Hz, 3J = 8.8 Hz, 1H, H-4ax), 1.90 (dd, 2J = 
14.0 Hz, 3J = 8.2 Hz, 1H, H-4eq), 1.63 (s, 3H, -CH3), 1.41 (s, 3H, -CH3) 
13C-NMR (100 MHz, CDCl3 + TMS) 
6.3.2 Attempts to chapter 4.1.2-4.1.3                                                                                                        - 79 -   
207.9 (C, C-6), 86.6 (CH, C-2), 83.9 (CH, C-3), 80.1 (C, C-1), 78.4(C, C-5), 74.1 (CH, C-
7), 56.2 (CH3, -OCH3), 33.9 (CH2, C-4), 20.8 (CH3, -CH3), 18.8 (CH3, -CH3) 
IR (neat): 3410 s, 2980 w, 2933 m, 2825 w, 1767 s, 1375 m, 1207 m, 1140 m, 1092 s, 956  
EI MS (RT):  no M+, 169 (4), 141 (100), 138 (10), 127 (15), 111 (22), 95 (70), 85 (59) 
HR MS: C10H14O4, Exact: 198.0883, Calcd.: 198.0892 
 
2a-Benzyloxy-8-oxabicyclo[3.2.1]oct-6-ene-3a-ol 96 
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GP4; Bicycled ketone rac-94 (1.9 g, 8.5 mmol, 1.0 eq) was dissolved in 8.5 mL THF at -
78°C. A DIBAH solution (1.2 M/toluene, 15.6 mL, 18.7 mmol, 2.2 eq) was added, slowly. 
The crude product was purified by column chromatography on silica gel (MTBE/CH 1:1) 
to afford cycloadduct 96 as white solid. 
 
Yield: 1.58 g (6.8 mmol), yellowish solid, 80%  
C14H16O3 (232.11) 
1H-NMR (400 MHz, CDCl3 + TMS) 
7.39-7.30 (m, 5H, Ar-H), 6.37 (dd, 3J = 2.0 Hz, 3J = 5.8 Hz, 1H, H-7), 6.32 (dd, 3J = 2.0 
Hz, 3J = 5.8 Hz, 1H, H-6), 4.70 (br.m, 1H, H-5), 4.69/4.57 (d, 2J = 12.0 Hz, 1H, -OCH2Ph), 
4.64 (br.d, 1H, H-1), 4.22 (dt, 3J = 1.0 Hz, 3J = 5.0 Hz, 1H, H-3), 3.77 (dd, 3J = 5.0 Hz, 1H, 
H-2), 2.60 (br.s, 1H, OH), 2.08 (m, 1H, H-4ax), 1.81 (dd, 2J = 15.0 Hz, 3J = 4.5 Hz, 1H, H-
4eq) 
13C-NMR (100 MHz, CDCl3 + TMS) 
137.6 (C, ipso-Ar-C), 136.6 (CH, C-6), 131.7 (CH, C-7), 78.3 (CH, C-5), 128.5-127.8 (CH, 
o,m,p-Ar-C), 78.2 (CH, C-1), 74.3 (CH, C-2), 71.2 (CH, C-3), 65.4 (CH2, -OCH2Ph), 32.9 
(CH2, C-4) 
IR (neat): 2942 m, 2920 m, 1454 m, 1350 m, 1190 m, 1092 s, 1028 s, 944 m 
EI MS (RT): 232 (2, M+), 214 (2), 141 (47), 126 (45), 108 (14), 91 (79), 81 (100) 
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2a-Benzyloxy-3a-methoxy-8-oxabicyclo[3.2.1]oct-6-ene 168 
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NaH (60 % suspension in oil, 7.9 g, 19.7 mmol, 2.0 eq) was dissolved in 25 mL THF and 
stirred at 0°C. In another R.B. bicycled alcohol 96 (2.3 g, 9.9 mmol, 1.0 eq) was dissolved 
in 15 mL THF, this mixture was added to the NaH solution and stirred for 1 h more at the 
same temperature. Then, CH3I (1.2 mL, 19.8 mmol, 2.0 eq) was added at 0°C and the 
resulting solution was stirred for 2 h more at 0°C then warm till the room temperature. The 
reaction mixture was washed with 15 mL of saturated solution of sodium thiosulfate and 
with 30 mL of distilled water. The aqueous phase was then extracted four times with 
MTBE. The organic layer was dried over Na2SO4 and concentrated under vacuum. The 
crude product was purified by column chromatography on silica gel (MTBE/CH 1:1) to 
afford cycloadduct 168.   
 
Yield: 2.1 g (8.5 mmol), yellowish oil, 86%  
C15H18O3 (246.13) 
1H-NMR (400 MHz, CDCl3 + TMS) 
7.38-7.28 (m, 5H, Ar-H), 6.37 (dd, 3J = 2.0 Hz, 3J = 5.7 Hz, 1H, H-7), 6.26 (dd, 3J = 1.9 
Hz, 3J = 5.7 Hz, 1H, H-6), 4.65 (m, 1H, H-5), 4.61 (m, 1H, H-1), 4.55/4.66 (d, 2J = 11.9 
Hz, 1H, -OCH2Ph), 3.78 (dd, 3J = 5.4 Hz, 1H, H-2), 3.68 (dt, 3J = 5.4 Hz, 3J = 1Hz, 1H, H-
3), 3.33 (s, 3H, -OCH3), 1.96 (m, 1H, H-4ax), 1.82 (dm, 1H, H-4eq) 
13C-NMR (100 MHz, CDCl3 + TMS) 
138.3 (C, ipso-Ar-C), 134.9 (CH, C-6), 132.1 (CH, C-7), 128.3-127.7 (CH, o,m,p-Ar-C), 
78.6 (CH, C-5), 78.1 (CH, C-1), 75.9 (CH, C-2), 75.5 (CH, C-3), 70.9 (CH2, -OCH2Ph), 
58.4 (CH3, -OCH3), 30.2 (CH2, C-4) 
IR (neat): 3030 w, 2942 s, 2873 m, 1454 m, 1376 w, 1349 m, 1211 m, 1103 s, 1089 s, 
1028 s, 925 m 
EI MS (RT): 246 (9, M+), 214 (5), 155 (46), 140 (39), 123 (49), 108 (10), 91 (79), 81 
(100) 
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6a-Benzyloxy-7a-methoxy-3,9-dioxa-tricyclo[3.3.1.02,4]nonane 174 
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GP5; Bicycled alkene 168 (2.0 g, 8.3 mmol, 1.0 eq) was dissolved in 17 mL DCM and 
cooled at 0°C. To this mixture m-CPBA (70-75%, 3.8 g, 16.6 mmol, 2.0 eq) dissolved in 
10 mL DCM was added and the resulting reaction mixture was stirred for 1.5 h at the same 
temperature. The crude product was purified by column chromatography on silica gel 
(MTBE/CH 1:1) to afford epoxy 174. 
 
Yield: 1.5 g (5.6 mmol), light yellowish solid, 68%  
C15H18O4 (262.30) 
1H-NMR (400 MHz, CDCl3 + TMS) 
7.42-7.38 (m, 5H, Ar-H), 4.59/4.68 (d, 2J = 12.0 Hz, 2H, -OCH2Ph), 4.20 (br.d, 3J = 4.5 
Hz, 1H, H-2), 4.18 (m, 1H, H-3), 3.84 (d, 3J = 3.2 Hz, 1H, H-7), 3.69 (br.d, 3J = 4.5 Hz, 
1H, H-1), 3.62 (m, 1H, H-5), 3.55 (d, 3J = 3.2 Hz, 1H, H-6), 3.40 (s, 3H, -OCH3), 1.95 (m, 
2H, H-4ax/eq) 
13C-NMR (100 MHz, CDCl3 + TMS) 
137.8 (C, ipso-Ar-C), 128.4-127.7 (CH, o,m,p-Ar-C), 75.2 (CH, C-1), 74.4 (CH, C-5), 72.6 
(CH, C-2), 71.5 (CH, C-3), 71.1 (CH2, -OCH2Ph), 58.2 (CH3, -OCH3), 53.9 (CH, C-7), 
53.3 (CH, C-6), 30.5 (CH2, C-4) 
IR (neat): 2949 m, 2923 m, 1453 m, 1371 w, 1205 s, 1107 s, 1087 s, 1026 s, 964 m 
EI MS (RT): 262 (14, M+), 172 (9), 156 (9), 154 (8), 139 (14), 123 (13), 107 (14), 91 
(100) 
Structure confirmation: H,H-COSY, HMBC, HMQC-Spectres 
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7a-Methoxy-3,9-dioxatricyclo[3.3.1.02,4]nonane-6a-ol 105 
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GP6; A catalytic amount of Pd/C (10%) was dissolved in 20 mL methanol. To this 
suspension a solution of benzyl ether (3.5 g, 13.2 mmol, 1.0 eq) in 40 mL methanol and 1.7 
mL AcOH was added. The crude product was purified by column chromatography on 
silica gel using MTBE as eluent to afford epoxy alcohol 105. 
 
Yield: 1.2 g (6.9 mmol), colourless solid, 52 %  
C8H12O4 (172. 18) 
1H-NMR (400 MHz, CDCl3 + TMS) 
4.19 (m, 1H, H-3), 4.16 (br.d, 3J = 5.0 Hz, 1H, H-2), 3.87 (m, 1H, H-1), 3.68 (d, 3J = 3.0 
Hz, 1H, H-7), 3.59 (m, 1H, H-5), 3.48 (d, 3J = 3.0 Hz, 1H, H-6), 3.40 (s, 3H, -OCH3), 
2.01/1.98 (m, 2H, H-4ax/eq) 
13C-NMR (100 MHz, CDCl3 + TMS) 
75.2 (CH, C-5), 74.0 (CH, C-1), 70.8 (CH, C-2), 67.2 (CH, C-3), 57.5 (CH3, -OCH3), 53.6 
(CH, C-7), 52.5 (CH, C-6), 29.0 (CH2, C-4) 
IR (neat): 3465 m, 2924 m, 2853 w, 1717 m, 1456 w, 1396 w, 1249 w, 1126 m, 1083 s  
EI MS (RT): 172 (30, M+), 140 (11), 116 (4), 115 (24), 97 (36), 83 (35), 73 (23), 71 (100)  
Structure confirmation: H,H-COSY, HMBC, HMQC-Spectres 
EA:  C = 55.73 %, Calcd. C = 55.81 % 
 H = 6.86 %, Calcd. H = 7.02 % 
X-rays :  Its x-rays crystal structure data can be seen in chapter 7, pp. 131 
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4a-Methoxy-2,7-dioxatricyclo[4.2.1.03,8]nonane-9ß-ol 108 
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GP7; Epoxy alcohol 105 (0.5 g, 2.9 mmol, 1.0 eq) was dissolved in 25 mL THF and to this 
mixture a solution of KOBut (0.4 g, 3.5 mmol, 1.2 eq) in 25 mL THF was added. The 
crude product was purified by column chromatography on silica gel using EA as eluent to 
afford 108. 
 
Yield: 0.3 g (1.8 mmol), white solid, 62 %  
C8H12O4 (172. 18) 
1H-NMR (400 MHz, CDCl3 + TMS) 
5.18 (dd, 3J = 5.0 Hz, 1H, H-7), 5.01 (dd, 3J = 6.0 Hz, 1H, H-2), 4.94 (dd, 3J = 5.0 Hz, 1H, 
H-6), 4.53 (m, 1H, H-5), 4.20 (br.s, 1H, H-1), 3.50 (dt, 3J = 10.0 Hz, 3J = 2.0 Hz, 1H, H-3), 
3.31 (s, 3H, -OCH3), 2.61 (m, 1H, H-4ax), 1.70 (dd, 3J = 10.0 Hz, 1H, H-4eq) 
13C-NMR (100 MHz, CDCl3 + TMS) 
89.7 (CH, C-2), 81.5 (CH, C-7), 80.4 (CH, C-1), 78.6 (CH, C-6), 74.6 (CH, C-5), 74.0 
(CH, C-3), 56.0 (CH3, -OCH3), 28.0 (CH2, C-4) 
IR (neat): 3338 m, 2975 w, 2915 w, 1695 s, 1491 s, 1049 s, 962 m 
EI MS (RT): 171 (2, M+ -1), 155 (2), 141 (2), 122 (6), 111 (95), 97 (10), 84 (100), 71 (23)  
Structure confirmation: H,H-COSY, HMBC, HMQC-Spectres 
X-rays :  Its x-rays crystal structure data can be seen in chapter 7, pp. 133 
 
 
9a-Methoxy-2,4,7-trioxa-tricyclo[4.2.2.03,8]decane-5-one 115 
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PCC (1.5 g, 6.8 mmol, 4.0 eq) and anhydrous sodium acetate (0.6 g, 6.8 mmol, 4.0 eq) 
were dissolved in 14 mL DCM and placed in a light-protected flask which containing 4?  
molecular sieves (previously activated) (1.7 g). The mixture was stirred under argon 
atmosphere for 30 min. Tricyclic oxetan 108 (0.3 g, 1.7 mmol, 1.0 eq) was dissolved in 5 
mL DCM and added to the obtained suspension, and stirring was maintained for 16 h at 
room temperature. The remaining solution was then diluted with 25 mL MTBE and then 
filtered through a short silica gel column (EA/MTBE 1:1) and concentrated under vacuum 
to afford 115. 
 
Yield: 0.04 g (0.2 mmol), yellowish solid, 12 %  
C8H10O5 (186. 16) 
1H-NMR (400 MHz, CDCl3 + TMS) 
6.15 (d, 3J = 4.5 Hz, 1H, H-7), 5.14 (dd, 3J = 2.0 Hz, 1H, H-2), 4.92 (ddt, 3J = 1.0 Hz, 1H, 
H-1), 4.88 (dd, 3J = 2.8 Hz, 1H, H-5), 3.63 (ddt, 3J =2.0 Hz, 3J =1.8 Hz, 1H, H-3), 3.38 (s, 
3H, -OCH3), 2.80 (ddd, 2J = 9.0 Hz, 3J = 2.8 Hz, 1H, H-4ax), 2.09 (ddd, 2J = 9.0 Hz, 3J = 
1.8 Hz, 3J = 1.0 Hz, 1H, H-4eq) 
13C-NMR (100 MHz, CDCl3 + TMS) 
168.4 (C, C-6), 100.7 (CH, C-7), 77.6 (CH, C-2), 68.0 (CH, C-3), 72.7 (CH, C-1), 69.2 
(CH, C-5), 56.2 (CH3, -OCH3), 25.7 (CH2, C-4) 
IR (neat): 2922 s, 1764 s, 1389 m, 1218 m, 1132 s, 1059 s, 960 s, 896 s, 859 m  
EI MS (RT):  no M+, 155 (7), 140 (13), 129 (10), 126 (9), 111 (100), 81 (52)  
X-rays :  Ist x-rays crystal structure data can be seen in chapter 7, pp. 135 
 
 
2a-Benzyloxy-3a-ethoxy-1,5-dimethyl-8-oxabicyclo[3.2.1]oct-6-ene 166 
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NaH (60 % suspension in oil, 9.1 g, 227.5 mmol, 5.0 eq) was dissolved in 75 mL THF and 
stirred at 0°C. In another R.B. bicyclic alcohol 46 (11.8 g, 45.5 mmol, 1.0 eq) was 
dissolved in 25 mL THF, this reaction mixture was added to the NaH solution and stirred 
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further for 1 h at the same temperature. Then, EtBr (17.0 mL, 227.5 mmol, 5.0 eq) and a 
catalytic amount of KI was added and the resulting solution was stirred for 2 h at 0°C then 
warm till the room temperature. The reaction mixture was washed with 160 mL of 
saturated solution of sodium thiosulfate and with 400 mL of distilled water. The aqueous 
phase was extracted four times with MTBE. The organic layer was dried over Na2SO4 and 
concentrated under vacuum. The crude product was purified by column chromatography 
on silica gel (MTBE/CH 1:5) to afford cycloadduct 166.   
 
Yield: 10.8 g (37.7 mmol), yellowish oil, 83 % 
            C18H24O3 (288.38) 
1H-NMR (400MHz, CDCl3 + TMS) 
7.35-7.33 (m, 5H, Ar-H), 6.10 (d, 3J = 5.8 Hz, 1H, H-7), 5.90 (d, 3J = 5.8 Hz, 1H, H-6), 
4.70 (d, 2J = 12.0 Hz, 1H, -OCH2Ph), 4.40 (d, 2J = 12.0 Hz, 1H, -OCH2Ph), 3.78 (td, 3J = 
1.2 Hz, 3J = 5.5 Hz, 1H, H-3), 3.46 (d, 3J = 5.5 Hz, 1H, H-2), 3.40 (m, 2H, -OCH2CH3), 
1.90 (dd, 2J = 14.4 Hz, 3J = 1.2 Hz, 1H, H-4ax), 1.78 (dd, 2J = 14.4 Hz, 3J = 5.0 Hz, 1H, H-
4eq), 1.38 (s, 3H, -CH3), 1.31 (s, 3H, -CH3), 1.17 (t, 3J = 7.0 Hz, 3H, -OCH2CH3) 
13C-NMR (100 MHz, CDCl3 + TMS) 
138.3 (C, ipso-Ar-C), 137.6 (CH, C-6), 135.2 (CH, C-7), 128.2-127.6 (CH, o,m,p-Ar-C), 
85.5 (C, C-1), 83.8 (C, C-5), 79.9 (CH, C-2), 72.8 (CH, C-3), 71.2 (CH2, -OCH2Ph), 65.2 
(CH2, -OCH2CH3), 37.5 (CH2, C-4), 24.0 (CH3, -CH3), 21.3 (CH3, -CH3), 15.6 (CH3, -
OCH2CH3) 
IR (neat): 2971 m, 2928 m, 2866 m, 1453 w, 1372 m, 1351 m, 1171 m, 1085 s, 1028 s, 
761 m, 736 m, 697 s 
EI MS (RT): 288 (6, M+), 242 (3), 215 (4), 182 (35), 137 (96), 124 (39), 109 (100), 91 
(99) 
 
 
6a-Benzyloxy-7a-ethoxy-1,5-dimethyl-3,9-dioxatricyclo[3.3.1.02,4]nonane 164 
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GP5; Bicyclic alkene 166 (9.6 g, 33.3 mmol, 1.0 eq) was dissolved in 200 mL DCM and 
cooled at 0°C. To this reaction mixture m-CPBA (70-75%, 19.7 g, 79.9 mmol, 2.4 eq) was 
added and the resulting reaction mixture was stirred for 1.5 h at the same temperature. The 
crude product was purified by column chromatography on silica gel (MTBE/CH 1:1) to 
afford epoxy 164. 
 
Yield: 8.1 g (26.6 mmol), colourless oil, 80 % 
                    C18H24O4 (304.38) 
1H-NMR (400MHz, CDCl3 + TMS) 
7.36-7.35 (m, 5H, Ar-H), 4.65 (d, 2J = 11.8 Hz, 1H, -OCH2Ph), 4.46 (d, 2J = 11.8 Hz, 1H, -
OCH2Ph), 3.72 (m, 1H, H-3), 3.65 (d, 3J = 3.3 Hz, 1H, H-6), 3.51 (m, 2H, -OCH2CH3), 
3.38 (d, 3J = 4.5 Hz, 1H, H-2), 3.35 (d, 3J = 3.3 Hz, 1H, H-7), 1.95 (dd, 2J = 14.8 Hz, 3J = 
1.8 Hz, 1H, H-4ax), 1.89 (dd, 2J = 14.8 Hz, 3J = 4.3 Hz,  1H, H-4eq), 1.39 (s, 3H, -CH3), 
1.37 (s, 3H, -CH3), 1.19 (t, 3J = 7.0 Hz, 3H, -OCH2CH3) 
13C-NMR (100 MHz, CDCl3 + TMS) 
138.0 (C, ipso-Ar-C), 128.6-127.8 (CH, o,m,p-Ar-C), 79.7 (C, C-1), 79.5 (C, C-5), 77.5 (C, 
C-2), 72.0 (CH2, -OCH2Ph), 71.2 (CH, C-3), 65.5 (CH2, -OCH2CH3), 58.4 (CH, C-6), 57.4 
(CH, C-7), 38.1 (CH2, C-4), 20.0 (CH3, -CH3), 17.3 (CH3, -CH3), 15.7 (CH3, -OCH2CH3) 
IR (neat): 2973 m, 2931 m, 2871 m, 1724 m, 1451 w, 1373 w, 1119 s, 1074 s, 737 s, 698 s 
EI MS (RT): no M+, 276 (29), 185 (31), 157 (43), 149 (43), 115 (37), 109 (33), 91 (100) 
 
 
 
7a-Ethoxy-1,5-dimethyl-3,9-dioxatricyclo[3.3.1.02,4]nonane-6a-ol 101 
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GP6; A catalytic amount of Pd/C (10%) was dissolved in 100 mL ethanol. To this 
suspension a solution of benzyl ether (6.6 g, 21.8 mmol, 1.0 eq) in 80 mL ethanol and 3.6 
mL AcOH was added. The crude product was purified by column chromatography on 
silica gel using MTBE as eluent to afford epoxy alcohol 101. 
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Yield: 3.0 g (14.0 mmol), white solid, 64 % 
           C11H18O4 (214.26) 
1H-NMR (400MHz, CDCl3 + TMS) 
4.20 (m, 1H, H-3), 4.09 (dd, 3J = 11.8 Hz, 1H, H-2), 3.79 (d, 3J = 3.3 Hz, 1H, H-7), 3.47 
(m, 2H, -OCH2CH3), 3.22 (d, 3J = 3.3 Hz, 1H, H-6), 2.05 (d, 3J = 11.8 Hz, 1H, -OH), 1.88 
(dt, 2J = 13.8 Hz, 3J = 4.5 Hz, 1H, H-4ax), 1.79 (dd, 2J = 13.8 Hz, 3J = 1.1 Hz, 1H, H-4eq), 
1.37 (s, 3H, -CH3), 1.30 (s, 3H, -CH3), 1.20 (t, 3J = 7.0 Hz, 3H, -OCH2CH3) 
13C-NMR (100 MHz, CDCl3 + TMS) 
80.1 (C, C-1), 78.7 (C, C-5), 76.1 (CH, C-2), 73.5 (CH, C-3), 63.9 (CH2, -OCH2CH3), 58.1 
(CH, C-6), 57.2 (CH, C-7), 39.8 (CH2, C-4), 21.3 (CH3, -CH3), 17.6 (CH3, -CH3), 15.2 
(CH3, -OCH2CH3) 
IR (neat): 3385 s, 2925 s, 2854 m, 1377 m, 1217 m, 1067 s, 1027 m, 798 w 
EI MS (RT): no M+, 169 (61), 157 (12), 109 (68), 99 (30), 95 (100), 71 (40) 
 
 
4a-Ethoxy-6,8-dimethyl -2,7-dioxatricyclo[4.2.1.03,8]nonane-9ß-ol 103 
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GP7; Epoxy alcohol 101 (0.5 g, 2.4 mmol, 1.0 eq) was dissolved in 20 mL THF and to this 
reaction mixture, a solution of KOBut (0.7 g, 6.0 mmol, 2.5 eq) in 20 mL THF was added. 
The crude product was purified by column chromatography on silica gel using EA as 
eluent to afford 103. 
 
Yield: 0.3 g (1.4 mmol), colourless oil, 58 % 
           C11H18O4 (214.26) 
1H-NMR (400MHz, CDCl3 + TMS) 
4.52 (s, 1H, H-7), 4.47 (d, 3J = 1.8 Hz, 1H, H-2), 4.28 (d, 3J = 6.0 Hz, 1H, H-6), 4.05 (m, 
1H, H-3), 3.53 (m, 2H, -OCH2CH3), 1.94 (m, 1H, H-4ax), 1.86 (dd, 2J = 12.0 Hz, 3J = 0.9 
Hz, 1H, H-4eq), 1.35 (s, 3H, -CH3), 1.29 (s, 3H, -CH3), 1.18 (t, 3J = 7.1 Hz, 3H, -
OCH2CH3) 
13C-NMR (100 MHz, CDCl3 + TMS) 
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94.3 (CH, C-2), 90.2 (CH, C-7), 79.4 (C, C-1), 76.8 (C, C-5), 74.7 (CH, C-6), 72.6 (CH, C-
3), 65.4 (CH2, -OCH2CH3), 36.5 (CH2, C-4), 21.5 (CH3, -CH3), 19.2 (CH3, -CH3), 16.3 
(CH3, -OCH2CH3) 
IR (neat): 3369 m, 2925 s, 2855 m, 1455 w, 1376 m, 1237 s, 1073 s, 701 m 
EI MS (RT): no M+, 185 (64), 167 (79), 149 (78), 132 (79), 114 (79), 91 (100), 71 (71) 
 
 
2a-Benzyloxy-3a-ethoxy-8-oxabicyclo[3.2.1]oct -6-ene 169 
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NaH (60 % suspension in oil, 11.8 g, 294.5 mmol, 5.0 eq) was dissolved in 75 mL THF 
and stirred at 0°C. In another R.B. bicyclic alcohol 96 (13.7 g, 58.9 mmol, 1.0 eq) was 
dissolved in 25 mL THF, this reaction mixture was added to the NaH solution and stirred 
further for 1 h at the same temperature. Then, EtBr (22.0 mL, 294.7 mmol, 5.0 eq) and a 
catalytic amount of KI was added and the resulting solution was stirred for 2 h more at 0°C 
then warm till the room temperature. The reaction mixture was washed with 160 mL of 
saturated solution of sodium thiosulfate and with 400 mL of distilled water. The aqueous 
phase was then extracted four times with MTBE. The organic layer was dried over Na2SO4 
and concentrated under vacuum. The crude product was purified by column 
chromatography on silica gel (MTBE/CH 1:1) to afford cycloadduct 169.   
 
Yield: 9.2 g (35.3 mmol), yellowish oil, 60 % 
                    C16H20O3 (260.33) 
1H-NMR (400MHz, CDCl3 + TMS) 
7.36-7.35 (m, 5H, Ar-H), 6.40 (dd, 3J = 6.0 Hz, 3J = 1.5 Hz, 1H, H-7), 6.20 (dd, 3J = 6.0 
Hz, 3J = 1.5 Hz, 1H, H-6), 4.66 (br.t, 3J = 1.9 Hz, 1H, H-1), 4.65 (d, 2J = 12.0 Hz, 1H, -
OCH2Ph), 4.61 (br.t, 3J = 1.9 Hz, 1H, H-5), 4.54 (d, 2J = 12.0 Hz, 1H, -OCH2Ph), 3.81 (m, 
1H, H-3), 3.77 (m, 1H, H-2), 3.47 (m, 2H, -OCH2CH3), 1.97 (ddd, 2J = 14.5 Hz, 3J = 8.9 
Hz, 1H, H-4eq), 1.78 (br.d, 2J = 14.5 Hz, 1H, H-4ax), 1.17 (t, 3J = 7.0 Hz, 3H, -OCH2CH3) 
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13C-NMR (100 MHz, CDCl3 + TMS) 
138.4 (C, ipso-Ar-C), 134.9 (CH, C-6), 132.2 (CH, C-7), 128.3-127.6 (CH, o,m,p-Ar-C), 
78.7 (CH, C-1), 78.2 (CH, C-5), 75.6 (CH, C-2), 73.4 (CH, C-3), 65.8 (CH2, -OCH2CH3), 
70.7 (CH2, -OCH2Ph), 31.3 (CH2, C-4), 15.6 (CH3, -OCH2CH3) 
IR (neat): 2941 m, 2864 m, 1454 w, 1346 m, 1207 m, 1084 s, 1028 s, 855 s 
EI MS (RT): 260 (2, M+), 215 (4), 169 (29), 123 (21), 105 (22), 91 (100), 81 (100) 
HR MS: C18H23NO3Na M+ + CH3CN + Na, Exact: 324.1576, Calcd.: 324.1573 
 
 
6a-Benzyloxy-7a-ethoxy-3,9-dioxatricyclo[3.3.1.02,4]nonane 175 
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GP5; Bicycled alkene 169 (5.0 g, 19.2 mmol, 1.0 eq) was dissolved in 100 mL DCM and 
cooled at 0°C. To this reaction mixture m-CPBA (70-75%, 11.4 g, 46.1 mmol, 2.4 eq) was 
added and the resulting reaction mixture was stirred for 1.5 h at the same temperature. The 
crude product was purified by column chromatography on silica gel (MTBE/CH 1:1) to 
afford epoxy 175. 
 
Yield: 4.2 g (14.4 mmol), colourless oil, 75 % 
                    C16H20O4 (276.33) 
1H-NMR (400MHz, CDCl3 + TMS) 
7.36-7.35 (m, 5H, Ar-H), 4.70 (d, 2J = 11.9 Hz, 1H, -OCH2Ph), 4.60 (d, 2J = 11.9 Hz, 1H, -
OCH2Ph), 4.20 (br.d, 3J = 4.0 Hz, 1H, H-1), 4.17 (m, 1H, H-5), 3.85 (d, 3J = 3.8 Hz, 1H, 
H-6), 3.75 (m, 1H, H-3), 3.67 (d, 3J = 4.0 Hz, 1H, H-7), 3.56 (m, 1H, H-2), 3.54 (m, 2H, -
OCH2CH3), 1.95 (dt, 2J = 14.9 Hz, 3J = 8.0 Hz, 3J = 4.0 Hz, 1H, H-4ax), 1.89 (dt, 2J = 14.9 
Hz, 3J = 3.3 Hz, 3J = 1.6 Hz, 1H, H-4eq), 1.19 (t, 3J = 7.0 Hz, 3H, -OCH2CH3) 
13C-NMR (100 MHz, CDCl3 + TMS) 
138.1 (C, ipso-Ar-C), 128.4-127.6 (CH, o,m,p-Ar-C), 75.4 (CH, C-1), 72.8 (CH, C-5), 72.1 
(CH, C-2), 71.6 (CH, C-3), 70.8 (CH2, -OCH2Ph), 65.9 (CH2, -OCH2CH3), 54.3 (CH, C-6), 
53.5 (CH, C-7), 31.7 (CH2, C-4), 15.6 (CH3, -OCH2CH3) 
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IR (neat): 3016 w, 2970 m, 2947 w, 1739 s, 1441 w, 1367 s, 1229 s, 1217 s, 1091 m, 1028 
w, 854 w 
EI MS (RT): 276 (10, M+), 204 (12), 178 (15), 139 (20), 111 (36), 97 (29), 91 (100), 72 
(30) 
 
 
7a-Ethoxy-3,9-dioxatricyclo[3.3.1.02,4]nonane-6a-ol 106 
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GP6; A catalytic amount of Pd/C (10%) was dissolved in 20 mL ethanol. To this 
suspension a solution of benzyl ether (3.6 g, 13.0 mmol, 1.0 eq) in 40 mL ethanol and 1.8 
mL AcOH was added. The crude product was purified by column chromatography on 
silica gel using MTBE as an eluent to afford epoxy alcohol 106. 
 
Yield: 1.2 g (6.5 mmol), white solid, 50 % 
                    C9H14O4 (186.21) 
1H-NMR (400MHz, CDCl3 + TMS) 
4.20 (br.d, 3J = 1.0 Hz, 1H, H-5), 4.17 (br.d, 3J = 4.5 Hz, 1H, H-1), 3.87 (m, 1H, H-2), 3.69 
(m, 2H, -OCH2CH3), 3.48 (d, 3J = 3.3 Hz, 1H, H-6), 3.37 (m, 1H, H-3), 3.33 (d, 3J = 9.9 
Hz, 1H, H-7), 2.0 (m, 2H, H-4ax/eq), 1.23 (t, 3J = 7.0 Hz, 3H, -OCH2CH3) 
13C-NMR (100 MHz, CDCl3 + TMS) 
74.1 (CH, C-1), 73.2 (CH, C-5), 70.9 (CH, C-3), 67.0 (CH, C-2), 65.4 (CH2, -OCH2CH3), 
53.9 (CH, C-6), 52.7 (CH, C-7), 30.0 (CH2, C-4), 15.3 (CH3, -OCH2CH3) 
IR (neat): 3471 s, 2970 m, 2879 w, 1378 m, 1242 m, 1132 w, 1052 s, 1030 s, 793 m, 710 s 
EI MS (RT): 186 (17, M+), 141 (17), 129 (20), 114 (27), 101 (29), 91 (20), 88 (48), 71 
(100) 
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4a-Ethoxy-2,7-dioxatricyclo[4.2.1.03,8]nonane-9ß-ol 109 
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GP7; Epoxy alcohol 106 (1.0 g, 5.4 mmol, 1.0 eq) was dissolved in 45 mL THF and to this 
mixture a solution of KOBut (1.5 g, 13.5 mmol, 2.5 eq) in 45 mL THF was added. The 
crude product was purified by column chromatography on silica gel using EA as an eluent 
to afford 109. 
 
Yield: 0.5 g (2.8 mmol), white solid, 52 % 
           C9H14O4 (186.21) 
1H-NMR (400MHz, CDCl3 + TMS) 
5.17 (dd, 3J = 10.0 Hz, 3J = 4.2 Hz, 1H, H-7), 4.96 (dd, 3J = 6.0 Hz, 3J = 1.6 Hz, 1H, H-2), 
4.93 (dd, 3J = 4.2 Hz, 3J = 1.6 Hz, 1H, H-1), 4.53 (d, 3J = 10.0 Hz, 1H, H-6), 4.20 (m, 1H, 
H-5), 3.60 (dt, 3J = 8.5 Hz, 3J = 2.0 Hz, 1H, H-3), 3.47 (m, 2H, -OCH2CH3), 2.63 (m, 1H, 
H-4eq), 2.10 (br.s, 1H, -OH), 1.75 (dq, 3J = 8.5 Hz, 3J = 0.8 Hz, 1H, H-4ax), 1.18 (t, 3J = 
7.0 Hz, 3H, -OCH2CH3) 
13C-NMR (100 MHz, CDCl3 + TMS) 
89.7 (CH, C-7), 82.1 (CH, C-2), 80.5 (CH, C-6), 78.6 (CH, C-1), 74.6 (CH, C-5), 72.4 
(CH, C-3), 63.8 (CH2, -OCH2CH3), 28.5 (CH2, C-4), 15.3 (CH3, -OCH2CH3) 
IR (neat): 3406 s, 2969 m, 2871 w, 1347 w, 1103 m, 1072 s, 1040 m, 984 s, 946 m, 921 w, 
764 m 
EI MS (RT): no M+, 157 (4), 140 (6), 127 (7), 111 (34), 99 (17), 86 (100), 71 (27) 
X-rays :  Ist x-rays crystal structure data can be seen in chapter 7, pp. 137 
 
4a-Ethoxy -2,7-dioxatricyclo[4.2.1.03,8]nonane-9-one 114 
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GP8; Oxalyl chloride (0.9 mL, 10.8 mmol, 4.0 eq) was dissolved in 40 mL DCM. To this 
reaction mixture DMSO (0.8 mL, 11.3 mmol, 4.2 eq) and tricyclic alcohol (0.5 g, 2.7 
mmol, 1.0 eq) in 15 mL DCM was added, at -78°C. The solution was stirred for 1h at same 
temperature and then NEt3 (3.4 mL, 24.3 mmol, 9.0 eq) was added. The crude product was 
purified by column chromatography on silica gel using EA as an eluent to afford 114. 
 
Yield: 0.3 g (1.6 mmol), yellowish oil, 60 % 
                    C9H12O4 (184.19) 
1H-NMR (400MHz, CDCl3 + TMS) 
5.34 (dd, 3J = 6.1 Hz, 3J = 2.2 Hz, 1H, H-7), 5.27 (dd, 3J = 4.4 Hz, 1H, H-2), 4.67 (m, 1H, 
H-5), 4.64 (m, 1H, H-1), 3.68 (m, 2H, -OCH2CH3), 3.52 (m, 1H, H-3), 2.18 (m, 1H, H-
4eq), 1.93 (dq, 3J = 8.0 Hz, 3J = 1.0 Hz, 1H, H-4ax), 1.20 (t, 3J = 7.0 Hz, 3H, -OCH2CH3) 
13C-NMR (100 MHz, CDCl3 + TMS) 
206.6 (C, C-6), 83.5 (CH, C-7), 80.1 (CH, C-2), 74.3 (CH, C-5), 73.9 (CH, C-3), 71.1 (CH, 
C-1), 64.1 (CH2, -OCH2CH3), 28.3 (CH2, C-4), 15.2 (CH3, -OCH2CH3) 
IR (neat): 3367 s, 2973 m, 2872 m, 1765 s, 1659 m, 1069 s, 1034 m, 986 m, 946 m, 898 m 
EI MS (RT): 185 (3, M+ +1), 184 (6, M+), 127 (50), 113 (14), 109 (26), 99 (40), 82 (100) 
 
 
 
2a-Benzyloxy-3a-propoxy-1,5-dimethyl-8-oxabicyclo[3.2.1]oct-6-ene 167 
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NaH (60 % suspension in oil, 3.0 g, 76.0 mmol, 5.0 eq) was dissolved in 50 mL THF and 
stirred at 0°C. In another R.B. bicyclic alcohol 46 (3.9 g, 15.2 mmol, 1.0 eq) was dissolved 
in 25 mL THF, this reaction mixture was added to the NaH solution and stirred further for 
1 h at the same temperature. Then, PrBr (7.4 mL, 76.0 mmol, 5.0 eq) and a catalytic 
amount of KI were added and the resulting solution was stirred for 2 h more at 0°C then 
warm till the room temperature. The reaction mixture was washed with 53 mL of saturated 
solution of sodium thiosulfate and with 150 mL of distilled water. The aqueous phase was 
then extracted four times with MTBE. The organic layer was dried over Na2SO4 and 
6.3.2 Attempts to chapter 4.1.2-4.1.3                                                                                                        - 93 -   
concentrated under vacuum. The crude product was purified by column chromatography 
on silica gel (MTBE/CH 1:2) to afford cycloadduct 167.   
 
Yield: 2.8 g (9.2 mmol), yellowish oil, 60% 
                    C19H26O3 (302.41) 
1H-NMR (400MHz, CDCl3 + TMS) 
7.35-7.34 (m, 5H, Ar-H), 6.10 (d, 3J = 5.8 Hz, 1H, H-7), 5.90 (d, 3J = 5.8 Hz, 1H, H-6), 
4.70 (d, 2J = 12.0 Hz, 1H, -OCH2Ph), 4.40 (d, 2J = 12.0 Hz, 1H, -OCH2Ph), 3.76 (td, 3J = 
1.2 Hz, 3J = 5.5 Hz, 1H, H-3), 3.46 (d, 3J = 5.5 Hz, 1H, H-2), 3.30 (m, 2H, - OCH2CH2CH3 
), 1.91 (dd, 2J = 14.4 Hz, 3J = 1.1 Hz, 1H, H-4ax), 1.77 (dd, 2J = 14.4 Hz, 3J = 5.2 Hz, 1H, 
H-4eq), 1.58 (m, 2H, -OCH2CH2CH3), 1.38 (s, 3H, -CH3), 1.32 (s, 3H, -CH3), 0.89 (t, 3J = 
7.3 Hz, 3H, -OCH2 CH2CH3) 
13C-NMR (100 MHz, CDCl3 + TMS) 
138.4 (C, ipso-Ar-C), 137.5 (CH, C-6), 135.3 (CH, C-7), 128.2-127.6 (CH, o,m,p-Ar-C), 
85.5 (C, C-1), 83.8 (C, C-5), 80.0 (CH, C-2), 73.1 (CH, C-3), 71.8 (CH2, -OCH2Ph), 71.1 
(CH2, -OCH2CH2CH3), 37.4 (CH2, C-4), 24.0 (CH3, -CH3), 23.3 (CH2, -OCH2CH2CH3), 
21.3 (CH3, -CH3), 10.8 (CH3, -OCH2CH2CH3) 
IR (neat): 2914 m, 2849 m, 1353 m, 1161 m, 1109 s, 1049 s, 949 m, 862 m, 748 s, 699 m 
EI MS (RT): no M+, 326 (1, M+ +1 +Na), 260 (7), 154 (40), 136 (12), 109 (100), 93 (29) 
 
 
 
6a-Benzyloxy-7a-propoxy -1,5-dimethyl-3,9-dioxatricyclo[3.3.1.02,4]nonane 173  
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GP5; Bicyclic alkene 167 (1.6 g, 5.3 mmol, 1.0 eq) was dissolved in 200 mL DCM and 
cooled at 0°C. To this reaction mixture m-CPBA (70-75%, 3.1 g, 12.7 mmol, 2.4 eq) was 
added and the resulting reaction mixture was stirred for 1.5 h at the same temperature. The 
crude product was purified by column chromatography on silica gel (MTBE/CH 1:2) to 
afford epoxy 173. 
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Yield: 1.3 g (4.1 mmol), white solid, 78 % 
           C19H26O4 (318.41) 
1H-NMR (400MHz, CDCl3 + TMS) 
7.35-7.34 (m, 5H, Ar-H), 4.70 (d, 2J = 11.8 Hz, 1H, -OCH2Ph), 4.40 (d, 2J = 11.8 Hz, 1H, -
OCH2Ph), 3.72 (td, 3J = 1.7 Hz, 3J = 4.5 Hz, 1H, H-3), 3.63 (d, 3J = 3.3 Hz, 1H, H-6), 3.45 
(m, 2H, - OCH2CH2CH3 ), 3.37 (d, 3J = 4.5 Hz, 1H, H-2), 3.34 (d, 3J = 3.3 Hz, 1H, H-7), 
1.98 (dd, 2J = 14.9 Hz, 3J = 1.7 Hz, 1H, H-4ax), 1.76 (dd, 2J = 14.9 Hz, 3J = 4.1 Hz, 1H, H-
4eq), 1.58 (q, 3J = 7.4 Hz 2H, -OCH2CH2CH3), 1.38 (s, 3H, -CH3), 1.30 (s, 3H, -CH3), 0.92 
(t, 3J = 7.4 Hz, 3H, -OCH2 CH2CH3) 
13C-NMR (100 MHz, CDCl3 + TMS) 
138.1 (C, ipso-Ar-C), 128.4-127.7 (CH, o,m,p-Ar-C), 79.8 (C, C-1), 79.5 (CH, C-2), 77.2 
(C, C-5), 72.3 (CH, C-3), 72.1 (CH2, -OCH2Ph), 71.1 (CH2, -OCH2CH2CH3), 58.4 (CH, C-
6), 57.5 (CH, C-7), 38.0 (CH2, C-4), 23.5 (CH2, -OCH2CH2CH3), 20.0 (CH3, -CH3), 17.3 
(CH3, -CH3), 10.9 (CH3, -OCH2CH2CH3) 
IR (neat): 3330 m, 2971 m, 2932 m, 2874 m, 1453 m, 1374 w, 1088 s, 986 s, 953 m, 699 s 
EI MS (RT): no M+, 259 (1), 213 (2), 192 (11), 171 (100), 129 (23), 91 (53), 71 (11) 
 
 
 
7a-Propoxy-1,5-dimethyl-3,9-dioxatricyclo[3.3.1.02,4]nonane-6a-ol 102 
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GP6; A catalytic amount of Pd/C (10%) was dissolved in 10 mL ethanol. To this 
suspension a solution of benzyl ether (1.2 g, 3.7 mmol, 1.0 eq) in 15 mL ethanol and 0.6 
mL AcOH was added. The crude product was purified by column chromatography on 
silica gel (MTBE/CH 1:1) to afford epoxy 102. 
 
Yield: 0.5 g (2.0 mmol), yellowish oil, 54 % 
                    C12H20O4 (228.28) 
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1H-NMR (400MHz, CDCl3 + TMS) 
3.68 (m, 1H, H-3), 3.58 (m, 1H, H-2), 3.52 (m, 1H, H-7), 3.46 (d, 3J = 3.1 Hz, 1H, H-6), 
3.28 (m, 2H, - OCH2CH2CH3 ), 3.02 (d, 3J = 9.8 Hz, 1H, -OH), 2.03 (dd, 2J = 15.2 Hz, 3J = 
1.4 Hz, 1H, H-4ax), 1.82 (dd, 2J = 15.2 Hz, 3J = 4.4 Hz, 1H, H-4eq), 1.62 (q, 3J = 7.0 Hz 
2H, -OCH2CH2CH3), 1.41 (s, 3H, -CH3), 1.32 (s, 3H, -CH3), 0.94 (t, 3J = 7.0 Hz, 3H, -
OCH2 CH2CH3) 
13C-NMR (100 MHz, CDCl3 + TMS) 
79.7 (C, C-1), 76.7 (C, C-5), 74.5 (CH, C-2), 72.0 (CH, C-3), 71.7 (CH2, -OCH2CH2CH3), 
58.0 (CH, C-6), 56.6 (CH, C-7), 36.8 (CH2, C-4), 23.1 (CH2, -OCH2CH2CH3), 19.9 (CH3, -
CH3), 17.0 (CH3, -CH3), 10.8 (CH3, -OCH2CH2CH3) 
IR (neat): 3499 s, 2970 m, 2932 m, 1371 w, 1118 w, 1074 s, 1038 m, 952 m, 876 m 
EI MS (RT): 229 (20, M+ +1), 212 (23), 185 (18), 171 (88), 129 (92), 113 (70), 95 (100), 
85 (92), 71 (81) 
HR MS: C14H23NO4Na M+ + CH3CN + Na, Exact: 292.1525, Calcd.: 292.1512 
 
 
7a-Propoxy-6,8-dimethyl -2,7-dioxatricyclo[4.2.1.03,8]nonane-9ß-ol  104 
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GP7; Epoxy alcohol 102 (0.2 g, 0.9 mmol, 1.0 eq) was dissolved in 10 mL THF and to this 
reaction mixture a solution of KOBut (0.7 g, 6.0 mmol, 2.0 eq) in 10 mL THF was added. 
The crude product was purified by column chromatography on silica gel using EA as 
eluent to afford 104. 
 
 
Yield: 0.1 g (0.5 mmol), dark yellow oil, 56 % 
           C12H20O4 (228.28) 
1H-NMR (400MHz, CDCl3 + TMS) 
4.67 (d, 3J = 1.8 Hz, 1H, H-2), 4.57 (s, 1H, H-7), 3.93 (s, 1H, H-6), 3.57 (dt, 3J = 8.5 Hz, 3J 
= 1.8 Hz, 1H, H-3), 3.37 (m, 2H, - OCH2CH2CH3 ), 2.29 (dq, 2J = 13.5 Hz, 3J = 8.5 Hz, 3J 
= 0.7 Hz, 1H, H-4ax), 1.87 (dd, 2J = 13.6 Hz, 3J = 9.0 Hz, 1H, H-4eq), 1.61 (s, 3H, -CH3), 
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1.57 (q, 3J = 6.9 Hz 2H, -OCH2CH2CH3), 1.45 (s, 3H, -CH3), 1.25 (br.s, 1H, -OH), 0.96 (t, 
3J = 7.4 Hz, 3H, -OCH2 CH2CH3) 
13C-NMR (100 MHz, CDCl3 + TMS) 
94.0 (CH, C-2), 85.6 (CH, C-7), 83.6 (C, C-1), 81.2 (C, C-5), 80.6 (CH, C-6), 73.8 (CH, C-
3), 70.4 (CH2, -OCH2CH2CH3), 35.2 (CH2, C-4), 23.0 (CH2, -OCH2CH2CH3), 21.7 (CH3, -
CH3), 19.2 (CH3, -CH3), 10.4 (CH3, -OCH2CH2CH3) 
IR (neat): 3427 s, 2973 m, 2932 s, 2873 m, 1374 m, 1201 m, 1094 s, 1070 s, 922 s, 959 m, 
894 m, 824 m 
EI MS (RT): no M+, 169 (19), 140 (15), 127 (25), 112 (100), 99 (26), 85 (29) 
 
 
2a-Benzyloxy-3a-propoxy-8-oxabicyclo[3.2.1]oct-6-ene 170 
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NaH (60 % suspension in oil, 2.4 g, 61.0 mmol, 5.0 eq) was dissolved in 50 mL THF and 
stirred at 0°C. In another R.B. bicyclic alcohol rac-96 (2.8 g, 12.2 mmol, 1.0 eq) was 
dissolved in 25 mL THF, this reaction mixture was added to the NaH solution and stirred 
further for 1 h at the same temperature. Then, PrBr (5.9 mL, 61.0 mmol, 5.0 eq) and a 
catalytic amount of KI was added and the resulting solution was stirred for further 2 h at 
0°C then warm till the room temperature. The reaction mixture was washed with 43 mL of 
saturated solution of sodium thiosulfate and with 127 mL of distilled water. The aqueous 
phase was then extracted four times with MTBE. The organic layer was dried over Na2SO4 
and concentrated under vacuum. The crude product was purified by column 
chromatography on silica gel (MTBE/CH x) to afford cycloadduct 170.   
 
Yield: 1.8 g (6.6 mmol), yellowish oil, 54% 
                    C17H22O3 (274.35) 
1H-NMR (400MHz, CDCl3 + TMS) 
7.36-7.34 (m, 5H, Ar-H), 6.38 (dd, 3J = 7.2 Hz, 3J = 1.1 Hz, 1H, H-7), 6.23 (dd, 3J = 7.2 
Hz, 3J = 1.7 Hz, 1H, H-6), 4.65 (m, 1H, H-1), 4.64 (d, 2J = 11.5 Hz, 1H, -OCH2Ph), 4.62 
(td, 3J = 1.6 Hz, 3J = 3.3 Hz, 1H, H-5), 4.52 (d, 2J = 11.5 Hz, 1H, -OCH2Ph), 3.79 (m, 2H, 
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H-2, H-3 ), 3.34 (t, 3J = 6.6 Hz, 2H, - OCH2CH2CH3 ), 1.96 (dd, 2J = 14.4 Hz, 3J = 4.2 Hz, 
1H, H-4ax), 1.78 (br,d, 2J = 14.4 Hz, 1H, H-4eq), 1.56 (m, 2H, -OCH2CH2CH3), 0.89 (t, 3J 
= 7.4 Hz, 3H, -OCH2 CH2CH3) 
13C-NMR (100 MHz, CDCl3 + TMS) 
138.5 (C, ipso-Ar-C), 134.8 (CH, C-6), 132.2 (CH, C-7), 128.3-127.7 (CH, o,m,p-Ar-C), 
78.8 (CH, C-2), 78.2 (CH, C-1), 75.9 (CH, C-5), 73.7 (CH, C-3), 72.4 (CH2, -OCH2Ph), 
70.7 (CH2, -OCH2CH2CH3), 31.1 (CH2, C-4), 23.3 (CH2, -OCH2CH2CH3), 10.8 (CH3, -
OCH2CH2CH3) 
IR (neat):2922 m, 2853 m, 1454 w, 1348 m, 1206 w, 1087 s, 1051 m, 1030 m, 732 s, 698 s 
EI MS (RT): 274 (1, M+), 232 (2), 214 (2), 185 (6), 141 (17), 126 (31), 91 (57), 81 (100) 
 
 
 
6a-Benzyloxy-7a-propoxy-3,9-dioxatricyclo[3.3.1.02,4]nonane 176 
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GP5; Bicyclic alkene 170 (1.6 g, 6.0 mmol, 1.0 eq) was dissolved in 230 mL DCM and 
cooled at 0°C. To this mixture m-CPBA (70-75%, 3.5 g, 14.4 mmol, 2.4 eq) was added and 
the resulting reaction mixture was stirred for 1.5 h at the same temperature. The crude 
product was purified by column chromatography on silica gel (MTBE/CH 1:2) to afford 
epoxy 176. 
 
Yield: 1.2 g (4.1 mmol), yellowish oil, 69 % 
           C17H22O4 (290.15) 
1H-NMR (400MHz, CDCl3 + TMS) 
7.38-7.35 (m, 5H, Ar-H), 4.67 (d, 2J = 11.4 Hz, 1H, -OCH2Ph), 4.59 (d, 2J = 11.4 Hz, 1H, -
OCH2Ph), 4.15 (br.d, 3J = 4.2 Hz, 1H, H-1), 3.92 (t, 3J = 4.0 Hz, 1H, H-5), 3.83 (d, 3J = 7.0 
Hz, 1H, H-6), 3.51 (d, 3J = 7.0 Hz, 1H, H-7), 3.37 (t, 3J = 6.3 Hz, 2H, - OCH2CH2CH3 ), 
3.05 (m, 1H, H-3), 3.01 (dd, 3J = 4.2 Hz, 3J = 1.1 Hz, H-2 ), 1.98 (dd, 2J = 14.2 Hz, 3J = 4.0 
Hz, 1H, H-4ax), 1.83 (br,d, 2J = 14.2 Hz, 1H, H-4eq), 1.51 (m, 2H, -OCH2CH2CH3), 0.91 
(t, 3J = 7.2 Hz, 3H, -OCH2 CH2CH3) 
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13C-NMR (100 MHz, CDCl3 + TMS) 
138.3 (C, ipso-Ar-C), 128.5-127.3 (CH, o,m,p-Ar-C), 73.1 (CH2, -OCH2Ph), 72.9 (CH, C-
1), 72.4 (CH, C-2), 70.2 (CH, C-5), 69.8 (CH, C-3), 69.5 (CH2, -OCH2CH2CH3), 60.1 (CH, 
C-6), 55.2 (CH, C-7), 28.8 (CH2, C-4), 22.7 (CH2, -OCH2CH2CH3), 10.5 (CH3, -
OCH2CH2CH3) 
IR (neat): 3328 w, 2969 m, 2929 m, 2864 w, 1447 m, 1369 w, 1078 s, 975 s, 946 m, 689 s 
EI MS (RT): no M+, 231 (3), 185 (1), 164 (10), 143 (100), 101 (12), 91 (65), 71 (6) 
 
7a-Propoxy-3,9-dioxa-tricyclo[3.3.1.02,4]nonane-6a-ol 107 
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GP6; A catalytic amount of Pd/C (10%) was dissolved in 15 mL ethanol. To this 
suspension a solution of benzyl ether (1.7 g, 5.7 mmol, 1.0 eq) in 25 mL ethanol and 0.9 
mL AcOH was added. The crude product was purified by column chromatography on 
silica gel (MTBE/CH 1:1) to afford epoxy 107. 
 
Yield: 0.54 g (2.7 mmol), yellow oil, 47 % 
           C10H16O4 (200.23) 
1H-NMR (400MHz, CDCl3 + TMS) 
4.28 (d, 3J = 4.1 Hz, 1H, H-1), 4.15 (t, 3J = 4.3 Hz, 1H, H-5), 3.75 (dd, 3J = 4.1 Hz, 3J = 1.1 
Hz, H-2 ), 3.52 (t, 3J = 6.0 Hz, 2H, - OCH2CH2CH3 ), 3.16 (dt, 3J = 5.2 Hz, 3J = 1.1 Hz, 
1H, H-3), 2.73 (d, 3J = 7.2 Hz, 1H, H-6), 2.61 (d, 3J = 7.2 Hz, 1H, H-7), 1.97 (m, 2H, H-
4ax,eq), 1.53 (m, 2H, -OCH2CH2CH3), 0.88 (t, 3J = 7.3 Hz, 3H, -OCH2 CH2CH3) 
13C-NMR (100 MHz, CDCl3 + TMS) 
76.1 (CH, C-1), 72.8 (CH, C-3), 71.6 (CH, C-5), 69.8 (CH2, -OCH2CH2CH3), 69.5 (CH, C-
2), 62.8 (CH, C-6), 58.3 (CH, C-7), 28.5 (CH2, C-4), 22.8 (CH2, -OCH2CH2CH3), 10.4 
(CH3, -OCH2CH2CH3) 
IR (neat): 3499 s, 2968 m, 2882 m, 1364 w, 1109 m, 1072 s, 1035 m, 948 m, 896 m 
EI MS (RT): 201 (7, M+ +1), 184 (15), 157 (8), 143 (38), 101 (74), 85 (53), 67 (100), 57 
(19) 
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4a-Propoxy-2,7-dioxatricyclo[4.2.1.03,8]nonane-9ß-ol 110 
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GP7; Epoxy alcohol 107 (0.4 g, 1.8 mmol, 1.0 eq) was dissolved in 20 mL THF and to this 
reaction mixture a solution of KOBut (0.4 g, 3.6 mmol, 2.0 eq) in 20 mL THF was added. 
The crude product was purified by column chromatography on silica gel using EA as 
eluent to afford 110. 
 
Yield: 0.18 g (0.88 mmol), yellowish oil, 49 % 
           C10H16O4 (200.23) 
1H-NMR (400MHz, CDCl3 + TMS) 
5.19 (dd, 3J = 9.7 Hz, 3J = 5.2 Hz, 1H, H-7), 5.05 (dd, 3J = 5.9 Hz, 3J = 1.3 Hz, H-2 ), 4.86 
(d, 3J = 9.6 Hz, 1H, H-6), 4.75 (m, 1H, H-5), 4.07 (dd, 3J = 5.1 Hz, 3J = 1.3 Hz, 1H, H-1), 
3.49 (t, 3J = 6.3 Hz, 2H, - OCH2CH2CH3 ), 3.31 (dt, 3J = 5.7 Hz, 3J = 1.2 Hz, 1H, H-3), 
2.07 (m, 1H, H-4ax), 1.70 (dd, 2J = 14.7 Hz, 3J = 1.1 Hz, 1H, H-4eq), 1.52 (m, 2H, -
OCH2CH2CH3), 0.90 (t, 3J = 7.1 Hz, 3H, -OCH2 CH2CH3) 
13C-NMR (100 MHz, CDCl3 + TMS) 
90.4 (CH, C-7), 88.6 (CH, C-2), 76.1 (CH, C-6), 73.7 (CH, C-1), 71.7 (CH, C-5), 70.2 
(CH2, -OCH2CH2CH3), 69.9 (CH, C-3), 27.8 (CH2, C-4), 22.9 (CH2, -OCH2CH2CH3), 10.6 
(CH3, -OCH2CH2CH3) 
IR (neat): 3427 s, 2972 w, 2928 m, 2869 m, 1370 w, 1201 m, 1082 s, 908 s, 963 m, 889 m 
EI MS (RT): no M+, 141 (10), 112 (9), 99 (20), 84 (100), 71 (32), 57 (26) 
 
 
2a,3a-Dibenzyloxy-1,5-dimethyl-8-oxabicyclo[3.2.1]oct-6-ene 177 
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Bicyclic alcohol rac-46 (3.9 g, 15.4 mmol, 1.0 eq) was dissolved in 30 mL THF. To this 
reaction mixture NaH (60 % suspension in oil, 1.2 g, 30.8 mmol, 2.0 eq) was added and  the 
resulting solution was heated to reflux at 70°C for 0.5 h. Then, BnBr (2.7 mL, 23.1 mmol, 
1.5 eq) was added and the reaction mixture was further heated for 15 h at the same 
temperature and cooled till room temperature. The remaining solution was dissolved in 20 
mL distilled water and 20 mL MTBE. The organic layer was washed with dist. water for 
three times. The aqueous phase was then extracted four times with MTBE. The organic 
layer was dried over Na2SO4 and concentrated under vacuum. The crude product was 
purified by column chromatography on silica gel (MTBE/CH 1: 5) to afford cycloadduct 
177.   
 
Yield: 4.8 g (13.7 mmol), yellowish oil, 89 % 
                    C23H26O3 (350.45) 
1H-NMR (400MHz, CDCl3 + TMS) 
7.29-7.31 (m, 10H, Ar-H), 6.11 (d, 3J = 5.9 Hz, 1H, H-7), 5.97 (d, 3J = 5.9 Hz, 1H, H-6), 
4.57/4.36 (d, 2J = 11.9 Hz, 1H, -OCH2Ph), 4.53/4.43 (d, 2J = 12.0 Hz, 1H, -OCH2Ph), 3.90 
(dt, 3J = 1.4 Hz, 3J = 5.5 Hz, 1H, H-3), 3.47 (d, 3J = 5.5 Hz, 1H, H-2), 1.96 (dd, 2J = 14.5 
Hz, 3J = 1.3 Hz, 1H, H-4eq), 1.80 (dd, 2J = 14.5 Hz, 3J = 5.5 Hz, 1H, H-4ax), 1.39 (s, 3H, 
CH3), 1.32 (s, 3H, CH3),  
13C-NMR (100 MHz, CDCl3 + TMS) 
138.8 (C, ipso- Ar-C), 138.2 (C, ipso-Ar-C), 137.6 (CH, C-6), 135.4 (CH, C-7), 128.3-
127.4 (CH, o,m,p-Ar-C), 85.6 (C, C-1), 83.8 (C, C-5), 80.3 (CH, C-2), 72.3 (CH, C-3), 
71.7 (CH2, -OCH2Ph), 71.4 (CH2, -OCH2Ph), 37.5 (CH2, C-4), 24.0 (CH3), 21.3 (CH3) 
IR (neat): 3001 w, 2867 w, 1496 m, 1453 m, 1350 m, 1168 s, 1097 s, 1028 m, 945 m 
EI MS (RT): 350 (4, M+), 259 (17), 242 (5), 199 (14), 153 (27), 137 (53), 109 (25), 96 
(27), 91 (100) 
Structure confirmation: H,H-COSY, HMBC, HMQC-Spectra 
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6a,7a-Dibenzyloxy-1,5-dimethyl-3,9-dioxatricyclo[3.3.1.02,4]nonane 97  
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GP5; Bicyclic alkene 177 (5.3 g, 15.2 mmol, 1.0 eq) was dissolved in 50 mL DCM and 
cooled at 0°C. To this reaction mixture m-CPBA (70-75%, 6.9 g, 30.4 mmol, 2.0 eq) was 
added and the resulting reaction mixture was stirred for 1.5 h at the same temperature. The 
crude product was purified by column chromatography on silica gel (MTBE/CH 1:1) to 
afford epoxy 97. 
 
Yield: 4.2 g (11.4 mmol), colourless oil, 75% 
                    C23H26O4 (366.45) 
1H-NMR (400MHz, CDCl3 + TMS) 
7.32-7.31 (m, 10H, Ar-H), 4.62/4.59 (d, 2J = 11.8 Hz, 1H, -OCH2Ph), 4.54/4.40 (d, 2J = 
11.8 Hz, 1H, -OCH2Ph), 3.87 (dt, 3J = 1.8 Hz, 3J = 4.4 Hz, 1H, H-3), 3.70 (d, 3J = 3.2 Hz, 
1H, H-7), 3.38 (d, 3J = 3.2 Hz, 1H, H-6), 3.41 (d, 3J = 4.4 Hz, 1H, H-2), 2.05 (dd, 2J = 14.9 
Hz, 3J = 1.6 Hz, 1H, H-4eq), 1.81 (dd, 2J = 14.9 Hz, 3J = 4.2 Hz, 1H, H-4ax), 1.39 (s, 3H, 
CH3), 1.30 (s, 3H, CH3),  
13C-NMR (100 MHz, CDCl3 + TMS) 
138.6 (C, ipso- Ar-C), 137.9 (C, ipso-Ar-C), 128.4-127.3 (CH, o,m,p-Ar-C), 80.1 (CH, C-
2), 79.5 (C, C-1), 77.3 (C, C-5), 72.2 (CH2, -OCH2Ph), 71.9 (CH, C-3), 71.5 (CH2, -
OCH2Ph), 58.4 (CH, C-6), 57.4 (CH, C-7), 38.1 (CH2, C-4), 20.0 (CH3), 17.4 (CH3) 
IR (neat): 3030 w, 2931 w, 2871 w, 1496 m, 1453 s, 1200 m, 1179 m, 1158 s, 952 s, 923 s, 
734 s, 696 s 
EI MS (RT): no M+, 276 (13), 219 (10), 193 (5), 169 (6), 147 (6), 105 (7), 91 (100) 
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2a,3a-Dibenzyloxy-8-oxabicyclo[3.2.1]oct-6-ene 178 
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Bicyclic alcohol rac-94 (5.4 g, 23.2 mmol, 1.0 eq) was dissolved in 40 mL THF. To this 
reaction mixture NaH (60 % suspension in oil, 1.9 g, 46.4 mmol, 2.0 eq) was added and  the 
resulting solution was heated to reflux at 70°C for 0.5 h. BnBr (4.2 mL, 34.8 mmol, 1.5 eq) 
was added and the reaction mixture further heated for 15 h at the same temperature and 
cooled till room temperature. The remaining solution was dissolved in 25 mL distilled 
water and 25 mL MTBE. The organic layer was washed with dist. water for three times. 
The aqueous phase was then extracted four times with MTBE. The organic layer was dried 
over Na2SO4 and concentrated under vacuum. The crude product was purified by column 
chromatography on silica gel (MTBE/CH 1: 2) to afford cycloadduct 178.   
 
 
Yield: 6.0 g (18.6 mmol), colourless oil, 80% 
                    C21H22O3 (322.40) 
1H-NMR (400MHz, CDCl3 + TMS) 
7.32-7.30 (m, 10H, Ar-H), 6.40 (dd, 3J = 6.1 Hz, 3J = 1.8 Hz, 1H, H-7), 6.30 (dd, 3J = 6.0 
Hz, 3J = 1.5 Hz, 1H, H-6), 4.66 (m, 1H, H-1), 4.65 (m, 1H, H-5), 4.60/4.57 (d, 2J = 11.9 
Hz, 1H, -OCH2Ph), 4.54/4.51 (d, 2J = 12.0 Hz, 1H, -OCH2Ph), 3.92 (m, 1H, H-3), 3.80 
(dd, 3J = 5.3 Hz, 3J = 3.8 Hz, 1H, H-2), 1.98 (qd, 2J = 14.6 Hz, 3J = 4.0 Hz, 1H, H-4eq), 
1.82 (td, 2J = 14.6 Hz, 3J = 1.3 Hz, 1H, H-4ax),  
13C-NMR (100 MHz, CDCl3 + TMS) 
139.0 (C, ipso- Ar-C), 138.4 (C, ipso-Ar-C), 134.9 (CH, C-6), 132.3 (CH, C-7), 128.3-
127.2 (CH, o,m,p-Ar-C), 78.6 (C, C-1), 78.1 (C, C-5), 76.1 (CH, C-2), 73.1 (CH, C-3), 
72.4 (CH2, -OCH2Ph), 70.9 (CH2, -OCH2Ph), 31.3 (CH2, C-4) 
IR (neat): 2948 m, 1453 m, 1272 m, 1176 w, 1096 s, 1070 s, 1026 s, 712 m, 698 m 
EI MS (RT): no M+, 248 (14), 141 (14), 124 (25), 111 (15), 105 (32), 91 (100), 69 (28) 
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6a,7a-Dibenzyloxy-3,9-dioxatricyclo[3.3.1.02,4]nonane 98 
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GP5; Bicyclic alkene 178 (5.5 g, 17.1 mmol, 1.0 eq) was dissolved in 50 mL DCM and 
cooled at 0°C. To this reaction mixture m-CPBA (70-75%, 10.1 g, 41.0 mmol, 2.4 eq) was 
added and the resulting reaction mixture was stirred for 1.5 h at the same temperature. The 
crude product was purified by column chromatography on silica gel (MTBE/CH 1:1) to 
afford epoxy 98. 
 
Yield: 4.1 g (12.0 mmol), colourless oil, 70 % 
                    C21H22O4 (338.40) 
1H-NMR (400MHz, CDCl3 + TMS) 
7.34-7.33 (m, 10H, Ar-H), 4.68/4.62 (d, 2J = 11.9 Hz, 1H, -OCH2Ph), 4.60/4.55 (d, 2J = 
12.0 Hz, 1H, -OCH2Ph), 4.26 (d, 3J = 3.90 Hz, 1H, H-1), 4.20 (m, 1H, H-3), 3.93 (d, 3J = 
3.2 Hz, 1H, H-6), 3.90 (m, 1H, H-2), 3.73 (t, 3J = 4.1 Hz, 1H, H-5), 3.61 (d 3J = 3.2 Hz, 
1H, H-7), 2.00 (td, 2J = 15.0 Hz, 3J = 3.9 Hz, 1H, H-4eq), 1.95 (td, 2J = 15.0 Hz, 3J = 1.8 
Hz, 1H, H-4ax),  
13C-NMR (100 MHz, CDCl3 + TMS) 
138.6 (C, ipso-Ar-C), 137.9 (C, ipso- Ar-C), 128.4-127.3 (CH, o,m,p-Ar-C), 75.8 (CH, C-
1), 72.8 (CH2, -OCH2Ph), 72.7 (CH, C-5), 72.1 (CH, C-2), 71.6 (CH, C-3), 71.1 (CH2, -
OCH2Ph), 54.3 (CH, C-6), 53.5 (CH, C-7), 31.9 (CH2, C-4) 
IR (neat): 2948 w, 2866 w, 1496 w, 1453 m, 1359 w, 1200 m, 1092 s, 1065 s, 1038 s, 
1027 s, 858 s, 733 s, 696 s 
EI MS (RT): 338 (3, M+), 247 (65), 141 (24), 111 (11), 107 (32), 91 (100), 69 (19) 
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6.3.3 Attempts to chapter 4.1.4      
 
2a-(1-Phenyl-ethoxy)-8-oxabicyclo[3.2.1]oct-6-ene-3a-ol (+)-118 
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GP4; Bicyclic ketone (+)-27A (1.1 g, 4.5 mmol, 1.0 eq) was dissolved in 5.0 mL THF at  
-78°C. A DIBAH solution (1.2 M/toluene, 7.5 mL, 9.0 mmol, 2.0 eq) was added, slowly. 
The crude product was purified by column chromatography on silica gel (MTBE/CH 1:1) 
to afford cycloadduct (+)-118 as white solid. 
 
Yield: 1.03 g (4.2 mmol), viscous oil, 93%  
C15H18O3 (246.13) 
1H-NMR (400 MHz, CDCl3 + TMS) 
7.36-7.33 (m, 5H, Ar-H), 6.35 (dd, 3J = 6.1 Hz, 3J = 1.6 Hz, 1H, H-7), 6.29 (dd, 3J = 6.1 
Hz, 3J = 1.8 Hz, 1H, H-6), 4.65 (br.m, 1H, H-5), 4.60 (q, 3J = 6.4 Hz, 1H, -OCH(CH3)Ph), 
4.35 (m, 1H, H-1), 4.22 (dt, 3J = 5.4 Hz, 3J = 1.2 Hz, 1H, H-3), 3.61 (dd, 3J = 5.4 Hz, 3J = 
4.4 Hz, 1H, H-2), 2.48 ( br.s, 1H, -OH), 2.01 (ddd, 2J = 14.7 Hz, 3J = 5.2 Hz, 3J = 4.2 Hz, 
1H, H-4eq), 1.81 (d, 2J = 14.7 Hz, 1H, H-4ax), 1.46 (d, 3J = 6.4 Hz, 3H, -OCH(CH3)Ph) 
13C-NMR (100 MHz, CDCl3 + TMS) 
143.1 (C, ipso-Ar-C), 136.5 (CH, C-6), 131.7 (CH, C-7), 128.6 (CH, o-Ar-C), 127.9 (CH, 
m-Ar-C), 126.2 (CH, p-Ar-C), 78.8 (CH, C-1), 78.3 (CH, C-5), 76.4 (CH, C-2), 72.4 (CH, - 
OCH(CH3)Ph), 65.0 (CH, C-3), 32.8 (CH2, C-4), 24.3 (CH3, -OCH(CH3)Ph) 
IR (neat):3514 s, 2942 w, 2916 m, 1455 w, 1348 w, 1272 m, 1055 s, 1024 s, 872 m, 689 m 
EI MS (RT): 246 (1, M+), 141 (47), 105 (55), 91 (3), 81 (100), 77 (9), 69 (4) 
HR MS: C15H18O3, Exact: 246.1257, Calcd.: 246.1256 
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2a-(1-phenyl-ethoxy)-3a-methoxy-8-oxabicyclo[3.2.1]oct-6-ene (+)-119 
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NaH (60 % suspension in oil, 0.3 g, 8.0 mmol, 2.0 eq) was dissolved in 5 mL THF and 
stirred at 0°C. In another R.B. bicycled alcohol (+)-118 (1.0 g, 4.0 mmol, 1.0 eq) was 
dissolved in 5 mL THF, this reaction mixture was added to the NaH solution and stirred for 
further 1 h at the same temperature. Then, CH3I (0.4 mL, 6.8 mmol, 1.7 eq) was added at 
0°C and the resulting solution was stirred for further 2 h at 0°C then warm till the room 
temperature. The reaction mixture was washed with 10 mL of saturated solution of sodium 
thiosulfate and with 30 mL of distilled water. The aqueous phase was then extracted four 
times with MTBE. The organic layer was dried over Na2SO4 and concentrated under 
vacuum. The crude product was purified by column chromatography on silica gel 
(MTBE/CH 1:1) to afford cycloadduct (+)-119.   
 
Yield: 0.8 g (3.3 mmol), yellow oil, 82%  
C16H20O3 (260.33) 
1H-NMR (400 MHz, CDCl3 + TMS) 
7.37-7.34 (m, 5H, Ar-H), 6.36 (dd, 3J = 6.0 Hz, 3J = 1.6 Hz, 1H, H-7), 6.24 (dd, 3J = 6.0 
Hz, 3J = 1.7 Hz, 1H, H-6), 4.59 (br.m, 1H, H-1), 4.50 (q, 3J = 6.5 Hz, 1H, -OCH(CH3)Ph), 
4.33 (br.m, 1H, H-5), 3.68 (dt, 3J = 5.4 Hz, 3J = 1.0 Hz, 1H, H-3), 3.62 (dd, 3J = 5.4 Hz, 3J 
= 4.0 Hz, 1H, H-2), 3.38 (s, 1H, -OCH3), 1.46 (d, 3J = 6.5 Hz, 3H, -OCH(CH3)Ph), 1.91 
(qd, 2J = 14.8 Hz, 3J = 5.0 Hz, 3J = 4.0 Hz, 1H, H-4eq), 1.80 (br.d, 2J = 14.7 Hz, 1H, H-
4ax) 
13C-NMR (100 MHz, CDCl3 + TMS) 
143.7 (C, ipso-Ar-C), 134.8 (CH, C-6), 132.3 (CH, C-7), 128.5 (CH, o-Ar-C), 127.6 (CH, 
m-Ar-C), 126.2 (CH, p-Ar-C), 79.3 (CH, C-1), 78.0 (CH, C-5), 76.0 (CH, C-2), 75.6 (CH, - 
OCH(CH3)Ph), 73.8 (CH, C-3), 58.5 (CH3, -OCH3), 30.3 (CH2, C-4), 24.4 (CH3, -
OCH(CH3)Ph) 
IR (neat): 2972 w, 2939 m, 2824 w, 1452 w, 1347 w, 1209 m, 1099 s, 1084 s, 1089 s, 
1021 m, 879 m, 700 s, 685 m 
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EI MS (RT): no M+, 251 (10), 161 (34), 116 (6), 105 (100), 101 (18), 87 (49), 78 (17) 
 
 
6a-(1-phenyl-ethoxy)-7a-methoxy-3,9-dioxatricyclo[3.3.1.02,4]nonane  
(+)-120 
 
1
2
3
76
4
5
(+)-119 (+)-120
O
OMe
O (R) Ph O
OMe
O (R) Ph
O
 
 
GP5; Bicycled alkene (+)-119 (0.8 g, 3.0 mmol, 1.0 eq) was dissolved in 5 mL DCM and 
cooled at 0°C. To this reaction mixture m-CPBA (70-75%, 1.4 g, 6.0 mmol, 2.0 eq) 
dissolved in 5 mL DCM was added and the resulting reaction mixture was stirred for 1.5 h 
at the same temperature. The crude product was purified by column chromatography on 
silica gel (MTBE/CH 1:1) to afford epoxy (+)-120. 
 
Yield: 0.7 g (2.6 mmol), light yellowish oil, 86 %  
C16H20O4 (276.33) 
1H-NMR (400 MHz, CDCl3 + TMS) 
7.36-7.34 (m, 5H, Ar-H), 4.52 (q, 3J = 6.5 Hz, 1H, -OCH(CH3)Ph), 4.10 (dd, 3J = 3.4 Hz, 
3J = 1.8 Hz, 1H, H-5), 3.90 (dd, 3J = 4.0 Hz, 1H, H-1), 3.82 (d, 3J = 3.3 Hz, 1H, H-6), 3.63 
(m, 1H, H-3), 3.53 (m, 1H, H-2), 3.51 (d, 3J = 3.3 Hz, 1H, H-7), 3.44 (s, 1H, -OCH3), 1.94 
(m, 2H, H-4ax,eq), 1.48 (d, 3J = 6.5 Hz, 3H, -OCH(CH3)Ph) 
13C-NMR (100 MHz, CDCl3 + TMS) 
143.3 (C, ipso-Ar-C), 128.6 (CH, o-Ar-C), 127.8 (CH, m-Ar-C), 126.2 (CH, p-Ar-C), 76.4 
(CH, C-1), 74.2 (CH, C-5), 73.8 (CH, C-2), 73.4 (CH, - OCH(CH3)Ph), 71.5 (CH, C-3), 
58.5 (CH3, -OCH3), 54.0 (CH, C-6), 53.4 (CH, C-7), 30.9 (CH2, C-4), 24.3 (CH3, -
OCH(CH3)Ph) 
IR (neat):2972 w, 2927 m, 2883 w, 1452 w, 1205 m, 1104 s, 1087 s, 1030 s, 879 m, 853 m 
EI MS (RT): 276 (5, M+), 171 (15), 156 (17), 139 (21), 111 (17), 105 (100), 97 (11), 77 
(10) 
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7a-Methoxy-3,9-dioxatricyclo[3.3.1.02,4]nonane-6a-ol (+)-121 
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GP6; A catalytic amount of Pd/C (10%) was dissolved in 20 mL methanol. To this 
suspension a solution of benzyl ether (0.7 g, 2.4 mmol, 1.0 eq) in 40 mL methanol and 0.4 
mL AcOH was added. The crude product was purified by column chromatography on 
silica gel using MTBE as eluent to afford epoxy alcohol (+)-121. 
 
Yield: 0.17 g (0.99 mmol), yellowish solid, 41 %  
C8H12O4 (172. 18) 
1H-NMR (400 MHz, CDCl3 + TMS) 
4.19 (m, 1H, H-3), 4.16 (br.d, 3J = 5.0 Hz, 1H, H-2), 3.87 (m, 1H, H-1), 3.68 (d, 3J = 3.0 
Hz, 1H, H-7), 3.59 (m, 1H, H-5), 3.48 (d, 3J = 3.0 Hz, 1H, H-6), 3.40 (s, 3H, -OCH3), 
2.01/1.98 (m, 2H, H-4ax/eq) 
13C-NMR (100 MHz, CDCl3 + TMS) 
75.2 (CH, C-5), 74.0 (CH, C-1), 70.8 (CH, C-2), 67.2 (CH, C-3), 57.5 (CH3, -OCH3), 53.6 
(CH, C-7), 52.5 (CH, C-6), 29.0 (CH2, C-4) 
IR (neat): 3465 m, 2924 m, 2853 w, 1717 m, 1456 w, 1396 w, 1249 w, 1126 m, 1083 s  
EI MS (RT): 172 (30, M+), 140 (11), 116 (4), 115 (24), 97 (36), 83 (35), 73 (23), 71 (100)  
 
4a-Methoxy-2,7-dioxatricyclo[4.2.1.03,8]nonane-9ß-ol (+)-122 
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GP7; Epoxy alcohol (+)-121 (0.2 g, 1.2 mmol, 1.0 eq) was dissolved in 10 mL THF and to 
this mixture a solution of KOBut (0.2 g, 1.4 mmol, 1.2 eq) in 10 mL THF was added. The 
crude product was purified by column chromatography on silica gel using EA as eluent to 
afford (+)-122. 
 
Yield: 0.11 g (0.64 mmol), yellowish oil, 53 %  
C8H12O4 (172. 18) 
1H-NMR (400 MHz, CDCl3 + TMS) 
5.18 (dd, 3J = 5.0 Hz, 1H, H-7), 5.01 (dd, 3J = 6.0 Hz, 1H, H-2), 4.94 (dd, 3J = 5.0 Hz, 1H, 
H-6), 4.53 (m, 1H, H-5), 4.20 (br.s, 1H, H-1), 3.50 (dt, 3J = 10.0 Hz, 3J = 2.0 Hz, 1H, H-3), 
3.31 (s, 3H, -OCH3), 2.61 (m, 1H, H-4eq), 1.70 (dd, 3J = 10.0 Hz, 1H, H-4ax) 
13C-NMR (100 MHz, CDCl3 + TMS) 
89.7 (CH, C-2), 81.5 (CH, C-7), 80.4 (CH, C-1), 78.6 (CH, C-6), 74.6 (CH, C-5), 74.0 
(CH, C-3), 56.0 (CH3, -OCH3), 28.0 (CH2, C-4) 
IR (neat): 3338 m, 2975 w, 2915 w, 1695 s, 1491 s, 1049 s, 962 m 
EI MS (RT): 171 (2, M+ -1), 155 (2), 141 (2), 122 (6), 111 (95), 97 (10), 84 (100), 71 (23)  
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6.3.4  Attempts to chapter 4.2 
 
Pyrrole-1-en- tert-butyl 127 
 
H
N N
O
1
5
4 3
2
81 127  
 
Pyrrole (4.2 mL, 60.0 mmol, 1.0 eq) was dissolved in 120mL THF and stirred at 0°C. To 
this solution Triethylamine (8.3 mL, 60.0 mmol, 1.0 eq), PivCl (8.1 mL, 66.0 mmol, 1.1 
eq) and a catalytic amount of DMAP were added. The resulting mixture was stirred for 20 
h at room temperature and then, the solvent was removed. The crude product was purified 
by column chromatography on silica gel (MTBE/CH 1:5) to afford 127.  
 
Yield: 6.3 g (42 mmol), yellowish oil, 70 %  
C9H13NO (151.21) 
1H-NMR (400MHz, CDCl3 + TMS) 
6.83 (d, 3J = 2.4 Hz, 1H, H-2), 6.81 (d, 3J = 2.2 Hz, 1H, H-5), 6.26 (d, 3J = 2.4 Hz, 1H, H-
3), 6.23 (d, 3J = 2.2 Hz, 1H, H-4), 1.27 (s, 9H, C(CH3)3) 
13C-NMR (100 MHz, CDCl3 + TMS) 
174.0 (C, C=O), 120.5 (CH, C-2), 117.7 (CH, C-5), 111.8 (CH, C-3), 108.0 (CH, C-4),  
40.1 (C, C(CH3)3), 26.4 (CH3, C(CH3)3) 
IR (neat):2975 m, 2935 w, 2876 w, 1811 w, 1698 s, 1483 m, 1302 m, 1198 s, 994 s, 730 w 
EI MS (RT): 151 (6, M+), 124 (1), 108 (2), 91 (2), 85 (100) 
 
 
Pyrrole-1-carboxylic acid tert-butyl ester 163 
 
 
H
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O
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5
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2
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Pyrrole (0.7 mL, 10.0 mmol, 1.0 eq) was dissolved in 20mL THF and stirred at 0°C. To 
this solution Triethylamine (1.4 mL, 10.0 mmol, 1.0 eq), BoC2O (2.4 g, 11.0 mmol, 1.1 eq) 
and a catalytic amount of DMAP were added. The resulting mixture was stirred for 16 h at 
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room temperature and then, the solvent was removed. The crude product was purified by 
column chromatography on silica gel (MTBE/CH 1:10) to afford 163.  
 
Yield: 1.3 g (7.8 mmol), colourless oil, 78 %  
C9H13NO2 (167.21) 
1H-NMR (400MHz, CDCl3 + TMS) 
7.18 (t, 3J = 2.4 Hz, 2H, H-2/H-5), 6.22 (t, 3J = 2.2 Hz, 2H, H-3/H-4), 1.59 (s, 9H, 
C(CH3)3) 
13C-NMR (100 MHz, CDCl3 + TMS) 
148.9 (C, C=O), 120.0 (CH, C-1), 119.9 (CH, C-5), 111.8 (CH, C-2), 111.0 (CH, C-3), 
83.4 (C, C(CH3)3), 27.9 (CH3, C(CH3)3) 
IR (neat): 2980 w, 2935 w, 1743 s, 1472 m, 1400 m, 1371 w, 1342 s, 1317 s, 1152 m, 
1075 m, 951 m, 737 m 
EI MS (RT): 168 (3, M+ +1), 167 (37, M+), 111 (69), 94 (60), 67 (86), 57 (100) 
 
 
Pyrrole-1-(Toluene-4-sulfonyl) 87 
 
 
H
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1
5
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Pyrrole (0.7 mL, 10.0 mmol, 1.0 eq) was added at 0°C to a solution of tBuOK (1.3 g, 11.6 
mmol, 1.2 eq) in 6.5 mL DMF. After 1 h stirring, at room temperature, the reaction mixture 
was cooled at 0°C and tosylchloride (2.7 g, 14.0 mmol, 1.4 eq) in 9.5 mL DMF was added. 
After one night at room temperature under stirring, the solution was poured into distilled 
water, extracted three times with EA and dried over Na2SO4. Crystallisation in heptane 
afforded product 87. 
 
Yield: 1.8 g (8.1 mmol), colourless solid, 81 %  
C11H11NO2S (221.28) 
m.p.:   91-92°C 
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1H-NMR (400MHz, CDCl3 + TMS) 
7.75 (d, 3J = 8.3 Hz, o-Ar-C), 7.66 (d, 3J = 8.3 Hz, 1H, o-Ar-C), 7.29 (d, 3J = 8.0 Hz, 1H, 
p-Ar-C), 7.34 (d, 3J = 8.0 Hz, 1H, p-Ar-C), 7.15 (d, 3J = 2.2 Hz, 1H, H-2), 6.82 (d, 3J = 2.1 
Hz, 1H, H-5), 6.29 (d, 3J = 2.2 Hz, 1H, H-3), 6.24 (d, 3J = 2.1 Hz, 1H, H-4), 2.06 (s, 3H, -
CH3) 
13C-NMR (100 MHz, CDCl3 + TMS) 
143.4 (C, p-Ar-C), 134.0 (C, ipso-Ar-C), 129.9-126.7 (CH, o,m-Ar-C), 120.6 (CH, C-2), 
117.6 (CH, C-5), 113.4 (CH, C-3), 107.8 (CH, C-4), 20.7 (CH3, -CH3) 
IR (neat): 3306 w, 2929 w, 1660 s, 1386 s, 1161 m, 1091 m, 1055 w, 931 m, 813 m, 740 s 
EI MS (RT): 221 (46, M+ ), 199 (38), 155 (45), 91 (100), 65 (16) 
 
Pyrrole-1-Methanesulfonyl 140 
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Pyrrole (4.2 mL, 60.0 mmol, 1.0 eq) in 60 mL THF was stirred at 0°C. To this solution 
triethylamine (8.3 mL, 60.0 mmol, 1.0 eq), MeSO2Cl (5.1 mL, 66.0 mmol, 1.1 eq) and a 
catalytic amount of DMAP were added. The resulting mixture was stirred for 1 h at room 
temperature and the remaining solution was washed with saturated sodium bicarbonate 
solution. The aqueous phase was then extracted four times with (MTBE/CH 1:1). The 
organic layer was dried over Na2SO4 and concentrated under vacuum. The crude product 
was purified by column chromatography on silica gel (MTBE/CH 1:1) to afford 140.   
 
Yield: 3.6 g (25.5 mmol), white solid, 42 %  
C5H7NO2S (145.18) 
m.p.:   55-56°C 
1H-NMR (400MHz, CDCl3 + TMS) 
7.12 (m, 2H, H-2/H-5), 6.37 (m, 2H, H-3/H-4), 3.14 (s, 3H, -CH3) 
13C-NMR (100 MHz, CDCl3 + TMS) 
123.5 (CH, C-2/C-5 ), 112.8 (CH, C-3/C-4), 39.7 (CH3, -CH3) 
IR (neat): 3158 w, 2927 w, 1359 s, 1190 s, 1169 s, 1064 m, 1034 m, 930 m 
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EI MS (RT): 146 (4, M++1 ), 145 (52, M+ ), 66 (100) 
 
 
2,5-Dimethyl-pyrrole-1-carboxylic acid tert-butyl ester 128 
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2,5-Dimethyl-pyrrole (0.5 mL, 5.0 mmol, 1.0 eq) was dissolved in 25 mL THF and stirred 
at 0°C. To this solution Triethylamine (0.7 mL, 5.0 mmol, 1.0 eq), BoC2O (1.2 g, 5.5 
mmol, 1.1 eq) and a catalytic amount of DMAP were added. The resulting mixture was 
stirred for 16 h at room temperature and then, the  solvent was removed. The crude product 
was purified by column chromatography on silica gel (MTBE/CH 1:5) to afford 128.  
 
Yield: 0.8 g (4.1 mmol), colourless oil, 82 %  
C11H17NO2 (195.26) 
1H-NMR (400MHz, CDCl3 + TMS) 
5.77 (s, 2H, H-3/H-4), 2.38 (s, 6H, -CH3), 1.59 (s, 9H, -C(CH3)3) 
13C-NMR (100 MHz, CDCl3 + TMS) 
150.5 (C, C=O), 131.2 (CH, C-2/C-5 ), 110.1 (CH, C-3/C-4), 83.2 (C, -C(CH3)3), 28.1 
(CH3, C(CH3)3), 16.5 (CH3, -CH3) 
IR (neat): 3090 w, 2977 w, 2931 w, 1737 s, 1389 m, 1369 s, 1333 s, 1311 s, 1249 m, 1122 
s, 782 m 
EI MS (RT): 195 (31, M+), 122 (16), 139 (68), 95 (66), 94 (100), 80 (7) 
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6.3.5 Attempts to chapter 4.3          
3a-amino-2a-benzyloxy-1,5-dimethyl-8-oxabicyclo[3.2.1]oct-6-ene 72 
rac-45
1
2
3
76
4
5
72
O
NH2
OBn
O
O
OBn
 
NH4OAc (8.0 g, 103.8 mmol, 10.7 eq) was dissolved in a vigorously stirred mixture of 
bicyclic ketone rac-45 (2.5 g, 9.7 mmol, 1.0 eq) and molecular sieves 3 ?  in 30 mL abs. 
MeOH. Then NaBH3CN (0.6 g, 9.7 mmol, 1.0 eq) was added portion wise within 30 min. 
The resulting reaction mixture was stirred for 3 days at room temperature and then 
acidified with concentrated HCl until pH 2-3. The MeOH was removed and the residue 
was dissolved in 63 mL MTBE and 6 mL water. The aqueous layer was washed with 
saturated KOH solution and then extracted three times with (EA/MTBE 1:1). The 
combined organic layer was washed once with saturated NaCl solution and dried over 
Na2SO4. After removal of the solvent the crude product was purified by column 
chromatography on silica gel (EA/MeOH 1:5). 
 
Yield: 1.6 g, (6.2 mmol), viscous oil, 64% 
C16H21NO2 (259.34) 
1H-NMR (400 MHz, CDCl3 + TMS) 
7.40-7.24 (m, 5H, Ar-H), 6.38 (d, 3J = 5.8 Hz, 1H, H-7), 6.18 (d, 3J = 5.8 Hz, 1H, H-6), 
5.23 (d, 3J = 9.3 Hz, 1H, NH), 4.86 (d, 2J = 11.7 Hz, 1H, -OCH2Ph), 4.50 (d, 2J = 11.7 Hz, 
1H, -OCH2Ph), 3.87 (t, 3J = 6.2 Hz, 1H, H-3), 3.53 (d, 3J = 6.3 Hz, 1H, H-2), 2.33 (dd, 2J = 
15.0 Hz, 3J = 6.0 Hz, 1H, H-4eq), 1.98 (d, 2J = 15.0 Hz, 1H, H-4ax), 1.35 (s, 3H, -CH3), 
1.33 (s, 3H, -CH3) 
13C-NMR (100 MHz, CDCl3 + TMS) 
139.8 (CH, C-6), 137.7 (C, ipso-Ar-C), 135.3 (CH, C-7), 128.5 (CH, o-Ar-C), 128.3 (CH, 
m-Ar-C), 128.0 (CH, p-Ar-C), 85.4 (CH, C-1), 84.0 (CH, C-5), 73.0 (CH2, -OCH2Ph), 70.4 
(CH, C-2), 46.2 (CH, C-3), 35.4 (CH2, C-4), 23.2 (CH3, -CH3), 20.9 (CH3, -CH3) 
IR (neat): 3251 m, 3034 w, 2974 m, 2835 m, 1586 s, 1513 s, 1454 s, 1375 m, 1206 s, 1181 
m, 1049 m, 895 m 
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EI MS (RT): 259 (5, M+), 232 (2), 200 (1), 182 (3), 167 (19), 152 (20), 136 (9), 109 (20), 
91 (100), 77 (11) 
3a-amino-(NH-tert-butyloxycarbonyl)-2a-benzyloxy-1,5-dimethyl-8-oxabicyclo[3.2.1]oct-
6-ene 138 
13872
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Amine 72 (1.6 g, 6.0 mmol, 1.0 eq) was dissolved in 20 mL THF and Et3N (0.8 mL, 6.0 
mmol, 1.0 eq). To this solution, a catalytic amount of DMAP was added and at 0°C cooled. 
At this temperature BOC2O (1.4 g, 6.6 mmol, 1.1 eq) was added and the resulting mixture 
was stirred for 16 h. Then, the solvent was removed and the remaining solution was 
purified by column chromatography on silica gel (MTBE/CH 1:1) to afford 138. 
 
Yield: 1.9 g, (5.3 mmol), colourless oil, 88% 
C21H29NO4 (359.46) 
1H-NMR (400 MHz, CDCl3 + TMS) 
7.29-7.37 (m, 5H, Ar-H), 6.15 (s, 2H, H-6/H-7), 5.23 (d, 3J = 9.3 Hz, 1H, NH), 4.58/4.34 
(d, 2J = 12.3 Hz, 1H, -OCH2Ph), 4.38 (dt, 3J = 6.6 Hz, 3J = 6.7 Hz, 1H, H-3), 3.59 (d, 3J = 
6.7 Hz, 1H, H-2), 2.07 (dd, 2J = 14.4 Hz, 3J = 6.6 Hz, 1H, H-4ax), 1.83 (d, 2J = 14.4 Hz, 
1H, H-4eq), 1.35 (s, 9H, C(CH3)3), 1.4 (s, 3H, -CH3), 1.3 (s, 3H, -CH3) 
13C-NMR (100 MHz, CDCl3 + TMS) 
155.6 (C, -O-C=O), 139.6 (CH, C-6), 137.9 (C, ipso-Ar-C), 135.8 (CH, C-7), 128.3 (CH, 
o-Ar-C), 128.1 (CH, m-Ar-C), 127.8 (CH, p-Ar-C), 85.7 (CH, C-1), 84.4 (CH, C-5), 79.1 
(C, C(CH3)3), 78.7 (CH, C-2), 71.5 (CH2, -OCH2Ph), 44.9 (CH, C-3), 40.2 (CH2, C-4), 
28.4 (CH3, C(CH3)3), 23.6 (CH3, -CH3), 21.1 (CH3, -CH3) 
IR (neat): 3469 m, 2976 m, 2931 m, 2871 w, 1809 m, 1756 m, 1712 s, 1493 s, 1455 m, 
1369 m, 1167 s, 1118 s, 1071 m, 950 m 
EI MS (70°C): 359 (1, M+), 303 (4), 268 (2), 251 (2), 227 (6), 195 (10), 167 (12), 152 
(31), 136 (33), 109 (30), 91 (100), 79 (8) 
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7a-amino-(NH-tert-butyloxycarbonyl)-6a-benzyloxy-1,5-dimethyl-3,9-
dioxatricyclo[3.3.1.02,4]nonane 135 
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Bicyclic alkene (9.1 g, 25.3 mmol, 1.0 eq) was dissolved in 90 mL DCM and cooled at 
0°C, then m-CPBA (70 - 75%, 14.6 g, 63.3 mmol, 2.5 eq) was added. The solution was 
stirred for 1.5 h at 0°C and then, in 450 mL MTBE dissolved. The remaining solution was 
washed for three times with a 5% Na2CO3 solution. The aqueous phase was extracted three 
times with MTBE. The combined organic layer was dried over Na2SO4, filtered, 
concentrated under vacuum and purified by column chromatography on silica gel 
(MTBE/CH 1:1) to afford epoxy 135. 
 
Yield: 8.2 g, (21.8 mmol), white solid, 86 % 
C21H29NO5 (375.46) 
1H-NMR (400 MHz, CDCl3 + TMS) 
7.30 (m, 5H, Ar-H), 5.03 (dt, 3J = 4.9 Hz, 3J = 2.3 Hz, 1H, H-3), 4.57/4.37 (d, 2J = 11.0 
Hz, 1H, -OCH2Ph), 3.55 (d, 3J = 2.8 Hz, 1H, H-7), 3.52 (d, 3J = 5.0 Hz, 1H, H-2), 3.41 (d, 
3J = 2.8 Hz, 1H, H-6), 2.15 (d, 2J = 15.2 Hz, 1H, H-4eq), 2.07 (dd, 2J = 15.1 Hz, 3J = 5.6 
Hz, 1H, H-4ax), 1.47 (s, 9H, C(CH3)3), 1.4 (s, 3H, -CH3), 1.3 (s, 3H, -CH3) 
13C-NMR (100 MHz, CDCl3 + TMS) 
155.9 (C, -O-C=O), 137.0 (C, ipso-Ar-C), 128.5 (CH, o-Ar-C), 128.3 (CH, m-Ar-C), 127.8 
(CH, p-Ar-C), 78.8 (CH, C-1), 77.4 (CH, C-5), 77.4 (CH, C-2), 76.7 (C, C(CH3)3), 71.7 
(CH2, -OCH2Ph), 57.6 (CH, C-6), 55.9 (CH, C-7), 44.8 (CH, C-3), 38.7 (CH2, C-4), 28.4 
(CH3, C(CH3)3), 19.9 (CH3, -CH3), 17.6 (CH3, -CH3) 
IR (neat): 3430 w, 2976 m, 2932 m, 2871 w, 1709 s, 1486 s, 1454 m, 1366 m, 1242 m, 
1161 s, 1090 s, 1060 m, 957 m 
EI MS (RT): 376 (1, M++1), 320 (10), 276 (7), 229 (3), 190 (10), 183 (12), 178 (10), 147 
(21), 128 (8), 114 (11), 108 (22), 91 (100), 84 (638) 
HR MS: C23H32N2O5Na M+ + CH3CN + Na, Exact: 439.2209, Calcd.: 439.2217 
 
6.3.5 Attempts to chapter 4.3                                                                                                          - 116 -                                                                                                                                                                                                                                           
1,3-dimethyl-4a-Benzyloxy-8ß-hydroxy-2-oxa-6-aza-(N-tert-butyloxycarbonyl)-
tricyclo[3.3.1.03,7]nonane 142 
and 1,3-dimethyl-4a-Benzyloxy-7ß-hydroxy-2-oxa-6-aza-(N-tert-butyloxycarbonyl)--
tricyclo[3.3.1.03,7]nonane 144 
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Epoxy alcohol (1.1 g, 2.8 mmol, 1.0 eq) was dissolved in 30mL THF. To this solution, 
PrMgCl (2M/Et2O, 1.9 mL, 3.7 mmol, 1.3 eq) was added at 0°C. The mixture was stirred 
for 4 h at room temperature, and then was washed with 5 mL NH4Cl, 2 mL NaK-tartrat 
solution and 50 mL MTBE and further stirred for 1 h. The aqueous phase was extracted 
several times with (MTBE/EE 1:1). The combined organic layer was dried over Na2SO4, 
filtered, concentrated under vacuum and purified by column chromatography on silica gel 
(EA/CH 1:2). 
 
Dates of Main Product 142: 
 
Yield: 0.8 g, (2.1 mmol), colourless oil, 75 % 
C21H29NO5 (375.46) 
1H-NMR (400 MHz, CDCl3 + TMS) 
7.29 (m, 5H, Ar-H), 4.64 (dd, 2J = 11.8 Hz, 3J = 4.3 Hz, 1H, H-3), 4.44 (m, 1H, H-7), 
4.40/3.72  (d, 2J = 26.0 Hz, 1H, -OCH2Ph), 4.12 (br.s, 1H, H-6), 3.60 (d, 3J = 3.6 Hz, 1H, 
H-2), 1.85 (dd, 2J = 13.7 Hz, 3J = 4.3 Hz, 1H, H-4eq), 1.71 (dt, 2J = 13.7 Hz, 3J = 1.6 Hz, 
3J = 1.0 Hz, 1H, H-4ax), 1.41 (s, 9H, C(CH3)3), 1.5 (s, 3H, -CH3), 1.3 (s, 3H, -CH3) 
13C-NMR (100 MHz, CDCl3 + TMS) 
153.9 (C, -O-C=O), 137.9 (C, ipso-Ar-C), 128.3-127.1 (CH, o,m,p-Ar-C), 88.8 (CH, C-1), 
84.3 (CH, C-2), 83.6 (CH, C-5), 80.0 (C, C(CH3)3), 79.6 (CH, C-6), 70.4 (CH2, -OCH2Ph), 
68.5 (CH, C-7), 55.5 (CH, C-3), 38.9 (CH2, C-4), 28.3 (CH3, C(CH3)3), 18.5 (CH3, -CH3), 
17.8 (CH3, -CH3) 
6.3.5 Attempts to chapter 4.3                                                                                                          - 117 -                                                                                                                                                                                                                                           
IR (neat): 3432 m, 2974 m, 2931 m, 2870 w, 1677 s, 1392 s, 1367 s, 1241 w, 1166 s, 1096 
s, 1076 s, 914 m, 730 s 
EI MS (RT): 376 (1, M++1), 320 (18), 274 (6), 212 (4), 191 (6), 186 (10), 170 (4), 149 (8), 
129 (6), 121 (13), 107 (28), 109 (36), 91 (24), 84 (100) 
X-rays :  Its x-rays crystal structure data can be seen in chapter 7, pp. 139 
 
 
1,3-dimethyl-4a-Benzyloxy-8-oxo-2-oxa-6-aza-(N-tert-
butyloxycarbonyl)tricyclo[3.3.1.03,7]nonane 149 
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GP8; Oxalyl chloride (0.7 mL, 7.7 mmol, 4.0 eq) was dissolved in 18 mL DCM. To this 
mixture, DMSO (0.6 mL, 8.1 mmol, 4.2 eq) and tricycle alcohol (0.7 g, 1.9 mmol, 1.0 eq) 
in 18 mL DCM was added at -78°C. The solution was stirred for 1h at -78°C and then NEt3 
(2.4 mL, 17.3 mmol, 9.0 eq) was added. Stirring was continued for 1h at -78°C and 1.5 h 
more at room temperature. The crude product was purified by column chromatography on 
silica gel (EA/CH 1:2). 
 
Yield: 0.6 g, (1.7 mmol), colourless oil, 87 % 
C21H27NO5 (373.44) 
1H-NMR (400 MHz, CDCl3 + TMS) 
7.32 (m, 5H, Ar-H), 4.66 (d, 2J = 12.0 Hz, 1H, -OCH2Ph), 4.50 (m, 1H, H-3), 4.42 (d, 2J = 
12.0 Hz, 1H, -OCH2Ph), 4.07 (s, 1H, H-7), 3.64 (d, 3J = 9.2 Hz, 1H, H-2), 2.16 (dd, 2J = 
14.1 Hz, 3J = 4.6 Hz, 1H, H-4eq), 1.90 (dd, 2J = 14.2 Hz, 3J = 1.2 Hz, 1H, H-4ax), 1.45 (s, 
9H, C(CH3)3), 1.55 (s, 3H, -CH3), 1.38 (s, 3H, -CH3) 
13C-NMR (100 MHz, CDCl3 + TMS) 
198.5 (C, C-6), 153.4 (C, -O-C=O), 137.6 (C, ipso-Ar-C), 128.4-127.8 (CH, o,m,p-Ar-C), 
85.8 (CH, C-1), 84.6 (CH, C-2), 81.0 (CH, C-5), 80.8 (C, C(CH3)3), 70.4 (CH2, -OCH2Ph), 
65.2 (CH, C-7), 56.0 (CH, C-3), 43.5 (CH2, C-4), 28.2 (CH3, C(CH3)3), 17.2 (CH3, -CH3), 
16.6 (CH3, -CH3) 
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IR (neat): 2975 m, 2932 m, 1772 m, 1694 s, 1391 s, 1367 s, 1241 w, 1165 s, 1096 s, 1027 
w, 933 w, 738 m 
 
3a-amino-2a-benzyloxy-8-oxabicyclo[3.2.1]oct-6-ene 136 
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NH4OAc (41.9 g, 544.6 mmol, 10.7 eq) was dissolved in a vigorously stirred mixture of 
bicyclic ketone rac-94 (11.71 g, 50.9 mmol, 1.0 eq) and molecular sieves 3 ?  in 150 mL 
abs. MeOH. Then NaBH3CN (3.2 g, 50.9 mmol, 1.0 eq) was added portion wise within 30 
min. The resulting reaction mixture was stirred for 3 days at room temperature and then 
acidified with concentrated HCl till pH 2-3. The MeOH was removed and the residue was 
dissolved in 330 mL MTBE and 33 mL water. The aqueous layer was washed with 
saturated KOH solution and then extracted three times with (EA/MTBE 1:1). The 
combined organic layer was washed once with saturated NaCl solution and dried over 
Na2SO4. After removal of the solvent the crude product was purified by column 
chromatography on silica gel (EA/MeOH 1:5). 
 
Yield: 6.5 g, (28.0 mmol), viscous yellowish oil, 55% 
C14H17NO2 (231.29) 
1H-NMR (400 MHz, CDCl3 + TMS) 
7.39-7.31 (m, 5H, Ar-H), 6.41 (dd, 3J = 6.0 Hz, 3J = 1.8 Hz, 1H, H-7), 6.30 (dd, 3J = 6.0 
Hz, 3J = 1.6 Hz, 1H, H-6), 4.87 (dd, 2J = 5.8 Hz, 3J = 1.5 Hz, 1H, H-1), 4.81 (d, 2J = 11.9 
Hz, 1H, -OCH2Ph), 4.62 (m, 1H, H-5), 4.55 (d, 2J = 11.9 Hz, 1H, -OCH2Ph), 3.81 (dt, 3J = 
5.6 Hz, 1H, H-3), 3.49 (d, 3J = 5.8 Hz, 1H, H-2), 2.25 (dd, 2J = 14.7 Hz, 3J = 5.8 Hz, 1H, 
H-4eq), 2.02 (br.d, 2J = 14.7 Hz, 1H, H-4ax) 
13C-NMR (100 MHz, CDCl3 + TMS) 
142.8 (CH, C-6), 138.5 (C, ipso-Ar-C), 131.7 (CH, C-7), 128.5 (CH, o-Ar-C), 128.3 (CH, 
m-Ar-C), 127.8 (CH, p-Ar-C), 82.9 (CH, C-1), 79.1 (CH, C-5), 72.5 (CH2, -OCH2Ph), 71.9 
(CH, C-2), 49.0 (CH, C-3), 29.0 (CH2, C-4) 
IR (neat): 3112 m, 2963 m, 2801 m, 1587 m, 1455 m, 1392 s, 1113 m, 737 m, 698 m 
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EI MS (RT): 232 (22, M+ + 1), 201 (19), 158 (46), 141 (69), 126 (41), 111 (21), 91 (100), 
81 (25), 69 (56) 
 
 
3a-amino-(NH-tert-butyloxycarbonyl)-2a-benzyloxy-8-oxabicyclo[3.2.1]oct-6-ene 137 
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Amine 136 (6.0 g, 26.0 mmol, 1.0 eq) was dissolved in 50 mL THF and Et3N (3.6 mL, 
26.0 mmol, 1.0 eq). To this solution, a catalytic amount of DMAP was added and cooled 
till 0°C. At this temperature BOC2O (6.2 g, 28.6 mmol, 1.1 eq) was added and the resulting 
mixture was stirred for 16 h. Solvent was removed and the remaining solution was purified 
by column chromatography on silica gel (MTBE/CH 1:1) to afford 137. 
 
 
Yield: 5.2 g, (15.7 mmol), white solid, 60 % 
C19H25NO4 (331.18) 
1H-NMR (400 MHz, CDCl3 + TMS) 
7.32-7.29 (m, 5H, Ar-H), 6.24 (dd, 3J = 6.1 Hz, 3J = 1.8 Hz, 1H, H-7), 6.18 (dd, 3J = 6.1 
Hz, 3J = 1.7 Hz, 1H, H-6), 4.77 (m, 1H, H-1), 4.71 (br.d, 1H, H-5), 4.58/4.70 (d, 2J = 12.3 
Hz, 1H, -OCH2Ph), 4.33 (m, 1H, H-3), 3.82 (br.s, 1H, NH), 3.27 (dd, 3J = 8.8 Hz, 1H, H-
2), 1.89 (dd, 2J = 15.0 Hz, 3J = 3.2 Hz, 1H, H-4eq), 1.53 (m, 1H, H-4ax), 1.49 (s, 9H, 
C(CH3)3) 
13C-NMR (100 MHz, CDCl3 + TMS) 
138.3 (C, ipso-Ar-C), 155.4 (C, -O-C=O), 132.0 (CH, C-6), 129.6 (CH, C-7), 128.3-127.7 
(CH, o,m,p-Ar-C), 79.0 (C, C(CH3)3), 78.5 (CH, C-5), 78.2 (2xCH, C-1/C-2), 72.1 (CH2, -
OCH2Ph), 66.0 (CH, C-3), 32.3 (CH2, C-4), 28.4 (CH3, C(CH3)3) 
IR (neat): 3466 w, 2924 m, 2853 m, 1809 w, 1711 s, 1493 m, 1455 m, 1366 m, 1163 s, 
1099 s, 966 m    
EI MS (RT): no M+, 311 (1), 275 (2), 258 (2), 240 (2), 181 (22), 149 (30), 108 (40), 91 
(100) 
Structure confirmation: H,H-COSY, HMBC, HMQC-Spectra 
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7a-amino-(NH-tert-butyloxycarbonyl)-6a-benzyloxy-3,9-dioxatricyclo[3.3.1.02,4]nonane 
134 
 
137 134
1
2
3
76
4
5
O
NH
OBn
O
O
O
NH
OBn
O
O
O
 
 
 
Bicyclic alkene (7.0 g, 21.1 mmol, 1.0 eq) was dissolved in 73 mL DCM and cooled at 
0°C, then m-CPBA (70 - 75%, 13.0 g, 52.8 mmol, 2.5 eq) was added. The solution was 
stirred for 1.5 h at 0°C and then dissolved in 300 mL MTBE. The remaining solution was 
washed for three times with 5% Na2CO3 solution. The aqueous phase was extracted three 
times with MTBE. The combined organic layer was dried over Na2SO4, filtered, 
concentrated under vacuum and purified by column chromatography on silica gel 
(MTBE/CH 1:1) to afford epoxy 134. 
 
Yield: 6.4 g, (18.5 mmol), white solid, 88% 
C19H25NO5 (347.41) 
1H-NMR (400 MHz, CDCl3 + TMS) 
7.33-7.35 (m, 5H, Ar-H), 4.44/4.57 (d, 2J = 11.5 Hz, 1H, -OCH2Ph), 4.19 (m, 1H, H-5), 
4.18 (m, 1H, H-1), 4.09 (br.s, 1H, H-3), 3.84 (m, 1H, H-2), 3.74 (d, 3J = 2.9 Hz, 1H, H-7), 
3.58 (d, 3J = 2.9 Hz, 1H, H-6), 2.14-2.04 (m, 2H, H-4ax/eq), 1.45 (s, 9H, C(CH3)3) 
13C-NMR (100 MHz, CDCl3 + TMS) 
155.8 (C, -O-C=O), 137.0 (C, ipso-Ar-C), 128.5-127.9 (CH, o,m,p-Ar-C), 79.8 (C, 
C(CH3)3), 72.3 (2xCH, C-1/C-5), 71.6 (CH, C-2), 71.4 (CH2, -OCH2Ph), 53.1 (CH, C-6), 
51.9 (CH, C-7), 44.5 (CH, C-3), 31.6 (CH2, C-4), 28.4 (CH3, C(CH3)3) 
IR (neat): 3338 m, 2975 w, 2928 w, 2870 w, 1694 s, 1490 s, 1364 w, 1246 m, 1163 s, 
1128 s, 1049 m, 1029 w, 962 w, 861 m 
EI MS (RT): no M+, 291 (17), 246 (29), 200 (50), 182 (6), 156 (21), 128 (25), 111 (14), 91 
(100), 73 (31) 
HR MS: C19H25O5, Exact: 347.1875, Calcd.: 347.1733 
Structure confirmation: H,H-COSY, HMBC, HMQC-Spectra 
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EA:  N = 3.89 %, Calcd. N = 4.03 % 
C = 65.41 %, Calcd. C = 65.69 % 
 H = 7.13 %, Calcd. H = 7.25 % 
X-rays :  Its x-rays crystal structure data can be seen in chapter 7, pp. 141 
 
 
4a-Benzyloxy-8ß-hydroxy-2-oxa-6-aza-(N-tert-butyloxycarbonyl)-
tricyclo[3.3.1.03,7]nonane 141 
and 4a-Benzyloxy-7ß-hydroxy-2-oxa-6-aza-(N-tert-butyloxycarbonyl)--
tricyclo[3.3.1.03,7]nonane 143 
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Epoxy alcohol (5.4 g, 15.5 mmol, 1.0 eq) was dissolved in 150mL THF. To this solution,  
PrMgCl (2M/Et2O, 10.1 mL, 20.1 mmol, 1.3 eq) was added at 0°C. The mixture was 
stirred for 3 h at room temperature, then washed with 19 mL NH4Cl, 4 mL NaK-tartrat 
solution and 9 mL MTBE. After washing the mixture was stirred for further 1 h. The 
aqueous phase was extracted ten times with (MTBE/EA 1:1). The combined organic layer 
was dried over Na2SO4, filtered, concentrated under vacuum and purified by column 
chromatography on silica gel (EA/CH 1:2). 
 
 
Dates of Main Product 141: 
 
Yield: 3.3 g, (9.5 mmol), colourless oil, 61 % 
C19H25NO5 (347.41) 
1H-NMR (400 MHz, CDCl3 + TMS) 
7.30-7.32 (m, 5H, Ar-H), 4.72 (m, 1H, H-7), 4.38/4.62 (d, 2J = 11.7 Hz, 1H, -OCH2Ph), 
4.59 (m, 1H, H-6), 4.50 (m, 1H, H-1), 4.15 (br.m, 1H, H-5), 4.00 (d, 3J = 21.3 Hz, 1H, H-
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3), 3.80 (d, 3J = 11.5 Hz, 1H, H-2), 1.80 (m, 1H, H-4ax), 1.75 (m, 1H, H-4eq), 1.46 (s, 9H, 
C(CH3)3) 
13C-NMR (100 MHz, CDCl3 + TMS) 
153.7 (C, -O-C=O), 137.6 (C, ipso-Ar-C), 128.4-127.3 (CH, o,m,p-Ar-C), 81.4 (CH, C-2), 
80.6 (CH, C-6), 80.2 (C, C(CH3)3), 79.4 (CH, C-7), 76.8 (CH, C-3), 70.1 (CH2, -OCH2Ph), 
63.3 (CH, C-5), 54.3 (CH, C-1), 32.2 (CH2, C-4), 28.4 (CH3, C(CH3)3) 
IR (neat): 3401 m, 3064 w, 2973 w, 2926 m, 2856 w, 1693 s, 1392 s, 1339 m, 1163 s, 
1100 s, 960 w, 878 m, 698 m 
EI MS (RT): 347 (10, M+), 291 (57), 246 (44), 205 (3), 185 (17), 156 (56), 139 (30), 111 
(18), 91 (100), 68 (26) 
 
 
4a-Benzyloxy-8-oxo-2-oxa-6-aza-(N-tert-butyloxycarbonyl)tricyclo[3.3.1.03,7]nonane 148 
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GP8; Oxalyl chloride (5.0 mL, 58.8 mmol, 4.0 eq) was dissolved in 140 mL DCM. To this 
mixture, DMSO (4.4 mL, 61.7 mmol, 4.2 eq) and tricycle alcohol (5.1 g, 14.7 mmol, 1.0 
eq) in 140 mL DCM were added at -78°C. The solution was stirred for 1h at -78°C and 
then NEt3 (18.3 mL, 132.3 mmol, 9.0 eq) was added. Stirring was continued for 1h at -
78°C and 1.5 h more at room temperature. The crude product was purified by column 
chromatography on silica gel (EA/CH 1:2). 
 
Yield: 3.6 g, (10.4 mmol), white solid, 71 % 
C19H23NO5 (345.16) 
1H-NMR (400 MHz, CDCl3 + TMS) 
7.30-7.32 (m, 5H, Ar-H), 4.80 (m, 1H, H-7), 4.61 (m, 1H, H-1), 4.44/4.63 (d, 2J = 11.7 Hz, 
1H, -OCH2Ph), 4.48 (m, 1H, H-5), 4.02 (m, 1H, H-3), 3.90 (br.d, 3J = 13.7 Hz, 1H, H-2), 
2.23 (ddd, 2J = 14.0 Hz, 3J = 3.8 Hz, 3J = 1.5 Hz, 1H, H-4eq), 2.02 (m, 1H, H-4ax), 1.43 (s, 
9H, C(CH3)3) 
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13C-NMR (100 MHz, CDCl3 + TMS) 
197.3 (C=O, C-6), 153.2 (C, -O-C=O), 137.2 (C, ipso-Ar-C), 128.4-127.3 (CH, o,m,p-Ar-
C), 81.2 (C, C(CH3)3), 79.9 (CH, C-2), 79.6 (CH, C-7), 74.1 (CH, C-3), 70.3 (CH2, -
OCH2Ph), 60.5 (CH, C-5), 55.7 (CH, C-1), 37.5 (CH2, C-4), 28.2 (CH3, C(CH3)3), 
IR (neat): 3405 (w), 2974 (w), 1777 (s), 1690 (s), 1367 (s), 1319 (m), 1242 (m), 1156 (s), 
1094 (s) 
EI MS (RT): 346 (7, M++1), 290 (7), 273 (24), 245 (36), 217 (82), 173 (12), 140 (34), 110 
(73), 91 (100) 
HR MS: C19H26N2O5Na M+ + CH3CN + Na, Exact: 409.1739, Calcd.: 409.1750 
Structure confirmation: H,H-COSY, HMBC, HMQC-Spectra 
X-rays :  Its x-rays crystal structure data can be seen in chapter 7, pp. 143-146  
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6.3.6 Attempts to chapter 4.4 
 
2-Benzyl-furan 151 
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Furan (1.5 mL, 20.0 mmol, 1.0 eq) was dissolved in 33 mL of THF and stirred at -10°C. 
Then, n-BuLi (1.6 M/hexane, 12.5 mL, 20.0 mmol, 1.0 eq) was added, slowly, at the same 
temperature and the resulting solution was stirred further 4 h more at room temperature. To 
this mixture BnBr (1.9 mL, 16.0 mmol, 0.8 eq) was added at -10°C and the resulting 
reaction mixture was stirred for 16 h at room temperature. The remaining solution was then 
washed with 20 mL of saturated solution of ammonium chloride. The aqueous phase was 
extracted three times with Et2O. The organic layer was dried over Na2SO4 and 
concentrated under vacuum. The crude product was purified by column chromatography 
on silica gel using CH as eluent to afford 151. 
 
Yield: 2.1 g (13.3 mmol), yellow oil, 67 %  
C11H10O (158.20) 
1H-NMR (400MHz, CDCl3 + TMS) 
7.32 (m, 1H, H-5), 7.29 (m, 2H, m-Ar-H), 7.21 (m, 3H, o,p-Ar-H), 6.28 (dd, 3J = 1.9 Hz, 3J 
= 0.5 Hz, 1H, H-4), 5.99 (qd, 3J = 3.1 Hz, 3J = 1.9 Hz, 1H, H-3), 4.02 (s, 2H, -CH2Ph) 
13C-NMR (100 MHz, CDCl3 + TMS) 
154.5 (C, C-2), 141.5 (CH, C-3), 138.1 (C, ipso-Ar-C), 128.7 (CH, o-Ar-C), 127.5 (CH, m-
Ar-C), 126.5 (CH, p-Ar-C), 110.3 (CH, C-4), 106.2 (CH, C-3), 34.5 (CH2, -CH2Ph) 
IR (neat): 2906 w, 1595 m, 1505 m, 1494 s, 1454 m, 1147 m, 1075 m, 1009 s, 727 s, 702 s 
EI MS (RT): 158 (100, M+), 129 (50), 115 (16), 91 (5), 82 (12) 
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2-(2,2-Dibromo-vinyl)-furan 160 
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Carbontetrabromide-triphenylphosphine reagent was prepared by adding PPh3 (2.9 g, 11.0 
mmol, 2.2 eq), zinc dust (1.0 mL, 150.0 mmol, 3.0 eq) and CBr4 (4.2 mL, 12.5 mmol, 2.5 
eq) in 31.0 mL DCM. The resulting mixture was stirred for 38 h at room temperature. 
Then, furfural (0.4 mL, 5.0 mmol, 1.0 eq) was added, slowly, at 0°C and the resulting 
solution was stirred for further 6 h until get room temperature. The remaining solution was 
then washed with sodium bicarbonate. The aqueous phase was extracted three times with 
CH. The organic layer was dried over Na2SO4 and concentrated under vacuum. The crude 
product was purified by column chromatography on silica gel using CH as eluent to afford 
160. 
Yield: 1.0 g (4.4 mmol), orange solid, 88 %  
C6H4Br2O (251.90) 
1H-NMR (400MHz, CDCl3 + TMS) 
7.58 (s, 1H, CH=CBr2), 7.43 (d, 3J = 0.5 Hz, 1H, H-5), 6.95 (t, 3J = 0.5 Hz, 1H, H-4), 6.46 
(d, 3J = 0.5 Hz, 1H, H-3) 
13C-NMR (100 MHz, CDCl3 + TMS) 
150.0 (C, C-2), 142.5 (CH, C-5), 132.5 (CH, CH=CBr2), 111.6 (CH, C-3), 112.5 (CH, C-
4), 87.1 (C, CH=CBr2) 
IR (neat): 3416 m, 1482 m, 1437 m, 1159 m, 1119 s, 1020 m, 947 w, 750 s, 721 s, 693 s 
EI MS (RT): 252 (100, M+), 201 (15), 183 (8), 152 (4), 164 (2), 76 (6) 
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7. X – RAY CRYSTAL STRUCTURES 
 
In the present work crystal structures for 10 compounds were obtained. Complete 
information about every structure was explained offering data collection about these 
parameters:  
 
- Details of structure determination  
- Coordinate and equivalents isotropic terminal parameters of C, N, O atoms 
- Atoms positions  
- Isotropic parameters of H atom 
- Wavelength  
- Unit cell dimensions (Bond length and  bond angle)    
- Calculated density     
- Absorption coefficient             
- Crystal size and Volume 
- Minimal and maximal residual electron density  
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2a-Benzyloxy-1,5-dimethyl-8-oxabicyclo[3.2.1]oct-6-en-3-one rac-45 
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Data collection and handling: 
 
Empirical formula C16H18O3 
Molecular weight (gmol-1) 258.30 
Crystal system monoclinic 
Space group P 21/c (No.14) 
Crystal colourless distorted octahedron 
Size (mm) 0.89 x 0.41 x 0.37 
a, b, c (? ) 7.680(2)   16.206(4)   11.371(2)    
a, ß, ? (degree) 90.00   92.81(2)   90.00 
Volume, V (? 3) 1413.6(6) 
Z 4 
dcalcd. (gcm-3) 1.214 
F(000) (e) 552 
Absorption coefficient µ (cm-1) 0.083 
Diffractometer Stoe IPDS area detector  
T (K) 300 (2) 
Wavelength, Mo Ka  radiation (? ) 0.71073 
Theta range for data collection    qmin = 2.19, qmax = 26.02    
Index ranges                       -9 = h = 9,   -19 = k = 19,   -13 = l = 13 
Reflections collected / unique     20125 / 2704 [R(I)int = 0.0472] 
Completeness to  q = 26.02         98 % 
Absorption correction                none 
Refinement method                    Full-matrix least-squares on F2 
Data / restraints / parameters     2704 / 0 / 172 
Goodness-of-fit on F2             0.959 
Final R indices [It > 2.0 s(I)]          R1 = 0.0341 , wR2 = 0.0633 
R indices (all data)               R1 = 0.0628 , wR2 = 0.0657 
Largest diff. peak and hole (eA-3)      0.714 and -0.104  
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2a-Benzyloxy-8-oxabicyclo[3.2.1]oct-6-en-3-one rac-94 
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Data collection and handling: 
 
Empirical formula C14H14O3 
Molecular weight (gmol-1) 230.25 
Crystal system monoclinic 
Space group I a (No.9) 
Crystal colourless plate || (010) 
Size (mm) 0.2 x 0.1 x 0.03 
a, b, c (? ) 8.795(2)   61.364(8)   8.842(2) 
a, ß, ? (degree) 90.00   90.18(2)   90.00 
Volume, V (? 3) 4772 (2) 
Z 16 
dcalcd. (gcm-3) 1.282 
F(000) (e) 1952 
Absorption coefficient µ (cm-1) 0.090 
Diffractometer Stoe IPDS area detector  
T (K) 300 (2) 
Wavelength, Mo Ka  radiation (? ) 0.71073 
Theta range for data collection    qmin = 1.99, qmax = 24.10    
Index ranges                       -9 = h = 10,   -69 = k = 70,   -10 = l = 9 
Reflections collected / unique     16690 / 7085 [R(I)int = 0.0702] 
Completeness to  q = 24.10         98 % 
Absorption correction                none 
Refinement method                    Full-matrix least-squares on F2 
Data / restraints / parameters     7085 / 2 / 333 
Goodness-of-fit on F2             0.940 
Final R indices [It > 2.0 s(I)]          R1 = 0.0569 , wR2 = 0.0796 
Absolute structure parameter       0.4(12) 
Largest diff. peak and hole  (eA-3)      0.262 and -0.220  
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3a-Methoxy-6,9-dioxatricyclo[3.3.1.02,4]nonan-2a-ol 105 
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Data collection and handling:  
 
Empirical formula C8H12O4 
Molecular weight (gmol-1) 172.18 
Crystal system Orthorhombic 
Space group P b c a (No.61)    
Crystal colourless plate || (010) 
Size (mm) 0.70 x 0.25 x 0.07 
a, b, c (? ) 10.402(2)   11.121(2)   13.855(4) 
a, ß, ? (degree) 90.00   90.00   90.00 
Volume, V (? 3) 1602.8(6) 
Z 8 
dcalcd. (gcm-3) 1.427 
F(000) (e) 736 
Absorption coefficient µ (cm-1) 0.115 
Diffractometer Stoe IPDS area detector  
T (K) 300 (2) 
Wavelength, Mo Ka  radiation (? ) 0.71073 
Theta range for data collection    qmin = 2.94, qmax = 26.07    
Index ranges                       -12 = h = 12,   -13 = k = 13,   -17 = l = 17 
Reflections collected / unique     21120 / 1570 [R(I)int = 0.0685] 
Completeness to  q = 26.07         100 % 
Absorption correction                none 
Refinement method                    Full-matrix least-squares on F2 
Data / restraints / parameters     1570 / 0 / 114 
Goodness-of-fit on F2             1.043 
Final R indices [It > 2.0 s(I)]          R1 = 0.0320 , wR2 = 0.0707 
R indices (all data)               R1 = 0.0628 , wR2 = 0.0657 
Extinction coefficient             0.0037(8) 
Largest diff. peak and hole (eA-3)      0.130 and -0.142  
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3a-Methoxy-2,7-dioxatricyclo[4.2.1.03,8]nonan-6ß-ol 108 
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Data collection and handling: 
 
Empirical formula C8H12O4 
Molecular weight (gmol-1) 172.18 
Crystal system Orthorhombic 
Space group P c a 21 (No.29)     
Crystal colourless  prism || [010] 
Size (mm) 0.38 x 0.89 x 0.48    
a, b, c (? ) 15.746(3)   5.902(1)   8.439(2) 
a, ß, ? (degree) 90.00   90.00   90.00 
Volume, V (? 3) 784.3(3) 
Z 4 
dcalcd. (gcm-3) 1.458 
F(000) (e) 368 
Absorption coefficient µ (cm-1) 0.117 
Diffractometer Stoe IPDS area detector  
T (K) 300 (2) 
Wavelength, Mo Ka  radiation (? ) 0.71073 
Theta range for data collection    qmin = 2.59, qmax = 25.96    
Index ranges                       -19 = h = 19,   -7 = k =7,   -10 = l = 10 
Reflections collected / unique     10261 / 1494 [R(I)int = 0.0326] 
Completeness to  q = 25.96         97.3 % 
Absorption correction, Extinction correction              none, none 
Refinement method                    Full-matrix least-squares on F2 
Data / restraints / parameters     1491 / 1 / 114 
Goodness-of-fit on F2             1.166 
Final R indices [It > 2.0 s(I)]          R1 = 0.0265 , wR2 = 0.0717 
R indices (all data)               R1 = 0.0278 , wR2 = 0.0721 
Extinction coefficient             0.012(9) 
Absolute structure parameter       0.0(9) 
Largest diff. peak and hole (eA-3)      0.146 and -0.140  
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3a-Methoxy-2,4,7-trioxa-tricyclo[4.2.2.03,8]octan-6-one 115 
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Data collection and handling:  
 
Empirical formula C8 H10 O5 
Molecular weight (gmol-1) 186.16 
Crystal system Monoclinic  
Space group P 21/n 
Size (mm) 0.37 x 0.30 x 0.18  
a, b, c (? ) 6.511(1) 8.283(2) 15.196(3) 
a, ß, ? (degree) 90.00   100.00   90.00 
Volume, V (? 3) 807.1(3) 
Z 4 
dcalcd. (gcm-3) 1.532 
F(000) (e) 392 
Absorption coefficient µ (cm-1) 0.129 
Diffractometer Stoe IPDS area detector  
T (K) 300 (2) 
Wavelength, Mo Ka  radiation (? ) 0.71073 
Theta range for data collection    qmin = 2.72, qmax = 26.05    
Index ranges                       -7 = h = 8,   -10 = k = 10,   -18 = l = 18 
Reflections collected / unique     11034 / 1569 [R(I)int = 0.0408] 
Completeness to  q = 26.05         99.9 % 
Absorption correction                none, none 
Refinement method                    Full-matrix least-squares on F2 
Data / restraints / parameters     1569 / 0 / 119 
Goodness-of-fit on F2             1.199 
Final R indices [It > 2.0 s(I)]          R1 = 0.0313 , wR2 = 0.0670 
R indices (all data)               R1 = 0.0477 , wR2 = 0.0690 
Minimal and maximal residual electron density 
(eA-3)      
0.006(3) 
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3a-Ethoxy-2,7-dioxatricyclo[4.2.1.03,8]nonan-6ß-ol 109 
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Data collection and handling:  
 
Empirical formula C9H14O4 
Molecular weight (gmol-1) 186.20 
Crystal system Orthorhombic 
Space group P 21  
Size (mm) 0.52 x 0.09 x 0.01 
a, b, c (? ) 5.988 (2)   9.327 (4)   15.752 (2) 
a, ß, ? (degree) 90.00   90.00   90.00 
Volume, V (? 3) 879.8(6) 
Z 4 
dcalcd. (gcm-3) 1.406 
F(000) (e) 400 
Absorption coefficient µ (cm-1) 0.110 
Diffractometer Stoe IPDS area detector  
T (K) 300 (2) 
Wavelength, Mo Ka  radiation (? ) 0.71073 
Theta range for data collection    qmin = 2.54, qmax = 26.06    
Index ranges                       -7 = h = 7,   -11 = k = 11,   -19 = l = 19 
Reflections collected / unique     12581 / 1736 [R(I)int = 0. 1256] 
Completeness to  q = 26.06         100% 
Absorption correction                none 
Decay correction yes (32%) 
Refinement method                    Full-matrix least-squares on F2 
Data / restraints / parameters     1736 / 2 / 77 
Goodness-of-fit on F2             1.017 
Final R indices [It > 2.0 s(I)]          R1 = 0.0501 , wR2 = 0.0619 
R indices (all data)               R1 = 0.1195 , wR2 = 0.0691 
Minimal and maximal residual electron density 
(eA-3)      
0.277 and -0.243  
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1,5-dimethyl-2a-Benzyloxy-6ß-hydroxy-2-oxa-3-aza-(N-tert-butyloxycarbonyl)-
tricyclo[3.3.1.03,7]nonane 142 
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Data collection and handling:  
 
Empirical formula C21H29NO5 
Molecular weight (gmol-1) 375.45 
Crystal system monoclinic 
Space group P 21/c 
Size (mm) 0.56 x 0.41 x 0.26 
a, b, c (? ) 12.579 (4)   8.094 (2)   20.794 (5) 
a, ß, ? (degree) 90.00   96.10(3)   90.00 
Volume, V (? 3) 2105.1(10) 
Z 4 
dcalcd. (gcm-3) 1.185 
F(000) (e) 808 
Absorption coefficient µ (cm-1) 0.084 
Diffractometer Stoe IPDS area detector  
T (K) 300 (2) 
Wavelength, Mo Ka  radiation (? ) 0.71073 
Theta range for data collection    qmin = 1.97, qmax = 24.15    
Index ranges                       -14 = h = 14,   -9 = k = 9,   -23 = l = 23 
Reflections collected / unique     23765 / 3313 [R(I)int = 0. 0908] 
Completeness to  q = 24.3       98.3% 
Absorption correction                none 
Refinement method                    Full-matrix least-squares on F2 
Data / restraints / parameters     3313 / 2 / 248 
Goodness-of-fit on F2             1.118 
Final R indices [It > 2.0 s(I)]          R1 = 0.0574, wR2 = 0.0669 
R indices (all data)               R1 = 0.1147 , wR2 = 0.0703 
Minimal and maximal residual electron density 
(eA-3)      
0.279 and -0.191 
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3a-amino-(NH-tert-butyloxycarbonyl)-2a-benzyloxy-6,9-dioxatricyclo[3.3.1.02,4]nonan 
134 
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Data collection and handling:  
 
Empirical formula C19H25NO5 
Molecular weight (gmol-1) 347.40 
Crystal system Monoclinic 
Space group P 21/n 
Size (mm) 0.33 x 0.33 x 0.06 
a, b, c (? ) 11.739(3)  10.598(2)  14.867(4) 
a, ß, ? (degree) 90.00   96.38(3)   90.00 
Volume, V (? 3) 1838.1(8) 
Z 4 
dcalcd. (gcm-3) 1.255 
F(000) (e) 744 
Absorption coefficient µ (cm-1) 0.091 
Diffractometer Stoe IPDS area detector  
T (K) 300 (2) 
Wavelength, Mo Ka  radiation (? ) 0.71073 
Theta range for data collection    qmin = 2.10, qmax = 25.98    
Index ranges                       -14 = h = 14,   -13 = k = 13,   -18 = l = 18 
Reflections collected / unique     25528 / 3439 [R(I)int = 0. 0990] 
Completeness to  q = 26         96% 
Absorption correction                none 
Refinement method                    Full-matrix least-squares on F2 
Data / restraints / parameters     3439/ 0 / 230 
Goodness-of-fit on F2             1.046 
Final R indices [It > 2.0 s(I)]          R1 = 0. 0403, wR2 = 0. 0475 
R indices (all data)               R1 = 0. 1144, wR2 = 0. 0511 
Minimal and maximal residual electron 
density (eA-3)      
0. 167 and -0.162 
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2a-Benzyloxy-6-oxo-2-oxa-3-aza-(N-tert-butyloxycarbonyl)tricyclo[3.3.1.03,7]nonane 148 
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Data collection and handling:  
 
Empirical formula C19H23NO5 
Molecular weight (gmol-1) 345.38 
Crystal system Orthorhombic 
Space group I a (No.9) 
Size (mm) 0.2 x 0.1 x 0.03 
a, b, c (? ) 29.615(8) 6.615(2) 18.645(6) 
a, ß, ? (degree) 90.00   90.00   90.00 
Volume, V (? 3) 3653 (2) 
Z 8 
dcalcd. (gcm-3) 1.256 
F(000) (e) 1472 
Absorption coefficient µ (cm-1) 0.091 
Diffractometer Stoe IPDS area detector  
T (K) 250 (2) 
Wavelength, Mo Ka  radiation (? ) 0.71073 
Theta range for data collection    qmin = 2.18, qmax = 26.26    
Index ranges                       -36 = h = 36,   -7 = k = 7,   -23 = l = 23 
Reflections collected / unique     48090 / 7083 [R(I)int = 0. 2740] 
Completeness to  q = 26.3      97.9% 
Absorption correction                none 
Refinement method                    Full-matrix least-squares on F2 
Data / restraints / parameters     7083 / 9 / 261 
Goodness-of-fit on F2             0.784 
Final R indices [It > 2.0 s(I)]          R1 = 0.0751 , wR2 = 0.0985 
R indices (all data)               R1 = 0.2731, wR2 = 0. 1272 
Absolute structure parameter       0.00 
Minimal and maximal residual electron density 
(eA-3)      
0.376 and -0.336  
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2a-Benzyloxy-6-oxo-2-oxa-3-aza-(N-tert-butyloxycarbonyl)tricyclo[3.3.1.03,7]nonane 148 
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Data collection and handling:  
 
Empirical formula C19H23NO5 
Molecular weight (gmol-1) 345.38 
Crystal system Orthorhombic 
Space group I a (No.9) 
Size (mm) 0.2 x 0.1 x 0.03 
a, b, c (? ) 29.615(8) 6.615(2) 18.645(6) 
a, ß, ? (degree) 90.00   90.00   90.00 
Volume, V (? 3) 3653 (2) 
Z 8 
dcalcd. (gcm-3) 1.256 
F(000) (e) 1472 
Absorption coefficient µ (cm-1) 0.091 
Diffractometer Stoe IPDS area detector  
T (K) 250 (2) 
Wavelength, Mo Ka  radiation (? ) 0.71073 
Theta range for data collection    qmin = 2.18, qmax = 26.26    
Index ranges                       -36 = h = 36,   -7 = k = 7,   -23 = l = 23 
Reflections collected / unique     48090 / 7083 [R(I)int = 0. 2740] 
Completeness to  q = 26.3      97.9% 
Absorption correction                none 
Refinement method                    Full-matrix least-squares on F2 
Data / restraints / parameters     7083 / 9 / 261 
Goodness-of-fit on F2             0.784 
Final R indices [It > 2.0 s(I)]          R1 = 0.0751 , wR2 = 0.0985 
R indices (all data)               R1 = 0.2731, wR2 = 0. 1272 
Absolute structure parameter       0.00 
Minimal and maximal residual electron density 
(eA-3)      
0. 376 and -0.336 
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